{
  "@context": "https://schema.org",
  "@type": "DataCatalogItem",
  "name": "Interface 2G0H_1",
  "description": "Protein-protein interaction interface between chains nan and nan",
  "identifier": "2G0H_1",
  "mainEntity": {
    "@context": "https://schema.org",
    "@type": "Protein",
    "@id": "#protein_2G0H",
    "dct:conformsTo": "https://bioschemas.org/profiles/Protein/0.11-RELEASE",
    "identifier": "2G0H",
    "name": "Protein 2G0H",
    "description": "Protein structure with PDB ID: 2G0H. Part of the ELIXIR 3D-BioInfo benchmark dataset. This protein participates in interface 2G0H_1 as a homodimer.",
    "url": "https://www.rcsb.org/structure/2G0H",
    "taxonomicRange": {
      "@type": "DefinedTerm",
      "name": "Homo sapiens",
      "inDefinedTermSet": "https://www.ncbi.nlm.nih.gov/taxonomy",
      "description": "Organism taxonomy information from PDB metadata",
      "termCode": "9606",
      "url": "https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=9606",
      "identifier": "taxonomy:9606"
    },
    "alternateName": [
      "PDB 2G0H",
      "Protein ID 2G0H"
    ],
    "hasRepresentation": [
      {
        "@type": "PropertyValue",
        "name": "PDB Structure",
        "value": "https://raw.githubusercontent.com/biofold/ppi-benchmark-fair/main/data/benchmark_pdb_format/2g0h_1.pdb.gz",
        "description": "Compressed PDB format structure file"
      },
      {
        "@type": "PropertyValue",
        "name": "mmCIF Structure",
        "value": "https://raw.githubusercontent.com/biofold/ppi-benchmark-fair/main/data/benchmark_mmcif_format/2g0h.cif.gz",
        "description": "Compressed mmCIF format structure file"
      },
      {
        "@type": "PropertyValue",
        "name": "PDB ID",
        "value": "2G0H",
        "description": "RCSB PDB identifier"
      }
    ],
    "additionalProperty": [
      {
        "@type": "PropertyValue",
        "name": "PDB_ID",
        "value": "2G0H",
        "description": "Protein Data Bank identifier (4 letters)"
      },
      {
        "@type": "PropertyValue",
        "name": "AssociatedInterface",
        "value": "2G0H_1",
        "description": "Interface this protein participates in"
      },
      {
        "@type": "PropertyValue",
        "name": "InterfaceSource",
        "value": "QSalign",
        "description": "Source of interface ID: QSalign"
      },
      {
        "@type": "PropertyValue",
        "name": "InterfaceChains",
        "value": "nan-nan",
        "description": "Chains involved in the interface"
      },
      {
        "@type": "PropertyValue",
        "name": "InterfaceClassification",
        "value": "Non-physiological",
        "description": "Classification of the associated interface"
      },
      {
        "@type": "PropertyValue",
        "name": "LabelInterfaceChains",
        "value": "A-B",
        "description": "Chains involved in the assembly interface"
      },
      {
        "@type": "PropertyValue",
        "name": "Gene",
        "value": "PPARG",
        "description": "Gene name associated with the protein"
      },
      {
        "@type": "PropertyValue",
        "name": "Superfamily",
        "value": "1.10.565.10",
        "description": "Protein superfamily classification"
      },
      {
        "@type": "PropertyValue",
        "name": "Pfam",
        "value": "PF00104",
        "description": "Pfam domain classification"
      },
      {
        "@type": "PropertyValue",
        "name": "PDBStructureMetadata",
        "description": "Structural metadata from RCSB Protein Data Bank",
        "value": "{\"pdb_id\": \"2G0H\", \"structure_metadata\": {\"pdb_id\": \"2G0H\", \"resolution\": 2.3, \"deposition_date\": \"2006-02-13T00:00:00+0000\", \"release_date\": \"2006-05-16T00:00:00+0000\", \"experimental_method\": null, \"source_organism\": [\"Homo sapiens\"], \"citation\": {\"title\": \"Structure-Based Drug Design of a Novel Family of PPARgamma Partial Agonists: Virtual Screening, X-ray Crystallography, and in Vitro/in Vivo Biological Activities\", \"doi\": \"10.1021/jm051129s\", \"authors\": [\"Lu, I.L.\", \"Huang, C.F.\", \"Peng, Y.H.\", \"Lin, Y.T.\", \"Hsieh, H.P.\", \"Chen, C.T.\", \"Lien, T.W.\", \"Lee, H.J.\", \"Mahindroo, N.\", \"Prakash, E.\", \"Yueh, A.\", \"Chen, H.Y.\", \"Goparaju, C.M.\", \"Chen, X.\", \"Liao, C.C.\", \"Chao, Y.S.\", \"Hsu, J.T.\", \"Wu, S.Y.\"]}, \"entity_count\": 3, \"r_factor\": null, \"space_group\": null, \"unit_cell\": {\"a\": 56.301, \"b\": 88.897, \"c\": 58.451, \"alpha\": 90.0, \"beta\": 90.8, \"gamma\": 90.0}, \"found_in_api\": true, \"obsolete\": false, \"replaced_by\": null, \"sequences\": {\"A\": \"ESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY\", \"B\": \"ESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY\"}, \"chain_info\": {\"A\": {\"entity_id\": \"1\", \"organism\": \"Homo sapiens\", \"sequence_length\": 271, \"polymer_type\": \"polypeptide(L)\", \"gene_name\": null}, \"B\": {\"entity_id\": \"1\", \"organism\": \"Homo sapiens\", \"sequence_length\": 271, \"polymer_type\": \"polypeptide(L)\", \"gene_name\": null}}, \"entity_info\": {\"1\": {\"entity_id\": \"1\", \"sequence\": \"ESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY\", \"organism\": \"Homo sapiens\", \"taxonomy_id\": 9606, \"chain_ids\": [\"A\", \"B\"], \"polymer_type\": \"polypeptide(L)\", \"sequence_length\": 271, \"gene_name\": null, \"uniprot_ids\": [\"P37231\"]}}, \"is_homomer\": true, \"sequence_clusters\": [{\"sequence\": \"ESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY\", \"entities\": [\"1\"], \"chain_count\": 2}], \"chain_ids\": [], \"entity_ids\": [\"1\", \"2\", \"3\"], \"polymer_composition\": \"homomeric protein\", \"homomer_type\": \"monomer\", \"homomer_chains\": 2, \"chain_count\": 2, \"unique_sequences\": 1, \"avg_sequence_length\": 271.0, \"min_sequence_length\": 271, \"max_sequence_length\": 271}, \"entity_metadata\": {\"1\": {\"entity_poly\": {\"nstd_linkage\": \"no\", \"nstd_monomer\": \"no\", \"pdbx_seq_one_letter_code\": \"ESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY\", \"pdbx_seq_one_letter_code_can\": \"ESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY\", \"pdbx_strand_id\": \"A,B\", \"rcsb_artifact_monomer_count\": 0, \"rcsb_conflict_count\": 0, \"rcsb_deletion_count\": 0, \"rcsb_entity_polymer_type\": \"Protein\", \"rcsb_insertion_count\": 0, \"rcsb_mutation_count\": 0, \"rcsb_non_std_monomer_count\": 0, \"rcsb_sample_sequence_length\": 271, \"type\": \"polypeptide(L)\"}, \"entity_src_gen\": [{\"gene_src_common_name\": \"human\", \"gene_src_genus\": \"Homo\", \"host_org_genus\": \"Escherichia\", \"host_org_species\": \"Escherichia coli\", \"pdbx_alt_source_flag\": \"sample\", \"pdbx_gene_src_gene\": \"PPARG, NR1C3\", \"pdbx_gene_src_ncbi_taxonomy_id\": \"9606\", \"pdbx_gene_src_scientific_name\": \"Homo sapiens\", \"pdbx_host_org_ncbi_taxonomy_id\": \"469008\", \"pdbx_host_org_scientific_name\": \"Escherichia coli BL21(DE3)\", \"pdbx_host_org_strain\": \"BL21(DE3)\", \"pdbx_host_org_vector_type\": \"plasmid\", \"pdbx_src_id\": 1, \"plasmid_name\": \"pGEX6P-1\"}], \"rcsb_cluster_flexibility\": {\"avg_rmsd\": 1.688, \"label\": \"Low\", \"link\": \"http://pdbflex.org/cluster.html#!/6ijrC/35670/2g0hA\", \"max_rmsd\": 5.828, \"provenance_code\": \"PDBFlex\"}, \"rcsb_cluster_membership\": [{\"cluster_id\": 113, \"identity\": 100}, {\"cluster_id\": 107, \"identity\": 95}, {\"cluster_id\": 117, \"identity\": 90}, {\"cluster_id\": 165, \"identity\": 70}, {\"cluster_id\": 266, \"identity\": 50}, {\"cluster_id\": 378, \"identity\": 30}], \"rcsb_entity_host_organism\": [{\"ncbi_common_names\": [\"Escherichia coli str. BL21(DE3)\", \"Escherichia coli strain BL21(DE3)\"], \"ncbi_parent_scientific_name\": \"Bacteria\", \"ncbi_scientific_name\": \"Escherichia coli BL21(DE3)\", \"ncbi_taxonomy_id\": 469008, \"pdbx_src_id\": 1, \"provenance_source\": \"Primary Data\", \"scientific_name\": \"Escherichia coli BL21(DE3)\", \"taxonomy_lineage\": [{\"depth\": 1, \"id\": \"131567\", \"name\": \"cellular organisms\"}, {\"depth\": 1, \"id\": \"131567\", \"name\": \"biota\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"Bacteria\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"Bacteria (ex Cavalier-Smith 1987)\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"Bacteria Woese et al. 2024\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"Bacteriobiota\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"bacteria\"}, {\"depth\": 2, \"id\": \"2\", \"name\": \"eubacteria\"}, {\"depth\": 3, \"id\": \"3379134\", \"name\": \"Pseudomonadati\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"Pseudomonadota\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"\\\"Alphaproteobacteriota\\\" Whitman et al. 2018\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"Alphaproteobacteriota\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"Proteobacteria\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"Proteobacteriota\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"proteobacteria\"}, {\"depth\": 4, \"id\": \"1224\", \"name\": \"purple photosynthetic bacteria and relatives\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"Gammaproteobacteria\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"Proteobacteria gamma subdivision\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"Pseudomonadia\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"Purple bacteria, gamma subdivision\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"g-proteobacteria\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"gamma proteobacteria\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"gamma subdivision\"}, {\"depth\": 5, \"id\": \"1236\", \"name\": \"gamma subgroup\"}, {\"depth\": 6, \"id\": \"91347\", \"name\": \"Enterobacterales\"}, {\"depth\": 6, \"id\": \"91347\", \"name\": \"Enterobacteriaceae and related endosymbionts\"}, {\"depth\": 6, \"id\": \"91347\", \"name\": \"Enterobacteriaceae group\"}, {\"depth\": 6, \"id\": \"91347\", \"name\": \"Enterobacteriales\"}, {\"depth\": 7, \"id\": \"543\", \"name\": \"Enterobacteriaceae\"}, {\"depth\": 7, \"id\": \"543\", \"name\": \"Enterobacteraceae\"}, {\"depth\": 7, \"id\": \"543\", \"name\": \"enterobacteria\"}, {\"depth\": 8, \"id\": \"561\", \"name\": \"Escherichia\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Escherichia coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Bacillus coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Bacterium coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Bacterium coli commune\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"E. coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Enterococcus coli\"}, {\"depth\": 9, \"id\": \"562\", \"name\": \"Escherichia/Shigella coli\"}, {\"depth\": 10, \"id\": \"469008\", \"name\": \"Escherichia coli BL21(DE3)\"}, {\"depth\": 10, \"id\": \"469008\", \"name\": \"Escherichia coli str. BL21(DE3)\"}, {\"depth\": 10, \"id\": \"469008\", \"name\": \"Escherichia coli strain BL21(DE3)\"}]}], \"rcsb_entity_source_organism\": [{\"common_name\": \"human\", \"ncbi_common_names\": [\"human\"], \"ncbi_parent_scientific_name\": \"Eukaryota\", \"ncbi_scientific_name\": \"Homo sapiens\", \"ncbi_taxonomy_id\": 9606, \"pdbx_src_id\": 1, \"provenance_source\": \"Primary Data\", \"scientific_name\": \"Homo sapiens\", \"source_type\": \"genetically engineered\", \"taxonomy_lineage\": [{\"depth\": 1, \"id\": \"131567\", \"name\": \"cellular organisms\"}, {\"depth\": 1, \"id\": \"131567\", \"name\": \"biota\"}, {\"depth\": 2, \"id\": \"2759\", \"name\": \"Eukaryota\"}, {\"depth\": 2, \"id\": \"2759\", \"name\": \"Eucarya\"}, {\"depth\": 2, \"id\": \"2759\", \"name\": \"Eucaryotae\"}, {\"depth\": 2, \"id\": \"2759\", \"name\": \"Eukarya\"}, {\"depth\": 2, \"id\": \"2759\", \"name\": \"Eukaryotae\"}, {\"depth\": 2, \"id\": \"2759\", \"name\": \"eukaryotes\"}, {\"depth\": 3, \"id\": \"33154\", \"name\": \"Opisthokonta\"}, {\"depth\": 3, \"id\": \"33154\", \"name\": \"Fungi/Metazoa group\"}, {\"depth\": 3, \"id\": \"33154\", \"name\": \"opisthokonts\"}, {\"depth\": 4, \"id\": \"33208\", \"name\": \"Metazoa\"}, {\"depth\": 4, \"id\": \"33208\", \"name\": \"Animalia\"}, {\"depth\": 4, \"id\": \"33208\", \"name\": \"animals\"}, {\"depth\": 4, \"id\": \"33208\", \"name\": \"metazoans\"}, {\"depth\": 4, \"id\": \"33208\", \"name\": \"multicellular animals\"}, {\"depth\": 5, \"id\": \"6072\", \"name\": \"Eumetazoa\"}, {\"depth\": 6, \"id\": \"33213\", \"name\": \"Bilateria\"}, {\"depth\": 7, \"id\": \"33511\", \"name\": \"Deuterostomia\"}, {\"depth\": 7, \"id\": \"33511\", \"name\": \"deuterostomes\"}, {\"depth\": 8, \"id\": \"7711\", \"name\": \"Chordata\"}, {\"depth\": 8, \"id\": \"7711\", \"name\": \"chordates\"}, {\"depth\": 9, \"id\": \"89593\", \"name\": \"Craniata\"}, {\"depth\": 10, \"id\": \"7742\", \"name\": \"Vertebrata\"}, {\"depth\": 10, \"id\": \"7742\", \"name\": \"vertebrates\"}, {\"depth\": 11, \"id\": \"7776\", \"name\": \"Gnathostomata\"}, {\"depth\": 11, \"id\": \"7776\", \"name\": \"jawed vertebrates\"}, {\"depth\": 12, \"id\": \"117570\", \"name\": \"Teleostomi\"}, {\"depth\": 13, \"id\": \"117571\", \"name\": \"Euteleostomi\"}, {\"depth\": 13, \"id\": \"117571\", \"name\": \"bony vertebrates\"}, {\"depth\": 14, \"id\": \"8287\", \"name\": \"Sarcopterygii\"}, {\"depth\": 15, \"id\": \"1338369\", \"name\": \"Dipnotetrapodomorpha\"}, {\"depth\": 16, \"id\": \"32523\", \"name\": \"Tetrapoda\"}, {\"depth\": 16, \"id\": \"32523\", \"name\": \"tetrapods\"}, {\"depth\": 17, \"id\": \"32524\", \"name\": \"Amniota\"}, {\"depth\": 17, \"id\": \"32524\", \"name\": \"amniotes\"}, {\"depth\": 18, \"id\": \"40674\", \"name\": \"Mammalia\"}, {\"depth\": 18, \"id\": \"40674\", \"name\": \"mammals\"}, {\"depth\": 19, \"id\": \"32525\", \"name\": \"Theria\"}, {\"depth\": 20, \"id\": \"9347\", \"name\": \"Eutheria\"}, {\"depth\": 20, \"id\": \"9347\", \"name\": \"Placentalia\"}, {\"depth\": 20, \"id\": \"9347\", \"name\": \"eutherian mammals\"}, {\"depth\": 20, \"id\": \"9347\", \"name\": \"placental mammals\"}, {\"depth\": 20, \"id\": \"9347\", \"name\": \"placentals\"}, {\"depth\": 21, \"id\": \"1437010\", \"name\": \"Boreoeutheria\"}, {\"depth\": 21, \"id\": \"1437010\", \"name\": \"Boreotheria\"}, {\"depth\": 22, \"id\": \"314146\", \"name\": \"Euarchontoglires\"}, {\"depth\": 23, \"id\": \"9443\", \"name\": \"Primates\"}, {\"depth\": 23, \"id\": \"9443\", \"name\": \"Primata\"}, {\"depth\": 23, \"id\": \"9443\", \"name\": \"primate\"}, {\"depth\": 23, \"id\": \"9443\", \"name\": \"primates\"}, {\"depth\": 24, \"id\": \"376913\", \"name\": \"Haplorrhini\"}, {\"depth\": 25, \"id\": \"314293\", \"name\": \"Simiiformes\"}, {\"depth\": 25, \"id\": \"314293\", \"name\": \"Anthropoidea\"}, {\"depth\": 26, \"id\": \"9526\", \"name\": \"Catarrhini\"}, {\"depth\": 27, \"id\": \"314295\", \"name\": \"Hominoidea\"}, {\"depth\": 27, \"id\": \"314295\", \"name\": \"ape\"}, {\"depth\": 27, \"id\": \"314295\", \"name\": \"apes\"}, {\"depth\": 28, \"id\": \"9604\", \"name\": \"Hominidae\"}, {\"depth\": 28, \"id\": \"9604\", \"name\": \"Pongidae\"}, {\"depth\": 28, \"id\": \"9604\", \"name\": \"great apes\"}, {\"depth\": 29, \"id\": \"207598\", \"name\": \"Homininae\"}, {\"depth\": 29, \"id\": \"207598\", \"name\": \"Homo/Pan/Gorilla group\"}, {\"depth\": 30, \"id\": \"9605\", \"name\": \"Homo\"}, {\"depth\": 30, \"id\": \"9605\", \"name\": \"humans\"}, {\"depth\": 31, \"id\": \"9606\", \"name\": \"Homo sapiens\"}, {\"depth\": 31, \"id\": \"9606\", \"name\": \"human\"}], \"rcsb_gene_name\": [{\"provenance_source\": \"Primary Data\", \"value\": \"PPARG\"}, {\"provenance_source\": \"Primary Data\", \"value\": \"NR1C3\"}]}], \"rcsb_genomic_lineage\": [{\"depth\": 1, \"id\": \"9606:3\", \"name\": \"Chromosome 3\"}, {\"depth\": 0, \"id\": \"9606\", \"name\": \"Homo sapiens\"}, {\"depth\": 2, \"id\": \"9606:3:peroxisome_proliferator_activated_receptor_gamma\", \"name\": \"peroxisome proliferator activated receptor gamma\"}], \"rcsb_polymer_entity\": {\"formula_weight\": 30.997, \"pdbx_description\": \"Peroxisome proliferator-activated receptor gamma\", \"pdbx_fragment\": \"Ligand binding domain(residues 207-477)\", \"pdbx_number_of_molecules\": 2, \"rcsb_multiple_source_flag\": \"N\", \"rcsb_source_part_count\": 1, \"rcsb_source_taxonomy_count\": 1, \"src_method\": \"man\", \"rcsb_macromolecular_names_combined\": [{\"name\": \"Peroxisome proliferator-activated receptor gamma\", \"provenance_code\": \"ECO:0000304\", \"provenance_source\": \"PDB Preferred Name\"}, {\"name\": \"PPAR-gamma\", \"provenance_code\": \"ECO:0000303\", \"provenance_source\": \"PDB Synonym\"}], \"rcsb_polymer_name_combined\": {\"names\": [\"Peroxisome proliferator-activated receptor gamma\"], \"provenance_source\": \"UniProt Name\"}}, \"rcsb_polymer_entity_align\": [{\"provenance_source\": \"SIFTS\", \"reference_database_accession\": \"P37231\", \"reference_database_name\": \"UniProt\", \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 271, \"ref_beg_seq_id\": 235}]}], \"rcsb_polymer_entity_annotation\": [{\"annotation_id\": \"PF00104\", \"assignment_version\": \"34.0\", \"name\": \"Ligand-binding domain of nuclear hormone receptor (Hormone_recep)\", \"provenance_source\": \"Pfam\", \"type\": \"Pfam\"}, {\"annotation_id\": \"GO:0010875\", \"name\": \"positive regulation of cholesterol efflux\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0010875\", \"name\": \"positive regulation of cholesterol efflux\"}, {\"id\": \"GO:0032879\", \"name\": \"regulation of localization\"}, {\"id\": \"GO:0006810\", \"name\": \"transport\"}, {\"id\": \"GO:0032373\", \"name\": \"positive regulation of sterol transport\"}, {\"id\": \"GO:0048518\", \"name\": \"positive regulation of biological process\"}, {\"id\": \"GO:0032368\", \"name\": \"regulation of lipid transport\"}, {\"id\": \"GO:0015850\", \"name\": \"organic hydroxy compound transport\"}, {\"id\": \"GO:0051179\", \"name\": \"localization\"}, {\"id\": \"GO:0010874\", \"name\": \"regulation of cholesterol efflux\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0015918\", \"name\": \"sterol transport\"}, {\"id\": \"GO:0032374\", \"name\": \"regulation of cholesterol transport\"}, {\"id\": \"GO:0032376\", \"name\": \"positive regulation of cholesterol transport\"}, {\"id\": \"GO:0032371\", \"name\": \"regulation of sterol transport\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0051049\", \"name\": \"regulation of transport\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0010876\", \"name\": \"lipid localization\"}, {\"id\": \"GO:0006869\", \"name\": \"lipid transport\"}, {\"id\": \"GO:1905954\", \"name\": \"positive regulation of lipid localization\"}, {\"id\": \"GO:0051234\", \"name\": \"establishment of localization\"}, {\"id\": \"GO:0032370\", \"name\": \"positive regulation of lipid transport\"}, {\"id\": \"GO:0051050\", \"name\": \"positive regulation of transport\"}, {\"id\": \"GO:1905952\", \"name\": \"regulation of lipid localization\"}, {\"id\": \"GO:0033036\", \"name\": \"macromolecule localization\"}, {\"id\": \"GO:0030301\", \"name\": \"cholesterol transport\"}, {\"id\": \"GO:0033344\", \"name\": \"cholesterol efflux\"}]}, {\"annotation_id\": \"GO:0003676\", \"name\": \"nucleic acid binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003676\", \"name\": \"nucleic acid binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:2001235\", \"name\": \"positive regulation of apoptotic signaling pathway\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0051716\", \"name\": \"cellular response to stimulus\"}, {\"id\": \"GO:0010647\", \"name\": \"positive regulation of cell communication\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0009967\", \"name\": \"positive regulation of signal transduction\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0023052\", \"name\": \"signaling\"}, {\"id\": \"GO:0048518\", \"name\": \"positive regulation of biological process\"}, {\"id\": \"GO:0009966\", \"name\": \"regulation of signal transduction\"}, {\"id\": \"GO:0043067\", \"name\": \"regulation of programmed cell death\"}, {\"id\": \"GO:2001235\", \"name\": \"positive regulation of apoptotic signaling pathway\"}, {\"id\": \"GO:0007154\", \"name\": \"cell communication\"}, {\"id\": \"GO:0048584\", \"name\": \"positive regulation of response to stimulus\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0007165\", \"name\": \"signal transduction\"}, {\"id\": \"GO:0048522\", \"name\": \"positive regulation of cellular process\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0023051\", \"name\": \"regulation of signaling\"}, {\"id\": \"GO:0043068\", \"name\": \"positive regulation of programmed cell death\"}, {\"id\": \"GO:0042981\", \"name\": \"regulation of apoptotic process\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0008219\", \"name\": \"cell death\"}, {\"id\": \"GO:0043065\", \"name\": \"positive regulation of apoptotic process\"}, {\"id\": \"GO:0097190\", \"name\": \"apoptotic signaling pathway\"}, {\"id\": \"GO:0048583\", \"name\": \"regulation of response to stimulus\"}, {\"id\": \"GO:0010646\", \"name\": \"regulation of cell communication\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0006915\", \"name\": \"apoptotic process\"}, {\"id\": \"GO:0012501\", \"name\": \"programmed cell death\"}, {\"id\": \"GO:0023056\", \"name\": \"positive regulation of signaling\"}, {\"id\": \"GO:2001233\", \"name\": \"regulation of apoptotic signaling pathway\"}]}, {\"annotation_id\": \"IPR001628\", \"name\": \"Zinc finger, nuclear hormone receptor-type\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 1, \"id\": \"IPR001628\", \"name\": \"Zinc finger, nuclear hormone receptor-type\"}]}, {\"annotation_id\": \"GO:0050699\", \"name\": \"WW domain binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0005515\", \"name\": \"protein binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0050699\", \"name\": \"WW domain binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0019904\", \"name\": \"protein domain specific binding\"}]}, {\"annotation_id\": \"GO:0015909\", \"name\": \"long-chain fatty acid transport\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0015711\", \"name\": \"organic anion transport\"}, {\"id\": \"GO:0046942\", \"name\": \"carboxylic acid transport\"}, {\"id\": \"GO:0006810\", \"name\": \"transport\"}, {\"id\": \"GO:0010876\", \"name\": \"lipid localization\"}, {\"id\": \"GO:0006869\", \"name\": \"lipid transport\"}, {\"id\": \"GO:0051234\", \"name\": \"establishment of localization\"}, {\"id\": \"GO:0015849\", \"name\": \"organic acid transport\"}, {\"id\": \"GO:0051179\", \"name\": \"localization\"}, {\"id\": \"GO:0015718\", \"name\": \"monocarboxylic acid transport\"}, {\"id\": \"GO:0015908\", \"name\": \"fatty acid transport\"}, {\"id\": \"GO:0033036\", \"name\": \"macromolecule localization\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0015909\", \"name\": \"long-chain fatty acid transport\"}]}, {\"annotation_id\": \"GO:0005829\", \"name\": \"cytosol\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0110165\", \"name\": \"cellular anatomical structure\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0005622\", \"name\": \"intracellular anatomical structure\"}, {\"id\": \"GO:0005737\", \"name\": \"cytoplasm\"}, {\"id\": \"GO:0005829\", \"name\": \"cytosol\"}]}, {\"annotation_id\": \"GO:0048384\", \"name\": \"retinoic acid receptor signaling pathway\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0051716\", \"name\": \"cellular response to stimulus\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0030522\", \"name\": \"intracellular receptor signaling pathway\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0023052\", \"name\": \"signaling\"}, {\"id\": \"GO:0009719\", \"name\": \"response to endogenous stimulus\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0048384\", \"name\": \"retinoic acid receptor signaling pathway\"}, {\"id\": \"GO:0009755\", \"name\": \"hormone-mediated signaling pathway\"}, {\"id\": \"GO:0035556\", \"name\": \"intracellular signal transduction\"}, {\"id\": \"GO:0007154\", \"name\": \"cell communication\"}, {\"id\": \"GO:0071495\", \"name\": \"cellular response to endogenous stimulus\"}, {\"id\": \"GO:0070887\", \"name\": \"cellular response to chemical stimulus\"}, {\"id\": \"GO:0009725\", \"name\": \"response to hormone\"}, {\"id\": \"GO:0042221\", \"name\": \"response to chemical\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0007165\", \"name\": \"signal transduction\"}, {\"id\": \"GO:0141193\", \"name\": \"nuclear receptor-mediated signaling pathway\"}, {\"id\": \"GO:0032870\", \"name\": \"cellular response to hormone stimulus\"}]}, {\"annotation_id\": \"GO:0043565\", \"name\": \"sequence-specific DNA binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0043565\", \"name\": \"sequence-specific DNA binding\"}, {\"id\": \"GO:0003677\", \"name\": \"DNA binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003676\", \"name\": \"nucleic acid binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:1902895\", \"name\": \"positive regulation of miRNA transcription\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0045893\", \"name\": \"positive regulation of DNA-templated transcription\"}, {\"id\": \"GO:0048518\", \"name\": \"positive regulation of biological process\"}, {\"id\": \"GO:0016070\", \"name\": \"RNA metabolic process\"}, {\"id\": \"GO:1902895\", \"name\": \"positive regulation of miRNA transcription\"}, {\"id\": \"GO:2000630\", \"name\": \"positive regulation of miRNA metabolic process\"}, {\"id\": \"GO:0010557\", \"name\": \"positive regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0080090\", \"name\": \"regulation of primary metabolic process\"}, {\"id\": \"GO:0006139\", \"name\": \"nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0032774\", \"name\": \"RNA biosynthetic process\"}, {\"id\": \"GO:0006351\", \"name\": \"DNA-templated transcription\"}, {\"id\": \"GO:0141187\", \"name\": \"nucleic acid biosynthetic process\"}, {\"id\": \"GO:0009893\", \"name\": \"positive regulation of metabolic process\"}, {\"id\": \"GO:0051252\", \"name\": \"regulation of RNA metabolic process\"}, {\"id\": \"GO:0061614\", \"name\": \"miRNA transcription\"}, {\"id\": \"GO:0009891\", \"name\": \"positive regulation of biosynthetic process\"}, {\"id\": \"GO:2000628\", \"name\": \"regulation of miRNA metabolic process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0010604\", \"name\": \"positive regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0019219\", \"name\": \"regulation of nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0010586\", \"name\": \"miRNA metabolic process\"}, {\"id\": \"GO:0048522\", \"name\": \"positive regulation of cellular process\"}, {\"id\": \"GO:2001141\", \"name\": \"regulation of RNA biosynthetic process\"}, {\"id\": \"GO:0009889\", \"name\": \"regulation of biosynthetic process\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0060255\", \"name\": \"regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0034654\", \"name\": \"nucleobase-containing compound biosynthetic process\"}, {\"id\": \"GO:0010467\", \"name\": \"gene expression\"}, {\"id\": \"GO:0009059\", \"name\": \"macromolecule biosynthetic process\"}, {\"id\": \"GO:0090304\", \"name\": \"nucleic acid metabolic process\"}, {\"id\": \"GO:0051254\", \"name\": \"positive regulation of RNA metabolic process\"}, {\"id\": \"GO:0010468\", \"name\": \"regulation of gene expression\"}, {\"id\": \"GO:0009058\", \"name\": \"biosynthetic process\"}, {\"id\": \"GO:1902680\", \"name\": \"positive regulation of RNA biosynthetic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0010556\", \"name\": \"regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0043170\", \"name\": \"macromolecule metabolic process\"}, {\"id\": \"GO:0006355\", \"name\": \"regulation of DNA-templated transcription\"}, {\"id\": \"GO:0019222\", \"name\": \"regulation of metabolic process\"}, {\"id\": \"GO:1902893\", \"name\": \"regulation of miRNA transcription\"}]}, {\"annotation_id\": \"GO:0050544\", \"name\": \"arachidonate binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0050544\", \"name\": \"arachidonate binding\"}, {\"id\": \"GO:0005504\", \"name\": \"fatty acid binding\"}, {\"id\": \"GO:0050542\", \"name\": \"icosanoid binding\"}, {\"id\": \"GO:0043177\", \"name\": \"organic acid binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0036041\", \"name\": \"long-chain fatty acid binding\"}, {\"id\": \"GO:0050543\", \"name\": \"icosatetraenoic acid binding\"}, {\"id\": \"GO:0043167\", \"name\": \"ion binding\"}, {\"id\": \"GO:0043168\", \"name\": \"anion binding\"}, {\"id\": \"GO:0008289\", \"name\": \"lipid binding\"}, {\"id\": \"GO:0031406\", \"name\": \"carboxylic acid binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0036094\", \"name\": \"small molecule binding\"}, {\"id\": \"GO:0033293\", \"name\": \"monocarboxylic acid binding\"}]}, {\"annotation_id\": \"GO:0043235\", \"name\": \"receptor complex\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0032991\", \"name\": \"protein-containing complex\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0043235\", \"name\": \"receptor complex\"}]}, {\"annotation_id\": \"GO:0003677\", \"name\": \"DNA binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0003677\", \"name\": \"DNA binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003676\", \"name\": \"nucleic acid binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0060336\", \"name\": \"negative regulation of type II interferon-mediated signaling pathway\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0051716\", \"name\": \"cellular response to stimulus\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0034341\", \"name\": \"response to type II interferon\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0034097\", \"name\": \"response to cytokine\"}, {\"id\": \"GO:0009966\", \"name\": \"regulation of signal transduction\"}, {\"id\": \"GO:0060334\", \"name\": \"regulation of type II interferon-mediated signaling pathway\"}, {\"id\": \"GO:0009607\", \"name\": \"response to biotic stimulus\"}, {\"id\": \"GO:0071346\", \"name\": \"cellular response to type II interferon\"}, {\"id\": \"GO:0007154\", \"name\": \"cell communication\"}, {\"id\": \"GO:0060331\", \"name\": \"negative regulation of response to type II interferon\"}, {\"id\": \"GO:0140888\", \"name\": \"interferon-mediated signaling pathway\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0071345\", \"name\": \"cellular response to cytokine stimulus\"}, {\"id\": \"GO:0002682\", \"name\": \"regulation of immune system process\"}, {\"id\": \"GO:0007165\", \"name\": \"signal transduction\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0006955\", \"name\": \"immune response\"}, {\"id\": \"GO:0051707\", \"name\": \"response to other organism\"}, {\"id\": \"GO:0045088\", \"name\": \"regulation of innate immune response\"}, {\"id\": \"GO:0050777\", \"name\": \"negative regulation of immune response\"}, {\"id\": \"GO:0060333\", \"name\": \"type II interferon-mediated signaling pathway\"}, {\"id\": \"GO:0009605\", \"name\": \"response to external stimulus\"}, {\"id\": \"GO:0060759\", \"name\": \"regulation of response to cytokine stimulus\"}, {\"id\": \"GO:0060761\", \"name\": \"negative regulation of response to cytokine stimulus\"}, {\"id\": \"GO:0048583\", \"name\": \"regulation of response to stimulus\"}, {\"id\": \"GO:0042221\", \"name\": \"response to chemical\"}, {\"id\": \"GO:0098542\", \"name\": \"defense response to other organism\"}, {\"id\": \"GO:0032102\", \"name\": \"negative regulation of response to external stimulus\"}, {\"id\": \"GO:0031348\", \"name\": \"negative regulation of defense response\"}, {\"id\": \"GO:0050776\", \"name\": \"regulation of immune response\"}, {\"id\": \"GO:0060330\", \"name\": \"regulation of response to type II interferon\"}, {\"id\": \"GO:0031347\", \"name\": \"regulation of defense response\"}, {\"id\": \"GO:0002831\", \"name\": \"regulation of response to biotic stimulus\"}, {\"id\": \"GO:0044419\", \"name\": \"biological process involved in interspecies interaction between organisms\"}, {\"id\": \"GO:0032101\", \"name\": \"regulation of response to external stimulus\"}, {\"id\": \"GO:0002832\", \"name\": \"negative regulation of response to biotic stimulus\"}, {\"id\": \"GO:0023057\", \"name\": \"negative regulation of signaling\"}, {\"id\": \"GO:0023052\", \"name\": \"signaling\"}, {\"id\": \"GO:0010648\", \"name\": \"negative regulation of cell communication\"}, {\"id\": \"GO:0019221\", \"name\": \"cytokine-mediated signaling pathway\"}, {\"id\": \"GO:0006950\", \"name\": \"response to stress\"}, {\"id\": \"GO:0080134\", \"name\": \"regulation of response to stress\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0045087\", \"name\": \"innate immune response\"}, {\"id\": \"GO:0043207\", \"name\": \"response to external biotic stimulus\"}, {\"id\": \"GO:0060336\", \"name\": \"negative regulation of type II interferon-mediated signaling pathway\"}, {\"id\": \"GO:0023051\", \"name\": \"regulation of signaling\"}, {\"id\": \"GO:0007166\", \"name\": \"cell surface receptor signaling pathway\"}, {\"id\": \"GO:0048585\", \"name\": \"negative regulation of response to stimulus\"}, {\"id\": \"GO:0006952\", \"name\": \"defense response\"}, {\"id\": \"GO:0001959\", \"name\": \"regulation of cytokine-mediated signaling pathway\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0140546\", \"name\": \"defense response to symbiont\"}, {\"id\": \"GO:0009968\", \"name\": \"negative regulation of signal transduction\"}, {\"id\": \"GO:1901652\", \"name\": \"response to peptide\"}, {\"id\": \"GO:0002683\", \"name\": \"negative regulation of immune system process\"}, {\"id\": \"GO:0001960\", \"name\": \"negative regulation of cytokine-mediated signaling pathway\"}, {\"id\": \"GO:0002376\", \"name\": \"immune system process\"}, {\"id\": \"GO:0010646\", \"name\": \"regulation of cell communication\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0045824\", \"name\": \"negative regulation of innate immune response\"}]}, {\"annotation_id\": \"GO:0050693\", \"name\": \"LBD domain binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0005515\", \"name\": \"protein binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0050693\", \"name\": \"LBD domain binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0019904\", \"name\": \"protein domain specific binding\"}]}, {\"annotation_id\": \"GO:0045165\", \"name\": \"cell fate commitment\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0032502\", \"name\": \"developmental process\"}, {\"id\": \"GO:0048869\", \"name\": \"cellular developmental process\"}, {\"id\": \"GO:0030154\", \"name\": \"cell differentiation\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0045165\", \"name\": \"cell fate commitment\"}]}, {\"annotation_id\": \"GO:0035357\", \"name\": \"peroxisome proliferator activated receptor signaling pathway\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0051716\", \"name\": \"cellular response to stimulus\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0030522\", \"name\": \"intracellular receptor signaling pathway\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0023052\", \"name\": \"signaling\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0035556\", \"name\": \"intracellular signal transduction\"}, {\"id\": \"GO:0007154\", \"name\": \"cell communication\"}, {\"id\": \"GO:0035357\", \"name\": \"peroxisome proliferator activated receptor signaling pathway\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0007165\", \"name\": \"signal transduction\"}, {\"id\": \"GO:0141193\", \"name\": \"nuclear receptor-mediated signaling pathway\"}]}, {\"annotation_id\": \"GO:0042789\", \"name\": \"mRNA transcription by RNA polymerase II\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0042789\", \"name\": \"mRNA transcription by RNA polymerase II\"}, {\"id\": \"GO:0016070\", \"name\": \"RNA metabolic process\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0034654\", \"name\": \"nucleobase-containing compound biosynthetic process\"}, {\"id\": \"GO:0010467\", \"name\": \"gene expression\"}, {\"id\": \"GO:0009299\", \"name\": \"mRNA transcription\"}, {\"id\": \"GO:0016071\", \"name\": \"mRNA metabolic process\"}, {\"id\": \"GO:0009059\", \"name\": \"macromolecule biosynthetic process\"}, {\"id\": \"GO:0090304\", \"name\": \"nucleic acid metabolic process\"}, {\"id\": \"GO:0006139\", \"name\": \"nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0032774\", \"name\": \"RNA biosynthetic process\"}, {\"id\": \"GO:0006351\", \"name\": \"DNA-templated transcription\"}, {\"id\": \"GO:0141187\", \"name\": \"nucleic acid biosynthetic process\"}, {\"id\": \"GO:0006366\", \"name\": \"transcription by RNA polymerase II\"}, {\"id\": \"GO:0009058\", \"name\": \"biosynthetic process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0043170\", \"name\": \"macromolecule metabolic process\"}]}, {\"annotation_id\": \"GO:1905563\", \"name\": \"negative regulation of vascular endothelial cell proliferation\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0008285\", \"name\": \"negative regulation of cell population proliferation\"}, {\"id\": \"GO:0008283\", \"name\": \"cell population proliferation\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0001935\", \"name\": \"endothelial cell proliferation\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:1905562\", \"name\": \"regulation of vascular endothelial cell proliferation\"}, {\"id\": \"GO:0001937\", \"name\": \"negative regulation of endothelial cell proliferation\"}, {\"id\": \"GO:1905563\", \"name\": \"negative regulation of vascular endothelial cell proliferation\"}, {\"id\": \"GO:0001936\", \"name\": \"regulation of endothelial cell proliferation\"}, {\"id\": \"GO:0042127\", \"name\": \"regulation of cell population proliferation\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0050678\", \"name\": \"regulation of epithelial cell proliferation\"}, {\"id\": \"GO:0101023\", \"name\": \"vascular endothelial cell proliferation\"}, {\"id\": \"GO:0050673\", \"name\": \"epithelial cell proliferation\"}, {\"id\": \"GO:0050680\", \"name\": \"negative regulation of epithelial cell proliferation\"}]}, {\"annotation_id\": \"IPR013088\", \"name\": \"Zinc finger, NHR/GATA-type\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR013088\", \"name\": \"Zinc finger, NHR/GATA-type\"}]}, {\"annotation_id\": \"GO:0000122\", \"name\": \"negative regulation of transcription by RNA polymerase II\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0016070\", \"name\": \"RNA metabolic process\"}, {\"id\": \"GO:0080090\", \"name\": \"regulation of primary metabolic process\"}, {\"id\": \"GO:1902679\", \"name\": \"negative regulation of RNA biosynthetic process\"}, {\"id\": \"GO:0032774\", \"name\": \"RNA biosynthetic process\"}, {\"id\": \"GO:0006139\", \"name\": \"nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0006351\", \"name\": \"DNA-templated transcription\"}, {\"id\": \"GO:0141187\", \"name\": \"nucleic acid biosynthetic process\"}, {\"id\": \"GO:0051252\", \"name\": \"regulation of RNA metabolic process\"}, {\"id\": \"GO:0006366\", \"name\": \"transcription by RNA polymerase II\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0045934\", \"name\": \"negative regulation of nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0019219\", \"name\": \"regulation of nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:2001141\", \"name\": \"regulation of RNA biosynthetic process\"}, {\"id\": \"GO:0010605\", \"name\": \"negative regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0009889\", \"name\": \"regulation of biosynthetic process\"}, {\"id\": \"GO:0006357\", \"name\": \"regulation of transcription by RNA polymerase II\"}, {\"id\": \"GO:0045892\", \"name\": \"negative regulation of DNA-templated transcription\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0000122\", \"name\": \"negative regulation of transcription by RNA polymerase II\"}, {\"id\": \"GO:0009892\", \"name\": \"negative regulation of metabolic process\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0060255\", \"name\": \"regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0034654\", \"name\": \"nucleobase-containing compound biosynthetic process\"}, {\"id\": \"GO:0010467\", \"name\": \"gene expression\"}, {\"id\": \"GO:0009059\", \"name\": \"macromolecule biosynthetic process\"}, {\"id\": \"GO:0090304\", \"name\": \"nucleic acid metabolic process\"}, {\"id\": \"GO:0010468\", \"name\": \"regulation of gene expression\"}, {\"id\": \"GO:0009058\", \"name\": \"biosynthetic process\"}, {\"id\": \"GO:0009890\", \"name\": \"negative regulation of biosynthetic process\"}, {\"id\": \"GO:0010558\", \"name\": \"negative regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0010556\", \"name\": \"regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0043170\", \"name\": \"macromolecule metabolic process\"}, {\"id\": \"GO:0006355\", \"name\": \"regulation of DNA-templated transcription\"}, {\"id\": \"GO:0019222\", \"name\": \"regulation of metabolic process\"}, {\"id\": \"GO:0051253\", \"name\": \"negative regulation of RNA metabolic process\"}]}, {\"annotation_id\": \"GO:1905599\", \"name\": \"positive regulation of low-density lipoprotein receptor activity\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:1905599\", \"name\": \"positive regulation of low-density lipoprotein receptor activity\"}]}, {\"annotation_id\": \"GO:0001228\", \"name\": \"DNA-binding transcription activator activity, RNA polymerase II-specific\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0000981\", \"name\": \"DNA-binding transcription factor activity, RNA polymerase II-specific\"}, {\"id\": \"GO:0140110\", \"name\": \"transcription regulator activity\"}, {\"id\": \"GO:0003700\", \"name\": \"DNA-binding transcription factor activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0001228\", \"name\": \"DNA-binding transcription activator activity, RNA polymerase II-specific\"}, {\"id\": \"GO:0001216\", \"name\": \"DNA-binding transcription activator activity\"}]}, {\"annotation_id\": \"GO:1904706\", \"name\": \"negative regulation of vascular associated smooth muscle cell proliferation\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:1904705\", \"name\": \"regulation of vascular associated smooth muscle cell proliferation\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0008285\", \"name\": \"negative regulation of cell population proliferation\"}, {\"id\": \"GO:0008283\", \"name\": \"cell population proliferation\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0048660\", \"name\": \"regulation of smooth muscle cell proliferation\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:1904706\", \"name\": \"negative regulation of vascular associated smooth muscle cell proliferation\"}, {\"id\": \"GO:0048659\", \"name\": \"smooth muscle cell proliferation\"}, {\"id\": \"GO:0048662\", \"name\": \"negative regulation of smooth muscle cell proliferation\"}, {\"id\": \"GO:0042127\", \"name\": \"regulation of cell population proliferation\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0033002\", \"name\": \"muscle cell proliferation\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:1990874\", \"name\": \"vascular associated smooth muscle cell proliferation\"}]}, {\"annotation_id\": \"GO:0045892\", \"name\": \"negative regulation of DNA-templated transcription\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0016070\", \"name\": \"RNA metabolic process\"}, {\"id\": \"GO:0080090\", \"name\": \"regulation of primary metabolic process\"}, {\"id\": \"GO:1902679\", \"name\": \"negative regulation of RNA biosynthetic process\"}, {\"id\": \"GO:0032774\", \"name\": \"RNA biosynthetic process\"}, {\"id\": \"GO:0006139\", \"name\": \"nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0006351\", \"name\": \"DNA-templated transcription\"}, {\"id\": \"GO:0141187\", \"name\": \"nucleic acid biosynthetic process\"}, {\"id\": \"GO:0051252\", \"name\": \"regulation of RNA metabolic process\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0045934\", \"name\": \"negative regulation of nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0019219\", \"name\": \"regulation of nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:2001141\", \"name\": \"regulation of RNA biosynthetic process\"}, {\"id\": \"GO:0010605\", \"name\": \"negative regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0009889\", \"name\": \"regulation of biosynthetic process\"}, {\"id\": \"GO:0045892\", \"name\": \"negative regulation of DNA-templated transcription\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0009892\", \"name\": \"negative regulation of metabolic process\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0060255\", \"name\": \"regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0034654\", \"name\": \"nucleobase-containing compound biosynthetic process\"}, {\"id\": \"GO:0010467\", \"name\": \"gene expression\"}, {\"id\": \"GO:0009059\", \"name\": \"macromolecule biosynthetic process\"}, {\"id\": \"GO:0090304\", \"name\": \"nucleic acid metabolic process\"}, {\"id\": \"GO:0010468\", \"name\": \"regulation of gene expression\"}, {\"id\": \"GO:0009058\", \"name\": \"biosynthetic process\"}, {\"id\": \"GO:0009890\", \"name\": \"negative regulation of biosynthetic process\"}, {\"id\": \"GO:0010558\", \"name\": \"negative regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0010556\", \"name\": \"regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0043170\", \"name\": \"macromolecule metabolic process\"}, {\"id\": \"GO:0006355\", \"name\": \"regulation of DNA-templated transcription\"}, {\"id\": \"GO:0019222\", \"name\": \"regulation of metabolic process\"}, {\"id\": \"GO:0051253\", \"name\": \"negative regulation of RNA metabolic process\"}]}, {\"annotation_id\": \"GO:0045923\", \"name\": \"positive regulation of fatty acid metabolic process\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0043436\", \"name\": \"oxoacid metabolic process\"}, {\"id\": \"GO:0042180\", \"name\": \"ketone metabolic process\"}, {\"id\": \"GO:0019216\", \"name\": \"regulation of lipid metabolic process\"}, {\"id\": \"GO:0048518\", \"name\": \"positive regulation of biological process\"}, {\"id\": \"GO:0006082\", \"name\": \"organic acid metabolic process\"}, {\"id\": \"GO:0080090\", \"name\": \"regulation of primary metabolic process\"}, {\"id\": \"GO:0009893\", \"name\": \"positive regulation of metabolic process\"}, {\"id\": \"GO:0062012\", \"name\": \"regulation of small molecule metabolic process\"}, {\"id\": \"GO:0045834\", \"name\": \"positive regulation of lipid metabolic process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0044281\", \"name\": \"small molecule metabolic process\"}, {\"id\": \"GO:0048522\", \"name\": \"positive regulation of cellular process\"}, {\"id\": \"GO:0045923\", \"name\": \"positive regulation of fatty acid metabolic process\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0006631\", \"name\": \"fatty acid metabolic process\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0019752\", \"name\": \"carboxylic acid metabolic process\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0010565\", \"name\": \"regulation of ketone metabolic process\"}, {\"id\": \"GO:0019217\", \"name\": \"regulation of fatty acid metabolic process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0032787\", \"name\": \"monocarboxylic acid metabolic process\"}, {\"id\": \"GO:0062013\", \"name\": \"positive regulation of small molecule metabolic process\"}, {\"id\": \"GO:0019222\", \"name\": \"regulation of metabolic process\"}, {\"id\": \"GO:0006629\", \"name\": \"lipid metabolic process\"}]}, {\"annotation_id\": \"GO:0004955\", \"name\": \"prostaglandin receptor activity\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0004954\", \"name\": \"prostanoid receptor activity\"}, {\"id\": \"GO:0060089\", \"name\": \"molecular transducer activity\"}, {\"id\": \"GO:0004930\", \"name\": \"G protein-coupled receptor activity\"}, {\"id\": \"GO:0004888\", \"name\": \"transmembrane signaling receptor activity\"}, {\"id\": \"GO:0038023\", \"name\": \"signaling receptor activity\"}, {\"id\": \"GO:0004953\", \"name\": \"icosanoid receptor activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0004955\", \"name\": \"prostaglandin receptor activity\"}]}, {\"annotation_id\": \"GO:0042752\", \"name\": \"regulation of circadian rhythm\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0048511\", \"name\": \"rhythmic process\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0007623\", \"name\": \"circadian rhythm\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0042752\", \"name\": \"regulation of circadian rhythm\"}]}, {\"annotation_id\": \"GO:0009755\", \"name\": \"hormone-mediated signaling pathway\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0051716\", \"name\": \"cellular response to stimulus\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0023052\", \"name\": \"signaling\"}, {\"id\": \"GO:0009719\", \"name\": \"response to endogenous stimulus\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0009755\", \"name\": \"hormone-mediated signaling pathway\"}, {\"id\": \"GO:0007154\", \"name\": \"cell communication\"}, {\"id\": \"GO:0071495\", \"name\": \"cellular response to endogenous stimulus\"}, {\"id\": \"GO:0070887\", \"name\": \"cellular response to chemical stimulus\"}, {\"id\": \"GO:0009725\", \"name\": \"response to hormone\"}, {\"id\": \"GO:0042221\", \"name\": \"response to chemical\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0007165\", \"name\": \"signal transduction\"}, {\"id\": \"GO:0032870\", \"name\": \"cellular response to hormone stimulus\"}]}, {\"annotation_id\": \"GO:0051393\", \"name\": \"alpha-actinin binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0008092\", \"name\": \"cytoskeletal protein binding\"}, {\"id\": \"GO:0005515\", \"name\": \"protein binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0051393\", \"name\": \"alpha-actinin binding\"}, {\"id\": \"GO:0042805\", \"name\": \"actinin binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0055088\", \"name\": \"lipid homeostasis\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0048878\", \"name\": \"chemical homeostasis\"}, {\"id\": \"GO:0042592\", \"name\": \"homeostatic process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0055088\", \"name\": \"lipid homeostasis\"}]}, {\"annotation_id\": \"GO:1901202\", \"name\": \"negative regulation of extracellular matrix assembly\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:1903054\", \"name\": \"negative regulation of extracellular matrix organization\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0051128\", \"name\": \"regulation of cellular component organization\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0051129\", \"name\": \"negative regulation of cellular component organization\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0030198\", \"name\": \"extracellular matrix organization\"}, {\"id\": \"GO:0044087\", \"name\": \"regulation of cellular component biogenesis\"}, {\"id\": \"GO:0016043\", \"name\": \"cellular component organization\"}, {\"id\": \"GO:0044085\", \"name\": \"cellular component biogenesis\"}, {\"id\": \"GO:0022607\", \"name\": \"cellular component assembly\"}, {\"id\": \"GO:1901201\", \"name\": \"regulation of extracellular matrix assembly\"}, {\"id\": \"GO:1901202\", \"name\": \"negative regulation of extracellular matrix assembly\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0071840\", \"name\": \"cellular component organization or biogenesis\"}, {\"id\": \"GO:1903053\", \"name\": \"regulation of extracellular matrix organization\"}, {\"id\": \"GO:0085029\", \"name\": \"extracellular matrix assembly\"}, {\"id\": \"GO:0043062\", \"name\": \"extracellular structure organization\"}, {\"id\": \"GO:0045229\", \"name\": \"external encapsulating structure organization\"}]}, {\"annotation_id\": \"GO:0050728\", \"name\": \"negative regulation of inflammatory response\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0031347\", \"name\": \"regulation of defense response\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0032101\", \"name\": \"regulation of response to external stimulus\"}, {\"id\": \"GO:0050728\", \"name\": \"negative regulation of inflammatory response\"}, {\"id\": \"GO:0006952\", \"name\": \"defense response\"}, {\"id\": \"GO:0048585\", \"name\": \"negative regulation of response to stimulus\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0009605\", \"name\": \"response to external stimulus\"}, {\"id\": \"GO:0050727\", \"name\": \"regulation of inflammatory response\"}, {\"id\": \"GO:0048583\", \"name\": \"regulation of response to stimulus\"}, {\"id\": \"GO:0006950\", \"name\": \"response to stress\"}, {\"id\": \"GO:0032102\", \"name\": \"negative regulation of response to external stimulus\"}, {\"id\": \"GO:0080134\", \"name\": \"regulation of response to stress\"}, {\"id\": \"GO:0031348\", \"name\": \"negative regulation of defense response\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0006954\", \"name\": \"inflammatory response\"}]}, {\"annotation_id\": \"GO:0043231\", \"name\": \"intracellular membrane-bounded organelle\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0043227\", \"name\": \"membrane-bounded organelle\"}, {\"id\": \"GO:0043229\", \"name\": \"intracellular organelle\"}, {\"id\": \"GO:0110165\", \"name\": \"cellular anatomical structure\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0005622\", \"name\": \"intracellular anatomical structure\"}, {\"id\": \"GO:0043226\", \"name\": \"organelle\"}, {\"id\": \"GO:0043231\", \"name\": \"intracellular membrane-bounded organelle\"}]}, {\"annotation_id\": \"GO:0003700\", \"name\": \"DNA-binding transcription factor activity\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0140110\", \"name\": \"transcription regulator activity\"}, {\"id\": \"GO:0003700\", \"name\": \"DNA-binding transcription factor activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0048469\", \"name\": \"cell maturation\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0032502\", \"name\": \"developmental process\"}, {\"id\": \"GO:0048869\", \"name\": \"cellular developmental process\"}, {\"id\": \"GO:0071695\", \"name\": \"anatomical structure maturation\"}, {\"id\": \"GO:0030154\", \"name\": \"cell differentiation\"}, {\"id\": \"GO:0048856\", \"name\": \"anatomical structure development\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0048468\", \"name\": \"cell development\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0048469\", \"name\": \"cell maturation\"}, {\"id\": \"GO:0021700\", \"name\": \"developmental maturation\"}]}, {\"annotation_id\": \"GO:0050692\", \"name\": \"DNA binding domain binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0005515\", \"name\": \"protein binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0050692\", \"name\": \"DNA binding domain binding\"}, {\"id\": \"GO:0019904\", \"name\": \"protein domain specific binding\"}]}, {\"annotation_id\": \"IPR001723\", \"name\": \"Nuclear hormone receptor\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 1, \"id\": \"IPR001723\", \"name\": \"Nuclear hormone receptor\"}]}, {\"annotation_id\": \"GO:0006631\", \"name\": \"fatty acid metabolic process\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0006631\", \"name\": \"fatty acid metabolic process\"}, {\"id\": \"GO:0043436\", \"name\": \"oxoacid metabolic process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0019752\", \"name\": \"carboxylic acid metabolic process\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0044281\", \"name\": \"small molecule metabolic process\"}, {\"id\": \"GO:0032787\", \"name\": \"monocarboxylic acid metabolic process\"}, {\"id\": \"GO:0006082\", \"name\": \"organic acid metabolic process\"}, {\"id\": \"GO:0006629\", \"name\": \"lipid metabolic process\"}]}, {\"annotation_id\": \"GO:1902894\", \"name\": \"negative regulation of miRNA transcription\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:1902894\", \"name\": \"negative regulation of miRNA transcription\"}, {\"id\": \"GO:0016070\", \"name\": \"RNA metabolic process\"}, {\"id\": \"GO:0080090\", \"name\": \"regulation of primary metabolic process\"}, {\"id\": \"GO:1902679\", \"name\": \"negative regulation of RNA biosynthetic process\"}, {\"id\": \"GO:0006139\", \"name\": \"nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0032774\", \"name\": \"RNA biosynthetic process\"}, {\"id\": \"GO:0006351\", \"name\": \"DNA-templated transcription\"}, {\"id\": \"GO:0141187\", \"name\": \"nucleic acid biosynthetic process\"}, {\"id\": \"GO:0051252\", \"name\": \"regulation of RNA metabolic process\"}, {\"id\": \"GO:0061614\", \"name\": \"miRNA transcription\"}, {\"id\": \"GO:2000628\", \"name\": \"regulation of miRNA metabolic process\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0045934\", \"name\": \"negative regulation of nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0019219\", \"name\": \"regulation of nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0010586\", \"name\": \"miRNA metabolic process\"}, {\"id\": \"GO:0010605\", \"name\": \"negative regulation of macromolecule metabolic process\"}, {\"id\": \"GO:2001141\", \"name\": \"regulation of RNA biosynthetic process\"}, {\"id\": \"GO:0009889\", \"name\": \"regulation of biosynthetic process\"}, {\"id\": \"GO:0045892\", \"name\": \"negative regulation of DNA-templated transcription\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0009892\", \"name\": \"negative regulation of metabolic process\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0060255\", \"name\": \"regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0034654\", \"name\": \"nucleobase-containing compound biosynthetic process\"}, {\"id\": \"GO:0010467\", \"name\": \"gene expression\"}, {\"id\": \"GO:0009059\", \"name\": \"macromolecule biosynthetic process\"}, {\"id\": \"GO:0090304\", \"name\": \"nucleic acid metabolic process\"}, {\"id\": \"GO:0010468\", \"name\": \"regulation of gene expression\"}, {\"id\": \"GO:0009058\", \"name\": \"biosynthetic process\"}, {\"id\": \"GO:0009890\", \"name\": \"negative regulation of biosynthetic process\"}, {\"id\": \"GO:0010558\", \"name\": \"negative regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:2000629\", \"name\": \"negative regulation of miRNA metabolic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0010556\", \"name\": \"regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0043170\", \"name\": \"macromolecule metabolic process\"}, {\"id\": \"GO:0006355\", \"name\": \"regulation of DNA-templated transcription\"}, {\"id\": \"GO:0019222\", \"name\": \"regulation of metabolic process\"}, {\"id\": \"GO:0051253\", \"name\": \"negative regulation of RNA metabolic process\"}, {\"id\": \"GO:1902893\", \"name\": \"regulation of miRNA transcription\"}]}, {\"annotation_id\": \"IPR003077\", \"name\": \"Peroxisome proliferator-activated receptor gamma\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 1, \"id\": \"IPR003074\", \"name\": \"Peroxisome proliferator-activated receptor\"}, {\"depth\": 2, \"id\": \"IPR003077\", \"name\": \"Peroxisome proliferator-activated receptor gamma\"}]}, {\"annotation_id\": \"GO:0043409\", \"name\": \"negative regulation of MAPK cascade\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0051716\", \"name\": \"cellular response to stimulus\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0023052\", \"name\": \"signaling\"}, {\"id\": \"GO:0023057\", \"name\": \"negative regulation of signaling\"}, {\"id\": \"GO:1902532\", \"name\": \"negative regulation of intracellular signal transduction\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0009966\", \"name\": \"regulation of signal transduction\"}, {\"id\": \"GO:0035556\", \"name\": \"intracellular signal transduction\"}, {\"id\": \"GO:0010648\", \"name\": \"negative regulation of cell communication\"}, {\"id\": \"GO:0007154\", \"name\": \"cell communication\"}, {\"id\": \"GO:1902531\", \"name\": \"regulation of intracellular signal transduction\"}, {\"id\": \"GO:0141124\", \"name\": \"intracellular signaling cassette\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0007165\", \"name\": \"signal transduction\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0023051\", \"name\": \"regulation of signaling\"}, {\"id\": \"GO:0048585\", \"name\": \"negative regulation of response to stimulus\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0043408\", \"name\": \"regulation of MAPK cascade\"}, {\"id\": \"GO:0009968\", \"name\": \"negative regulation of signal transduction\"}, {\"id\": \"GO:0048583\", \"name\": \"regulation of response to stimulus\"}, {\"id\": \"GO:0000165\", \"name\": \"MAPK cascade\"}, {\"id\": \"GO:0010646\", \"name\": \"regulation of cell communication\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0043409\", \"name\": \"negative regulation of MAPK cascade\"}]}, {\"annotation_id\": \"GO:1904893\", \"name\": \"negative regulation of receptor signaling pathway via STAT\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0051716\", \"name\": \"cellular response to stimulus\"}, {\"id\": \"GO:0097696\", \"name\": \"cell surface receptor signaling pathway via STAT\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0023052\", \"name\": \"signaling\"}, {\"id\": \"GO:0023057\", \"name\": \"negative regulation of signaling\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0009966\", \"name\": \"regulation of signal transduction\"}, {\"id\": \"GO:0010648\", \"name\": \"negative regulation of cell communication\"}, {\"id\": \"GO:0007154\", \"name\": \"cell communication\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0007165\", \"name\": \"signal transduction\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0023051\", \"name\": \"regulation of signaling\"}, {\"id\": \"GO:0007166\", \"name\": \"cell surface receptor signaling pathway\"}, {\"id\": \"GO:0048585\", \"name\": \"negative regulation of response to stimulus\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0009968\", \"name\": \"negative regulation of signal transduction\"}, {\"id\": \"GO:0048583\", \"name\": \"regulation of response to stimulus\"}, {\"id\": \"GO:0010646\", \"name\": \"regulation of cell communication\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:1904893\", \"name\": \"negative regulation of receptor signaling pathway via STAT\"}, {\"id\": \"GO:1904892\", \"name\": \"regulation of receptor signaling pathway via STAT\"}]}, {\"annotation_id\": \"GO:0046965\", \"name\": \"nuclear retinoid X receptor binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0008134\", \"name\": \"transcription factor binding\"}, {\"id\": \"GO:0042974\", \"name\": \"nuclear retinoic acid receptor binding\"}, {\"id\": \"GO:0061629\", \"name\": \"RNA polymerase II-specific DNA-binding transcription factor binding\"}, {\"id\": \"GO:0016922\", \"name\": \"nuclear receptor binding\"}, {\"id\": \"GO:0005515\", \"name\": \"protein binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0046965\", \"name\": \"nuclear retinoid X receptor binding\"}, {\"id\": \"GO:0140297\", \"name\": \"DNA-binding transcription factor binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0140297\", \"name\": \"DNA-binding transcription factor binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0008134\", \"name\": \"transcription factor binding\"}, {\"id\": \"GO:0005515\", \"name\": \"protein binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0140297\", \"name\": \"DNA-binding transcription factor binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0070888\", \"name\": \"E-box binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0070888\", \"name\": \"E-box binding\"}, {\"id\": \"GO:0003677\", \"name\": \"DNA binding\"}, {\"id\": \"GO:0043565\", \"name\": \"sequence-specific DNA binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003690\", \"name\": \"double-stranded DNA binding\"}, {\"id\": \"GO:0003676\", \"name\": \"nucleic acid binding\"}, {\"id\": \"GO:0000977\", \"name\": \"RNA polymerase II transcription regulatory region sequence-specific DNA binding\"}, {\"id\": \"GO:0000987\", \"name\": \"cis-regulatory region sequence-specific DNA binding\"}, {\"id\": \"GO:1990837\", \"name\": \"sequence-specific double-stranded DNA binding\"}, {\"id\": \"GO:0000976\", \"name\": \"transcription cis-regulatory region binding\"}, {\"id\": \"GO:0001067\", \"name\": \"transcription regulatory region nucleic acid binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0000978\", \"name\": \"RNA polymerase II cis-regulatory region sequence-specific DNA binding\"}]}, {\"annotation_id\": \"GO:0032869\", \"name\": \"cellular response to insulin stimulus\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0051716\", \"name\": \"cellular response to stimulus\"}, {\"id\": \"GO:1901699\", \"name\": \"cellular response to nitrogen compound\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0009719\", \"name\": \"response to endogenous stimulus\"}, {\"id\": \"GO:0043434\", \"name\": \"response to peptide hormone\"}, {\"id\": \"GO:1901700\", \"name\": \"response to oxygen-containing compound\"}, {\"id\": \"GO:0071375\", \"name\": \"cellular response to peptide hormone stimulus\"}, {\"id\": \"GO:1901698\", \"name\": \"response to nitrogen compound\"}, {\"id\": \"GO:1901701\", \"name\": \"cellular response to oxygen-containing compound\"}, {\"id\": \"GO:0071495\", \"name\": \"cellular response to endogenous stimulus\"}, {\"id\": \"GO:0070887\", \"name\": \"cellular response to chemical stimulus\"}, {\"id\": \"GO:0009725\", \"name\": \"response to hormone\"}, {\"id\": \"GO:0042221\", \"name\": \"response to chemical\"}, {\"id\": \"GO:0032868\", \"name\": \"response to insulin\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0032869\", \"name\": \"cellular response to insulin stimulus\"}, {\"id\": \"GO:0032870\", \"name\": \"cellular response to hormone stimulus\"}]}, {\"annotation_id\": \"GO:0032376\", \"name\": \"positive regulation of cholesterol transport\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0032879\", \"name\": \"regulation of localization\"}, {\"id\": \"GO:0032373\", \"name\": \"positive regulation of sterol transport\"}, {\"id\": \"GO:0006810\", \"name\": \"transport\"}, {\"id\": \"GO:0048518\", \"name\": \"positive regulation of biological process\"}, {\"id\": \"GO:0032368\", \"name\": \"regulation of lipid transport\"}, {\"id\": \"GO:0015850\", \"name\": \"organic hydroxy compound transport\"}, {\"id\": \"GO:0051179\", \"name\": \"localization\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0015918\", \"name\": \"sterol transport\"}, {\"id\": \"GO:0032374\", \"name\": \"regulation of cholesterol transport\"}, {\"id\": \"GO:0032376\", \"name\": \"positive regulation of cholesterol transport\"}, {\"id\": \"GO:0032371\", \"name\": \"regulation of sterol transport\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0051049\", \"name\": \"regulation of transport\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0010876\", \"name\": \"lipid localization\"}, {\"id\": \"GO:0006869\", \"name\": \"lipid transport\"}, {\"id\": \"GO:1905954\", \"name\": \"positive regulation of lipid localization\"}, {\"id\": \"GO:0051234\", \"name\": \"establishment of localization\"}, {\"id\": \"GO:0032370\", \"name\": \"positive regulation of lipid transport\"}, {\"id\": \"GO:0051050\", \"name\": \"positive regulation of transport\"}, {\"id\": \"GO:1905952\", \"name\": \"regulation of lipid localization\"}, {\"id\": \"GO:0033036\", \"name\": \"macromolecule localization\"}, {\"id\": \"GO:0030301\", \"name\": \"cholesterol transport\"}]}, {\"annotation_id\": \"GO:0016525\", \"name\": \"negative regulation of angiogenesis\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0032501\", \"name\": \"multicellular organismal process\"}, {\"id\": \"GO:0050793\", \"name\": \"regulation of developmental process\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0001525\", \"name\": \"angiogenesis\"}, {\"id\": \"GO:1901342\", \"name\": \"regulation of vasculature development\"}, {\"id\": \"GO:0007275\", \"name\": \"multicellular organism development\"}, {\"id\": \"GO:0035239\", \"name\": \"tube morphogenesis\"}, {\"id\": \"GO:0048856\", \"name\": \"anatomical structure development\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0051239\", \"name\": \"regulation of multicellular organismal process\"}, {\"id\": \"GO:0022603\", \"name\": \"regulation of anatomical structure morphogenesis\"}, {\"id\": \"GO:0048731\", \"name\": \"system development\"}, {\"id\": \"GO:0001568\", \"name\": \"blood vessel development\"}, {\"id\": \"GO:0032502\", \"name\": \"developmental process\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:2000026\", \"name\": \"regulation of multicellular organismal development\"}, {\"id\": \"GO:0048514\", \"name\": \"blood vessel morphogenesis\"}, {\"id\": \"GO:0035295\", \"name\": \"tube development\"}, {\"id\": \"GO:2000181\", \"name\": \"negative regulation of blood vessel morphogenesis\"}, {\"id\": \"GO:0051093\", \"name\": \"negative regulation of developmental process\"}, {\"id\": \"GO:0016525\", \"name\": \"negative regulation of angiogenesis\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0001944\", \"name\": \"vasculature development\"}, {\"id\": \"GO:0072359\", \"name\": \"circulatory system development\"}, {\"id\": \"GO:1901343\", \"name\": \"negative regulation of vasculature development\"}, {\"id\": \"GO:0009653\", \"name\": \"anatomical structure morphogenesis\"}, {\"id\": \"GO:0045765\", \"name\": \"regulation of angiogenesis\"}, {\"id\": \"GO:0048646\", \"name\": \"anatomical structure formation involved in morphogenesis\"}, {\"id\": \"GO:0051241\", \"name\": \"negative regulation of multicellular organismal process\"}]}, {\"annotation_id\": \"GO:1905461\", \"name\": \"positive regulation of vascular associated smooth muscle cell apoptotic process\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0043068\", \"name\": \"positive regulation of programmed cell death\"}, {\"id\": \"GO:0010657\", \"name\": \"muscle cell apoptotic process\"}, {\"id\": \"GO:0034393\", \"name\": \"positive regulation of smooth muscle cell apoptotic process\"}, {\"id\": \"GO:0034390\", \"name\": \"smooth muscle cell apoptotic process\"}, {\"id\": \"GO:0042981\", \"name\": \"regulation of apoptotic process\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0048518\", \"name\": \"positive regulation of biological process\"}, {\"id\": \"GO:0010660\", \"name\": \"regulation of muscle cell apoptotic process\"}, {\"id\": \"GO:0043067\", \"name\": \"regulation of programmed cell death\"}, {\"id\": \"GO:0008219\", \"name\": \"cell death\"}, {\"id\": \"GO:0034391\", \"name\": \"regulation of smooth muscle cell apoptotic process\"}, {\"id\": \"GO:0043065\", \"name\": \"positive regulation of apoptotic process\"}, {\"id\": \"GO:0010661\", \"name\": \"positive regulation of muscle cell apoptotic process\"}, {\"id\": \"GO:1905288\", \"name\": \"vascular associated smooth muscle cell apoptotic process\"}, {\"id\": \"GO:1905461\", \"name\": \"positive regulation of vascular associated smooth muscle cell apoptotic process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:1905459\", \"name\": \"regulation of vascular associated smooth muscle cell apoptotic process\"}, {\"id\": \"GO:0006915\", \"name\": \"apoptotic process\"}, {\"id\": \"GO:0012501\", \"name\": \"programmed cell death\"}, {\"id\": \"GO:0048522\", \"name\": \"positive regulation of cellular process\"}]}, {\"annotation_id\": \"GO:0010629\", \"name\": \"negative regulation of gene expression\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0009889\", \"name\": \"regulation of biosynthetic process\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0009892\", \"name\": \"negative regulation of metabolic process\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0060255\", \"name\": \"regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0010467\", \"name\": \"gene expression\"}, {\"id\": \"GO:0009059\", \"name\": \"macromolecule biosynthetic process\"}, {\"id\": \"GO:0010468\", \"name\": \"regulation of gene expression\"}, {\"id\": \"GO:0010629\", \"name\": \"negative regulation of gene expression\"}, {\"id\": \"GO:0009058\", \"name\": \"biosynthetic process\"}, {\"id\": \"GO:0009890\", \"name\": \"negative regulation of biosynthetic process\"}, {\"id\": \"GO:0010558\", \"name\": \"negative regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0010556\", \"name\": \"regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0043170\", \"name\": \"macromolecule metabolic process\"}, {\"id\": \"GO:0019222\", \"name\": \"regulation of metabolic process\"}, {\"id\": \"GO:0010605\", \"name\": \"negative regulation of macromolecule metabolic process\"}]}, {\"annotation_id\": \"IPR000536\", \"name\": \"Nuclear hormone receptor, ligand-binding domain\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 1, \"id\": \"IPR000536\", \"name\": \"Nuclear hormone receptor, ligand-binding domain\"}]}, {\"annotation_id\": \"GO:0070412\", \"name\": \"R-SMAD binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0046332\", \"name\": \"SMAD binding\"}, {\"id\": \"GO:0005515\", \"name\": \"protein binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0070412\", \"name\": \"R-SMAD binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:1903845\", \"name\": \"negative regulation of cellular response to transforming growth factor beta stimulus\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0071363\", \"name\": \"cellular response to growth factor stimulus\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0048585\", \"name\": \"negative regulation of response to stimulus\"}, {\"id\": \"GO:1903844\", \"name\": \"regulation of cellular response to transforming growth factor beta stimulus\"}, {\"id\": \"GO:0071560\", \"name\": \"cellular response to transforming growth factor beta stimulus\"}, {\"id\": \"GO:0009719\", \"name\": \"response to endogenous stimulus\"}, {\"id\": \"GO:0090287\", \"name\": \"regulation of cellular response to growth factor stimulus\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0090288\", \"name\": \"negative regulation of cellular response to growth factor stimulus\"}, {\"id\": \"GO:1903845\", \"name\": \"negative regulation of cellular response to transforming growth factor beta stimulus\"}, {\"id\": \"GO:0071495\", \"name\": \"cellular response to endogenous stimulus\"}, {\"id\": \"GO:0071559\", \"name\": \"response to transforming growth factor beta\"}, {\"id\": \"GO:0048583\", \"name\": \"regulation of response to stimulus\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0070848\", \"name\": \"response to growth factor\"}]}, {\"annotation_id\": \"GO:0090258\", \"name\": \"negative regulation of mitochondrial fission\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0051128\", \"name\": \"regulation of cellular component organization\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0050793\", \"name\": \"regulation of developmental process\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0016043\", \"name\": \"cellular component organization\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0048856\", \"name\": \"anatomical structure development\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0071840\", \"name\": \"cellular component organization or biogenesis\"}, {\"id\": \"GO:0022603\", \"name\": \"regulation of anatomical structure morphogenesis\"}, {\"id\": \"GO:0007005\", \"name\": \"mitochondrion organization\"}, {\"id\": \"GO:0032502\", \"name\": \"developmental process\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0051129\", \"name\": \"negative regulation of cellular component organization\"}, {\"id\": \"GO:0051093\", \"name\": \"negative regulation of developmental process\"}, {\"id\": \"GO:0048285\", \"name\": \"organelle fission\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0000266\", \"name\": \"mitochondrial fission\"}, {\"id\": \"GO:0033043\", \"name\": \"regulation of organelle organization\"}, {\"id\": \"GO:0009653\", \"name\": \"anatomical structure morphogenesis\"}, {\"id\": \"GO:0006996\", \"name\": \"organelle organization\"}, {\"id\": \"GO:0010639\", \"name\": \"negative regulation of organelle organization\"}, {\"id\": \"GO:0090258\", \"name\": \"negative regulation of mitochondrial fission\"}, {\"id\": \"GO:0090140\", \"name\": \"regulation of mitochondrial fission\"}, {\"id\": \"GO:0010821\", \"name\": \"regulation of mitochondrion organization\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}]}, {\"annotation_id\": \"GO:0008217\", \"name\": \"regulation of blood pressure\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0032501\", \"name\": \"multicellular organismal process\"}, {\"id\": \"GO:0003008\", \"name\": \"system process\"}, {\"id\": \"GO:0003013\", \"name\": \"circulatory system process\"}, {\"id\": \"GO:0008217\", \"name\": \"regulation of blood pressure\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0065008\", \"name\": \"regulation of biological quality\"}, {\"id\": \"GO:0008015\", \"name\": \"blood circulation\"}]}, {\"annotation_id\": \"GO:0000976\", \"name\": \"transcription cis-regulatory region binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0003677\", \"name\": \"DNA binding\"}, {\"id\": \"GO:0043565\", \"name\": \"sequence-specific DNA binding\"}, {\"id\": \"GO:1990837\", \"name\": \"sequence-specific double-stranded DNA binding\"}, {\"id\": \"GO:0000976\", \"name\": \"transcription cis-regulatory region binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003690\", \"name\": \"double-stranded DNA binding\"}, {\"id\": \"GO:0003676\", \"name\": \"nucleic acid binding\"}, {\"id\": \"GO:0001067\", \"name\": \"transcription regulatory region nucleic acid binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0097677\", \"name\": \"STAT family protein binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0008134\", \"name\": \"transcription factor binding\"}, {\"id\": \"GO:0061629\", \"name\": \"RNA polymerase II-specific DNA-binding transcription factor binding\"}, {\"id\": \"GO:0005515\", \"name\": \"protein binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0140297\", \"name\": \"DNA-binding transcription factor binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0097677\", \"name\": \"STAT family protein binding\"}]}, {\"annotation_id\": \"GO:0001890\", \"name\": \"placenta development\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0032502\", \"name\": \"developmental process\"}, {\"id\": \"GO:0001890\", \"name\": \"placenta development\"}, {\"id\": \"GO:0048513\", \"name\": \"animal organ development\"}, {\"id\": \"GO:0048856\", \"name\": \"anatomical structure development\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}]}, {\"annotation_id\": \"GO:0010628\", \"name\": \"positive regulation of gene expression\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0009889\", \"name\": \"regulation of biosynthetic process\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0048518\", \"name\": \"positive regulation of biological process\"}, {\"id\": \"GO:0060255\", \"name\": \"regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0010467\", \"name\": \"gene expression\"}, {\"id\": \"GO:0009059\", \"name\": \"macromolecule biosynthetic process\"}, {\"id\": \"GO:0010557\", \"name\": \"positive regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0010468\", \"name\": \"regulation of gene expression\"}, {\"id\": \"GO:0009893\", \"name\": \"positive regulation of metabolic process\"}, {\"id\": \"GO:0009058\", \"name\": \"biosynthetic process\"}, {\"id\": \"GO:0010628\", \"name\": \"positive regulation of gene expression\"}, {\"id\": \"GO:0009891\", \"name\": \"positive regulation of biosynthetic process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0010556\", \"name\": \"regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0010604\", \"name\": \"positive regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0043170\", \"name\": \"macromolecule metabolic process\"}, {\"id\": \"GO:0019222\", \"name\": \"regulation of metabolic process\"}, {\"id\": \"GO:0048522\", \"name\": \"positive regulation of cellular process\"}]}, {\"annotation_id\": \"GO:0071456\", \"name\": \"cellular response to hypoxia\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0036293\", \"name\": \"response to decreased oxygen levels\"}, {\"id\": \"GO:0051716\", \"name\": \"cellular response to stimulus\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0071453\", \"name\": \"cellular response to oxygen levels\"}, {\"id\": \"GO:0071456\", \"name\": \"cellular response to hypoxia\"}, {\"id\": \"GO:0036294\", \"name\": \"cellular response to decreased oxygen levels\"}, {\"id\": \"GO:0070887\", \"name\": \"cellular response to chemical stimulus\"}, {\"id\": \"GO:0033554\", \"name\": \"cellular response to stress\"}, {\"id\": \"GO:0001666\", \"name\": \"response to hypoxia\"}, {\"id\": \"GO:0006950\", \"name\": \"response to stress\"}, {\"id\": \"GO:0042221\", \"name\": \"response to chemical\"}, {\"id\": \"GO:0070482\", \"name\": \"response to oxygen levels\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009628\", \"name\": \"response to abiotic stimulus\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}]}, {\"annotation_id\": \"GO:0045087\", \"name\": \"innate immune response\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0044419\", \"name\": \"biological process involved in interspecies interaction between organisms\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0006955\", \"name\": \"immune response\"}, {\"id\": \"GO:0051707\", \"name\": \"response to other organism\"}, {\"id\": \"GO:0006952\", \"name\": \"defense response\"}, {\"id\": \"GO:0140546\", \"name\": \"defense response to symbiont\"}, {\"id\": \"GO:0009605\", \"name\": \"response to external stimulus\"}, {\"id\": \"GO:0009607\", \"name\": \"response to biotic stimulus\"}, {\"id\": \"GO:0002376\", \"name\": \"immune system process\"}, {\"id\": \"GO:0098542\", \"name\": \"defense response to other organism\"}, {\"id\": \"GO:0006950\", \"name\": \"response to stress\"}, {\"id\": \"GO:0045087\", \"name\": \"innate immune response\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0043207\", \"name\": \"response to external biotic stimulus\"}]}, {\"annotation_id\": \"GO:0030855\", \"name\": \"epithelial cell differentiation\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0032502\", \"name\": \"developmental process\"}, {\"id\": \"GO:0060429\", \"name\": \"epithelium development\"}, {\"id\": \"GO:0048869\", \"name\": \"cellular developmental process\"}, {\"id\": \"GO:0030154\", \"name\": \"cell differentiation\"}, {\"id\": \"GO:0048856\", \"name\": \"anatomical structure development\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0009888\", \"name\": \"tissue development\"}, {\"id\": \"GO:0030855\", \"name\": \"epithelial cell differentiation\"}]}, {\"annotation_id\": \"GO:0030514\", \"name\": \"negative regulation of BMP signaling pathway\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0051716\", \"name\": \"cellular response to stimulus\"}, {\"id\": \"GO:0007178\", \"name\": \"cell surface receptor protein serine/threonine kinase signaling pathway\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0071363\", \"name\": \"cellular response to growth factor stimulus\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0023052\", \"name\": \"signaling\"}, {\"id\": \"GO:0023057\", \"name\": \"negative regulation of signaling\"}, {\"id\": \"GO:0090092\", \"name\": \"regulation of transmembrane receptor protein serine/threonine kinase signaling pathway\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0009966\", \"name\": \"regulation of signal transduction\"}, {\"id\": \"GO:0090288\", \"name\": \"negative regulation of cellular response to growth factor stimulus\"}, {\"id\": \"GO:0030514\", \"name\": \"negative regulation of BMP signaling pathway\"}, {\"id\": \"GO:0010648\", \"name\": \"negative regulation of cell communication\"}, {\"id\": \"GO:0007154\", \"name\": \"cell communication\"}, {\"id\": \"GO:0071495\", \"name\": \"cellular response to endogenous stimulus\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0007165\", \"name\": \"signal transduction\"}, {\"id\": \"GO:0030509\", \"name\": \"BMP signaling pathway\"}, {\"id\": \"GO:0007167\", \"name\": \"enzyme-linked receptor protein signaling pathway\"}, {\"id\": \"GO:0071773\", \"name\": \"cellular response to BMP stimulus\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0023051\", \"name\": \"regulation of signaling\"}, {\"id\": \"GO:0007166\", \"name\": \"cell surface receptor signaling pathway\"}, {\"id\": \"GO:0030510\", \"name\": \"regulation of BMP signaling pathway\"}, {\"id\": \"GO:0048585\", \"name\": \"negative regulation of response to stimulus\"}, {\"id\": \"GO:0009719\", \"name\": \"response to endogenous stimulus\"}, {\"id\": \"GO:0090287\", \"name\": \"regulation of cellular response to growth factor stimulus\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0009968\", \"name\": \"negative regulation of signal transduction\"}, {\"id\": \"GO:0071772\", \"name\": \"response to BMP\"}, {\"id\": \"GO:0048583\", \"name\": \"regulation of response to stimulus\"}, {\"id\": \"GO:0010646\", \"name\": \"regulation of cell communication\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0141091\", \"name\": \"transforming growth factor beta receptor superfamily signaling pathway\"}, {\"id\": \"GO:0070848\", \"name\": \"response to growth factor\"}, {\"id\": \"GO:0090101\", \"name\": \"negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway\"}]}, {\"annotation_id\": \"GO:0001221\", \"name\": \"transcription coregulator binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0008134\", \"name\": \"transcription factor binding\"}, {\"id\": \"GO:0001221\", \"name\": \"transcription coregulator binding\"}, {\"id\": \"GO:0005515\", \"name\": \"protein binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0010888\", \"name\": \"negative regulation of lipid storage\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0032879\", \"name\": \"regulation of localization\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0019915\", \"name\": \"lipid storage\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0010876\", \"name\": \"lipid localization\"}, {\"id\": \"GO:1905953\", \"name\": \"negative regulation of lipid localization\"}, {\"id\": \"GO:0051179\", \"name\": \"localization\"}, {\"id\": \"GO:0010883\", \"name\": \"regulation of lipid storage\"}, {\"id\": \"GO:1905952\", \"name\": \"regulation of lipid localization\"}, {\"id\": \"GO:0010888\", \"name\": \"negative regulation of lipid storage\"}, {\"id\": \"GO:0033036\", \"name\": \"macromolecule localization\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0170062\", \"name\": \"nutrient storage\"}]}, {\"annotation_id\": \"GO:0000785\", \"name\": \"chromatin\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0043229\", \"name\": \"intracellular organelle\"}, {\"id\": \"GO:0110165\", \"name\": \"cellular anatomical structure\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0005622\", \"name\": \"intracellular anatomical structure\"}, {\"id\": \"GO:0043226\", \"name\": \"organelle\"}, {\"id\": \"GO:0043228\", \"name\": \"membraneless organelle\"}, {\"id\": \"GO:0043232\", \"name\": \"intracellular membraneless organelle\"}, {\"id\": \"GO:0000785\", \"name\": \"chromatin\"}, {\"id\": \"GO:0005694\", \"name\": \"chromosome\"}]}, {\"annotation_id\": \"GO:0060392\", \"name\": \"negative regulation of SMAD protein signal transduction\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0051716\", \"name\": \"cellular response to stimulus\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0007178\", \"name\": \"cell surface receptor protein serine/threonine kinase signaling pathway\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0023057\", \"name\": \"negative regulation of signaling\"}, {\"id\": \"GO:0023052\", \"name\": \"signaling\"}, {\"id\": \"GO:0090092\", \"name\": \"regulation of transmembrane receptor protein serine/threonine kinase signaling pathway\"}, {\"id\": \"GO:1902532\", \"name\": \"negative regulation of intracellular signal transduction\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0009966\", \"name\": \"regulation of signal transduction\"}, {\"id\": \"GO:0010648\", \"name\": \"negative regulation of cell communication\"}, {\"id\": \"GO:0035556\", \"name\": \"intracellular signal transduction\"}, {\"id\": \"GO:0007154\", \"name\": \"cell communication\"}, {\"id\": \"GO:1902531\", \"name\": \"regulation of intracellular signal transduction\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0141124\", \"name\": \"intracellular signaling cassette\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0007165\", \"name\": \"signal transduction\"}, {\"id\": \"GO:0007167\", \"name\": \"enzyme-linked receptor protein signaling pathway\"}, {\"id\": \"GO:0023051\", \"name\": \"regulation of signaling\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0007166\", \"name\": \"cell surface receptor signaling pathway\"}, {\"id\": \"GO:0048585\", \"name\": \"negative regulation of response to stimulus\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0009968\", \"name\": \"negative regulation of signal transduction\"}, {\"id\": \"GO:0060395\", \"name\": \"SMAD protein signal transduction\"}, {\"id\": \"GO:0048583\", \"name\": \"regulation of response to stimulus\"}, {\"id\": \"GO:0010646\", \"name\": \"regulation of cell communication\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0060390\", \"name\": \"regulation of SMAD protein signal transduction\"}, {\"id\": \"GO:0060392\", \"name\": \"negative regulation of SMAD protein signal transduction\"}, {\"id\": \"GO:0090101\", \"name\": \"negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway\"}]}, {\"annotation_id\": \"GO:0000981\", \"name\": \"DNA-binding transcription factor activity, RNA polymerase II-specific\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0000981\", \"name\": \"DNA-binding transcription factor activity, RNA polymerase II-specific\"}, {\"id\": \"GO:0140110\", \"name\": \"transcription regulator activity\"}, {\"id\": \"GO:0003700\", \"name\": \"DNA-binding transcription factor activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0042953\", \"name\": \"lipoprotein transport\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0051179\", \"name\": \"localization\"}, {\"id\": \"GO:0045184\", \"name\": \"establishment of protein localization\"}, {\"id\": \"GO:0071705\", \"name\": \"nitrogen compound transport\"}, {\"id\": \"GO:0015031\", \"name\": \"protein transport\"}, {\"id\": \"GO:0006810\", \"name\": \"transport\"}, {\"id\": \"GO:0033036\", \"name\": \"macromolecule localization\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0042953\", \"name\": \"lipoprotein transport\"}, {\"id\": \"GO:0008104\", \"name\": \"intracellular protein localization\"}, {\"id\": \"GO:0044872\", \"name\": \"lipoprotein localization\"}, {\"id\": \"GO:0051234\", \"name\": \"establishment of localization\"}]}, {\"annotation_id\": \"GO:0030512\", \"name\": \"negative regulation of transforming growth factor beta receptor signaling pathway\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0051716\", \"name\": \"cellular response to stimulus\"}, {\"id\": \"GO:0030512\", \"name\": \"negative regulation of transforming growth factor beta receptor signaling pathway\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0007178\", \"name\": \"cell surface receptor protein serine/threonine kinase signaling pathway\"}, {\"id\": \"GO:0071363\", \"name\": \"cellular response to growth factor stimulus\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0023057\", \"name\": \"negative regulation of signaling\"}, {\"id\": \"GO:0023052\", \"name\": \"signaling\"}, {\"id\": \"GO:0071560\", \"name\": \"cellular response to transforming growth factor beta stimulus\"}, {\"id\": \"GO:0090092\", \"name\": \"regulation of transmembrane receptor protein serine/threonine kinase signaling pathway\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0009966\", \"name\": \"regulation of signal transduction\"}, {\"id\": \"GO:0010648\", \"name\": \"negative regulation of cell communication\"}, {\"id\": \"GO:0007154\", \"name\": \"cell communication\"}, {\"id\": \"GO:0017015\", \"name\": \"regulation of transforming growth factor beta receptor signaling pathway\"}, {\"id\": \"GO:0071495\", \"name\": \"cellular response to endogenous stimulus\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0007165\", \"name\": \"signal transduction\"}, {\"id\": \"GO:0007167\", \"name\": \"enzyme-linked receptor protein signaling pathway\"}, {\"id\": \"GO:0023051\", \"name\": \"regulation of signaling\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0007166\", \"name\": \"cell surface receptor signaling pathway\"}, {\"id\": \"GO:0048585\", \"name\": \"negative regulation of response to stimulus\"}, {\"id\": \"GO:1903844\", \"name\": \"regulation of cellular response to transforming growth factor beta stimulus\"}, {\"id\": \"GO:0009719\", \"name\": \"response to endogenous stimulus\"}, {\"id\": \"GO:0090287\", \"name\": \"regulation of cellular response to growth factor stimulus\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0009968\", \"name\": \"negative regulation of signal transduction\"}, {\"id\": \"GO:0071559\", \"name\": \"response to transforming growth factor beta\"}, {\"id\": \"GO:0048583\", \"name\": \"regulation of response to stimulus\"}, {\"id\": \"GO:0007179\", \"name\": \"transforming growth factor beta receptor signaling pathway\"}, {\"id\": \"GO:0010646\", \"name\": \"regulation of cell communication\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0070848\", \"name\": \"response to growth factor\"}, {\"id\": \"GO:0141091\", \"name\": \"transforming growth factor beta receptor superfamily signaling pathway\"}, {\"id\": \"GO:0090101\", \"name\": \"negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway\"}]}, {\"annotation_id\": \"GO:0043537\", \"name\": \"negative regulation of blood vessel endothelial cell migration\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0040013\", \"name\": \"negative regulation of locomotion\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:2000145\", \"name\": \"regulation of cell motility\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0043535\", \"name\": \"regulation of blood vessel endothelial cell migration\"}, {\"id\": \"GO:0043542\", \"name\": \"endothelial cell migration\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0010596\", \"name\": \"negative regulation of endothelial cell migration\"}, {\"id\": \"GO:0043537\", \"name\": \"negative regulation of blood vessel endothelial cell migration\"}, {\"id\": \"GO:0040012\", \"name\": \"regulation of locomotion\"}, {\"id\": \"GO:0030334\", \"name\": \"regulation of cell migration\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0010594\", \"name\": \"regulation of endothelial cell migration\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:2000146\", \"name\": \"negative regulation of cell motility\"}, {\"id\": \"GO:0043534\", \"name\": \"blood vessel endothelial cell migration\"}, {\"id\": \"GO:0016477\", \"name\": \"cell migration\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0048870\", \"name\": \"cell motility\"}, {\"id\": \"GO:0040011\", \"name\": \"locomotion\"}, {\"id\": \"GO:0030336\", \"name\": \"negative regulation of cell migration\"}]}, {\"annotation_id\": \"GO:0071404\", \"name\": \"cellular response to low-density lipoprotein particle stimulus\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0051716\", \"name\": \"cellular response to stimulus\"}, {\"id\": \"GO:0071404\", \"name\": \"cellular response to low-density lipoprotein particle stimulus\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0009719\", \"name\": \"response to endogenous stimulus\"}, {\"id\": \"GO:0042221\", \"name\": \"response to chemical\"}, {\"id\": \"GO:0055094\", \"name\": \"response to lipoprotein particle\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:1901698\", \"name\": \"response to nitrogen compound\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0071402\", \"name\": \"cellular response to lipoprotein particle stimulus\"}]}, {\"annotation_id\": \"GO:1904597\", \"name\": \"negative regulation of connective tissue replacement involved in inflammatory response wound healing\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0032501\", \"name\": \"multicellular organismal process\"}, {\"id\": \"GO:1904597\", \"name\": \"negative regulation of connective tissue replacement involved in inflammatory response wound healing\"}, {\"id\": \"GO:0034104\", \"name\": \"negative regulation of tissue remodeling\"}, {\"id\": \"GO:0002246\", \"name\": \"wound healing involved in inflammatory response\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:1905204\", \"name\": \"negative regulation of connective tissue replacement\"}, {\"id\": \"GO:1904596\", \"name\": \"regulation of connective tissue replacement involved in inflammatory response wound healing\"}, {\"id\": \"GO:0006950\", \"name\": \"response to stress\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0097709\", \"name\": \"connective tissue replacement\"}, {\"id\": \"GO:0051239\", \"name\": \"regulation of multicellular organismal process\"}, {\"id\": \"GO:0009611\", \"name\": \"response to wounding\"}, {\"id\": \"GO:0042060\", \"name\": \"wound healing\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0002248\", \"name\": \"connective tissue replacement involved in inflammatory response wound healing\"}, {\"id\": \"GO:0006952\", \"name\": \"defense response\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0034103\", \"name\": \"regulation of tissue remodeling\"}, {\"id\": \"GO:0090594\", \"name\": \"inflammatory response to wounding\"}, {\"id\": \"GO:0048771\", \"name\": \"tissue remodeling\"}, {\"id\": \"GO:1905203\", \"name\": \"regulation of connective tissue replacement\"}, {\"id\": \"GO:0006954\", \"name\": \"inflammatory response\"}, {\"id\": \"GO:0051241\", \"name\": \"negative regulation of multicellular organismal process\"}]}, {\"annotation_id\": \"GO:0004879\", \"name\": \"nuclear receptor activity\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0004879\", \"name\": \"nuclear receptor activity\"}, {\"id\": \"GO:0000981\", \"name\": \"DNA-binding transcription factor activity, RNA polymerase II-specific\"}, {\"id\": \"GO:0060089\", \"name\": \"molecular transducer activity\"}, {\"id\": \"GO:0140110\", \"name\": \"transcription regulator activity\"}, {\"id\": \"GO:0003700\", \"name\": \"DNA-binding transcription factor activity\"}, {\"id\": \"GO:0038023\", \"name\": \"signaling receptor activity\"}, {\"id\": \"GO:0098531\", \"name\": \"ligand-modulated transcription factor activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0030224\", \"name\": \"monocyte differentiation\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0032502\", \"name\": \"developmental process\"}, {\"id\": \"GO:0002573\", \"name\": \"myeloid leukocyte differentiation\"}, {\"id\": \"GO:0048869\", \"name\": \"cellular developmental process\"}, {\"id\": \"GO:0030097\", \"name\": \"hemopoiesis\"}, {\"id\": \"GO:0048468\", \"name\": \"cell development\"}, {\"id\": \"GO:1903131\", \"name\": \"mononuclear cell differentiation\"}, {\"id\": \"GO:0030099\", \"name\": \"myeloid cell differentiation\"}, {\"id\": \"GO:0030154\", \"name\": \"cell differentiation\"}, {\"id\": \"GO:0048856\", \"name\": \"anatomical structure development\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0030224\", \"name\": \"monocyte differentiation\"}, {\"id\": \"GO:0002521\", \"name\": \"leukocyte differentiation\"}]}, {\"annotation_id\": \"IPR003074\", \"name\": \"Peroxisome proliferator-activated receptor\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"depth\": 1, \"id\": \"IPR003074\", \"name\": \"Peroxisome proliferator-activated receptor\"}]}, {\"annotation_id\": \"GO:0033993\", \"name\": \"response to lipid\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0033993\", \"name\": \"response to lipid\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0042221\", \"name\": \"response to chemical\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}]}, {\"annotation_id\": \"GO:0045600\", \"name\": \"positive regulation of fat cell differentiation\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0032502\", \"name\": \"developmental process\"}, {\"id\": \"GO:0045444\", \"name\": \"fat cell differentiation\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0045600\", \"name\": \"positive regulation of fat cell differentiation\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0050793\", \"name\": \"regulation of developmental process\"}, {\"id\": \"GO:0048869\", \"name\": \"cellular developmental process\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0048518\", \"name\": \"positive regulation of biological process\"}, {\"id\": \"GO:0045595\", \"name\": \"regulation of cell differentiation\"}, {\"id\": \"GO:0051094\", \"name\": \"positive regulation of developmental process\"}, {\"id\": \"GO:0045597\", \"name\": \"positive regulation of cell differentiation\"}, {\"id\": \"GO:0030154\", \"name\": \"cell differentiation\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0045598\", \"name\": \"regulation of fat cell differentiation\"}, {\"id\": \"GO:0048522\", \"name\": \"positive regulation of cellular process\"}]}, {\"annotation_id\": \"GO:1900076\", \"name\": \"regulation of cellular response to insulin stimulus\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0051716\", \"name\": \"cellular response to stimulus\"}, {\"id\": \"GO:1901699\", \"name\": \"cellular response to nitrogen compound\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0009719\", \"name\": \"response to endogenous stimulus\"}, {\"id\": \"GO:0043434\", \"name\": \"response to peptide hormone\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:1901700\", \"name\": \"response to oxygen-containing compound\"}, {\"id\": \"GO:0071375\", \"name\": \"cellular response to peptide hormone stimulus\"}, {\"id\": \"GO:1901698\", \"name\": \"response to nitrogen compound\"}, {\"id\": \"GO:1900076\", \"name\": \"regulation of cellular response to insulin stimulus\"}, {\"id\": \"GO:1901701\", \"name\": \"cellular response to oxygen-containing compound\"}, {\"id\": \"GO:0071495\", \"name\": \"cellular response to endogenous stimulus\"}, {\"id\": \"GO:0070887\", \"name\": \"cellular response to chemical stimulus\"}, {\"id\": \"GO:0009725\", \"name\": \"response to hormone\"}, {\"id\": \"GO:0048583\", \"name\": \"regulation of response to stimulus\"}, {\"id\": \"GO:0042221\", \"name\": \"response to chemical\"}, {\"id\": \"GO:0032868\", \"name\": \"response to insulin\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0032869\", \"name\": \"cellular response to insulin stimulus\"}, {\"id\": \"GO:0032870\", \"name\": \"cellular response to hormone stimulus\"}]}, {\"annotation_id\": \"GO:0045944\", \"name\": \"positive regulation of transcription by RNA polymerase II\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0045893\", \"name\": \"positive regulation of DNA-templated transcription\"}, {\"id\": \"GO:0048518\", \"name\": \"positive regulation of biological process\"}, {\"id\": \"GO:0016070\", \"name\": \"RNA metabolic process\"}, {\"id\": \"GO:0010557\", \"name\": \"positive regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0080090\", \"name\": \"regulation of primary metabolic process\"}, {\"id\": \"GO:0006139\", \"name\": \"nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0032774\", \"name\": \"RNA biosynthetic process\"}, {\"id\": \"GO:0141187\", \"name\": \"nucleic acid biosynthetic process\"}, {\"id\": \"GO:0009893\", \"name\": \"positive regulation of metabolic process\"}, {\"id\": \"GO:0006351\", \"name\": \"DNA-templated transcription\"}, {\"id\": \"GO:0051252\", \"name\": \"regulation of RNA metabolic process\"}, {\"id\": \"GO:0006366\", \"name\": \"transcription by RNA polymerase II\"}, {\"id\": \"GO:0009891\", \"name\": \"positive regulation of biosynthetic process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0010604\", \"name\": \"positive regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0019219\", \"name\": \"regulation of nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0048522\", \"name\": \"positive regulation of cellular process\"}, {\"id\": \"GO:2001141\", \"name\": \"regulation of RNA biosynthetic process\"}, {\"id\": \"GO:0009889\", \"name\": \"regulation of biosynthetic process\"}, {\"id\": \"GO:0006357\", \"name\": \"regulation of transcription by RNA polymerase II\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0060255\", \"name\": \"regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0045944\", \"name\": \"positive regulation of transcription by RNA polymerase II\"}, {\"id\": \"GO:0034654\", \"name\": \"nucleobase-containing compound biosynthetic process\"}, {\"id\": \"GO:0010467\", \"name\": \"gene expression\"}, {\"id\": \"GO:0009059\", \"name\": \"macromolecule biosynthetic process\"}, {\"id\": \"GO:0090304\", \"name\": \"nucleic acid metabolic process\"}, {\"id\": \"GO:0051254\", \"name\": \"positive regulation of RNA metabolic process\"}, {\"id\": \"GO:0010468\", \"name\": \"regulation of gene expression\"}, {\"id\": \"GO:0009058\", \"name\": \"biosynthetic process\"}, {\"id\": \"GO:1902680\", \"name\": \"positive regulation of RNA biosynthetic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0010556\", \"name\": \"regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0043170\", \"name\": \"macromolecule metabolic process\"}, {\"id\": \"GO:0006355\", \"name\": \"regulation of DNA-templated transcription\"}, {\"id\": \"GO:0019222\", \"name\": \"regulation of metabolic process\"}]}, {\"annotation_id\": \"GO:0030522\", \"name\": \"intracellular receptor signaling pathway\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0051716\", \"name\": \"cellular response to stimulus\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0030522\", \"name\": \"intracellular receptor signaling pathway\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0023052\", \"name\": \"signaling\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0035556\", \"name\": \"intracellular signal transduction\"}, {\"id\": \"GO:0007154\", \"name\": \"cell communication\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0007165\", \"name\": \"signal transduction\"}]}, {\"annotation_id\": \"GO:0042593\", \"name\": \"glucose homeostasis\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0048878\", \"name\": \"chemical homeostasis\"}, {\"id\": \"GO:0042592\", \"name\": \"homeostatic process\"}, {\"id\": \"GO:0042593\", \"name\": \"glucose homeostasis\"}, {\"id\": \"GO:0033500\", \"name\": \"carbohydrate homeostasis\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}]}, {\"annotation_id\": \"GO:0042802\", \"name\": \"identical protein binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0042802\", \"name\": \"identical protein binding\"}, {\"id\": \"GO:0005515\", \"name\": \"protein binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0050872\", \"name\": \"white fat cell differentiation\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0032502\", \"name\": \"developmental process\"}, {\"id\": \"GO:0045444\", \"name\": \"fat cell differentiation\"}, {\"id\": \"GO:0048869\", \"name\": \"cellular developmental process\"}, {\"id\": \"GO:0030154\", \"name\": \"cell differentiation\"}, {\"id\": \"GO:0050872\", \"name\": \"white fat cell differentiation\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}]}, {\"annotation_id\": \"GO:0010745\", \"name\": \"negative regulation of macrophage derived foam cell differentiation\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0032502\", \"name\": \"developmental process\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0050793\", \"name\": \"regulation of developmental process\"}, {\"id\": \"GO:0048869\", \"name\": \"cellular developmental process\"}, {\"id\": \"GO:0051093\", \"name\": \"negative regulation of developmental process\"}, {\"id\": \"GO:0010742\", \"name\": \"macrophage derived foam cell differentiation\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0045595\", \"name\": \"regulation of cell differentiation\"}, {\"id\": \"GO:0010745\", \"name\": \"negative regulation of macrophage derived foam cell differentiation\"}, {\"id\": \"GO:0090077\", \"name\": \"foam cell differentiation\"}, {\"id\": \"GO:0030154\", \"name\": \"cell differentiation\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0010743\", \"name\": \"regulation of macrophage derived foam cell differentiation\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0045596\", \"name\": \"negative regulation of cell differentiation\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}]}, {\"annotation_id\": \"GO:0030154\", \"name\": \"cell differentiation\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0032502\", \"name\": \"developmental process\"}, {\"id\": \"GO:0048869\", \"name\": \"cellular developmental process\"}, {\"id\": \"GO:0030154\", \"name\": \"cell differentiation\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}]}, {\"annotation_id\": \"GO:0030509\", \"name\": \"BMP signaling pathway\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0051716\", \"name\": \"cellular response to stimulus\"}, {\"id\": \"GO:0071773\", \"name\": \"cellular response to BMP stimulus\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0007178\", \"name\": \"cell surface receptor protein serine/threonine kinase signaling pathway\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0071363\", \"name\": \"cellular response to growth factor stimulus\"}, {\"id\": \"GO:0007166\", \"name\": \"cell surface receptor signaling pathway\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0023052\", \"name\": \"signaling\"}, {\"id\": \"GO:0009719\", \"name\": \"response to endogenous stimulus\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0007154\", \"name\": \"cell communication\"}, {\"id\": \"GO:0071495\", \"name\": \"cellular response to endogenous stimulus\"}, {\"id\": \"GO:0071772\", \"name\": \"response to BMP\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0141091\", \"name\": \"transforming growth factor beta receptor superfamily signaling pathway\"}, {\"id\": \"GO:0007165\", \"name\": \"signal transduction\"}, {\"id\": \"GO:0070848\", \"name\": \"response to growth factor\"}, {\"id\": \"GO:0030509\", \"name\": \"BMP signaling pathway\"}, {\"id\": \"GO:0007167\", \"name\": \"enzyme-linked receptor protein signaling pathway\"}]}, {\"annotation_id\": \"GO:0001227\", \"name\": \"DNA-binding transcription repressor activity, RNA polymerase II-specific\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0000981\", \"name\": \"DNA-binding transcription factor activity, RNA polymerase II-specific\"}, {\"id\": \"GO:0001227\", \"name\": \"DNA-binding transcription repressor activity, RNA polymerase II-specific\"}, {\"id\": \"GO:0140110\", \"name\": \"transcription regulator activity\"}, {\"id\": \"GO:0001217\", \"name\": \"DNA-binding transcription repressor activity\"}, {\"id\": \"GO:0003700\", \"name\": \"DNA-binding transcription factor activity\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0090575\", \"name\": \"RNA polymerase II transcription regulator complex\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0090575\", \"name\": \"RNA polymerase II transcription regulator complex\"}, {\"id\": \"GO:0043227\", \"name\": \"membrane-bounded organelle\"}, {\"id\": \"GO:0032991\", \"name\": \"protein-containing complex\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0005622\", \"name\": \"intracellular anatomical structure\"}, {\"id\": \"GO:0005634\", \"name\": \"nucleus\"}, {\"id\": \"GO:0140513\", \"name\": \"nuclear protein-containing complex\"}, {\"id\": \"GO:0005667\", \"name\": \"transcription regulator complex\"}, {\"id\": \"GO:0043231\", \"name\": \"intracellular membrane-bounded organelle\"}, {\"id\": \"GO:0043229\", \"name\": \"intracellular organelle\"}, {\"id\": \"GO:0110165\", \"name\": \"cellular anatomical structure\"}, {\"id\": \"GO:0043226\", \"name\": \"organelle\"}]}, {\"annotation_id\": \"IPR050234\", \"name\": \"Nuclear hormone receptor family NR1 subfamily\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR050234\", \"name\": \"Nuclear hormone receptor family NR1 subfamily\"}]}, {\"annotation_id\": \"GO:1904179\", \"name\": \"positive regulation of adipose tissue development\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0032502\", \"name\": \"developmental process\"}, {\"id\": \"GO:0032501\", \"name\": \"multicellular organismal process\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0050793\", \"name\": \"regulation of developmental process\"}, {\"id\": \"GO:0061448\", \"name\": \"connective tissue development\"}, {\"id\": \"GO:0060612\", \"name\": \"adipose tissue development\"}, {\"id\": \"GO:1904179\", \"name\": \"positive regulation of adipose tissue development\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0048513\", \"name\": \"animal organ development\"}, {\"id\": \"GO:0048518\", \"name\": \"positive regulation of biological process\"}, {\"id\": \"GO:0009888\", \"name\": \"tissue development\"}, {\"id\": \"GO:0051094\", \"name\": \"positive regulation of developmental process\"}, {\"id\": \"GO:1904177\", \"name\": \"regulation of adipose tissue development\"}, {\"id\": \"GO:0048856\", \"name\": \"anatomical structure development\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0051240\", \"name\": \"positive regulation of multicellular organismal process\"}, {\"id\": \"GO:0051239\", \"name\": \"regulation of multicellular organismal process\"}]}, {\"annotation_id\": \"GO:0010887\", \"name\": \"negative regulation of cholesterol storage\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0010878\", \"name\": \"cholesterol storage\"}, {\"id\": \"GO:0032879\", \"name\": \"regulation of localization\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0010887\", \"name\": \"negative regulation of cholesterol storage\"}, {\"id\": \"GO:0019915\", \"name\": \"lipid storage\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0010876\", \"name\": \"lipid localization\"}, {\"id\": \"GO:1905953\", \"name\": \"negative regulation of lipid localization\"}, {\"id\": \"GO:0051179\", \"name\": \"localization\"}, {\"id\": \"GO:0010883\", \"name\": \"regulation of lipid storage\"}, {\"id\": \"GO:1905952\", \"name\": \"regulation of lipid localization\"}, {\"id\": \"GO:0010888\", \"name\": \"negative regulation of lipid storage\"}, {\"id\": \"GO:0033036\", \"name\": \"macromolecule localization\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0170062\", \"name\": \"nutrient storage\"}, {\"id\": \"GO:0010885\", \"name\": \"regulation of cholesterol storage\"}]}, {\"annotation_id\": \"GO:0045668\", \"name\": \"negative regulation of osteoblast differentiation\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0032502\", \"name\": \"developmental process\"}, {\"id\": \"GO:0045667\", \"name\": \"regulation of osteoblast differentiation\"}, {\"id\": \"GO:0032501\", \"name\": \"multicellular organismal process\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0050793\", \"name\": \"regulation of developmental process\"}, {\"id\": \"GO:0048869\", \"name\": \"cellular developmental process\"}, {\"id\": \"GO:0045668\", \"name\": \"negative regulation of osteoblast differentiation\"}, {\"id\": \"GO:0051093\", \"name\": \"negative regulation of developmental process\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0045595\", \"name\": \"regulation of cell differentiation\"}, {\"id\": \"GO:0001649\", \"name\": \"osteoblast differentiation\"}, {\"id\": \"GO:0001503\", \"name\": \"ossification\"}, {\"id\": \"GO:0030154\", \"name\": \"cell differentiation\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0045596\", \"name\": \"negative regulation of cell differentiation\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}]}, {\"annotation_id\": \"GO:0000978\", \"name\": \"RNA polymerase II cis-regulatory region sequence-specific DNA binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0003677\", \"name\": \"DNA binding\"}, {\"id\": \"GO:0043565\", \"name\": \"sequence-specific DNA binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003690\", \"name\": \"double-stranded DNA binding\"}, {\"id\": \"GO:0003676\", \"name\": \"nucleic acid binding\"}, {\"id\": \"GO:0000977\", \"name\": \"RNA polymerase II transcription regulatory region sequence-specific DNA binding\"}, {\"id\": \"GO:0000987\", \"name\": \"cis-regulatory region sequence-specific DNA binding\"}, {\"id\": \"GO:1990837\", \"name\": \"sequence-specific double-stranded DNA binding\"}, {\"id\": \"GO:0000976\", \"name\": \"transcription cis-regulatory region binding\"}, {\"id\": \"GO:0001067\", \"name\": \"transcription regulatory region nucleic acid binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0000978\", \"name\": \"RNA polymerase II cis-regulatory region sequence-specific DNA binding\"}]}, {\"annotation_id\": \"GO:0003682\", \"name\": \"chromatin binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0003682\", \"name\": \"chromatin binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0048662\", \"name\": \"negative regulation of smooth muscle cell proliferation\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0008285\", \"name\": \"negative regulation of cell population proliferation\"}, {\"id\": \"GO:0008283\", \"name\": \"cell population proliferation\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0048660\", \"name\": \"regulation of smooth muscle cell proliferation\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0048659\", \"name\": \"smooth muscle cell proliferation\"}, {\"id\": \"GO:0048662\", \"name\": \"negative regulation of smooth muscle cell proliferation\"}, {\"id\": \"GO:0042127\", \"name\": \"regulation of cell population proliferation\"}, {\"id\": \"GO:0048523\", \"name\": \"negative regulation of cellular process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0033002\", \"name\": \"muscle cell proliferation\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}]}, {\"annotation_id\": \"GO:0070165\", \"name\": \"positive regulation of adiponectin secretion\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0010647\", \"name\": \"positive regulation of cell communication\"}, {\"id\": \"GO:0032501\", \"name\": \"multicellular organismal process\"}, {\"id\": \"GO:0032879\", \"name\": \"regulation of localization\"}, {\"id\": \"GO:0045184\", \"name\": \"establishment of protein localization\"}, {\"id\": \"GO:0003008\", \"name\": \"system process\"}, {\"id\": \"GO:0071705\", \"name\": \"nitrogen compound transport\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0070163\", \"name\": \"regulation of adiponectin secretion\"}, {\"id\": \"GO:1904951\", \"name\": \"positive regulation of establishment of protein localization\"}, {\"id\": \"GO:0070165\", \"name\": \"positive regulation of adiponectin secretion\"}, {\"id\": \"GO:0007154\", \"name\": \"cell communication\"}, {\"id\": \"GO:0051179\", \"name\": \"localization\"}, {\"id\": \"GO:0070162\", \"name\": \"adiponectin secretion\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0008104\", \"name\": \"intracellular protein localization\"}, {\"id\": \"GO:0065008\", \"name\": \"regulation of biological quality\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0010817\", \"name\": \"regulation of hormone levels\"}, {\"id\": \"GO:0035592\", \"name\": \"establishment of protein localization to extracellular region\"}, {\"id\": \"GO:0009306\", \"name\": \"protein secretion\"}, {\"id\": \"GO:0051234\", \"name\": \"establishment of localization\"}, {\"id\": \"GO:0050708\", \"name\": \"regulation of protein secretion\"}, {\"id\": \"GO:0051046\", \"name\": \"regulation of secretion\"}, {\"id\": \"GO:0060986\", \"name\": \"endocrine hormone secretion\"}, {\"id\": \"GO:1903829\", \"name\": \"positive regulation of protein localization\"}, {\"id\": \"GO:0051240\", \"name\": \"positive regulation of multicellular organismal process\"}, {\"id\": \"GO:0046883\", \"name\": \"regulation of hormone secretion\"}, {\"id\": \"GO:0032880\", \"name\": \"regulation of protein localization\"}, {\"id\": \"GO:0006810\", \"name\": \"transport\"}, {\"id\": \"GO:0023052\", \"name\": \"signaling\"}, {\"id\": \"GO:0048518\", \"name\": \"positive regulation of biological process\"}, {\"id\": \"GO:1903532\", \"name\": \"positive regulation of secretion by cell\"}, {\"id\": \"GO:0046879\", \"name\": \"hormone secretion\"}, {\"id\": \"GO:0071692\", \"name\": \"protein localization to extracellular region\"}, {\"id\": \"GO:0051222\", \"name\": \"positive regulation of protein transport\"}, {\"id\": \"GO:0032940\", \"name\": \"secretion by cell\"}, {\"id\": \"GO:1903530\", \"name\": \"regulation of secretion by cell\"}, {\"id\": \"GO:0046887\", \"name\": \"positive regulation of hormone secretion\"}, {\"id\": \"GO:0051047\", \"name\": \"positive regulation of secretion\"}, {\"id\": \"GO:0023061\", \"name\": \"signal release\"}, {\"id\": \"GO:0051239\", \"name\": \"regulation of multicellular organismal process\"}, {\"id\": \"GO:0048522\", \"name\": \"positive regulation of cellular process\"}, {\"id\": \"GO:0023051\", \"name\": \"regulation of signaling\"}, {\"id\": \"GO:0046903\", \"name\": \"secretion\"}, {\"id\": \"GO:0051049\", \"name\": \"regulation of transport\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0070201\", \"name\": \"regulation of establishment of protein localization\"}, {\"id\": \"GO:0140352\", \"name\": \"export from cell\"}, {\"id\": \"GO:0007267\", \"name\": \"cell-cell signaling\"}, {\"id\": \"GO:0051223\", \"name\": \"regulation of protein transport\"}, {\"id\": \"GO:0050714\", \"name\": \"positive regulation of protein secretion\"}, {\"id\": \"GO:0050886\", \"name\": \"endocrine process\"}, {\"id\": \"GO:0051050\", \"name\": \"positive regulation of transport\"}, {\"id\": \"GO:0015031\", \"name\": \"protein transport\"}, {\"id\": \"GO:0033036\", \"name\": \"macromolecule localization\"}, {\"id\": \"GO:0009914\", \"name\": \"hormone transport\"}, {\"id\": \"GO:0010646\", \"name\": \"regulation of cell communication\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0023056\", \"name\": \"positive regulation of signaling\"}]}, {\"annotation_id\": \"IPR022590\", \"name\": \"Peroxisome proliferator-activated receptor gamma, N-terminal\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR022590\", \"name\": \"Peroxisome proliferator-activated receptor gamma, N-terminal\"}]}, {\"annotation_id\": \"GO:0006629\", \"name\": \"lipid metabolic process\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0006629\", \"name\": \"lipid metabolic process\"}]}, {\"annotation_id\": \"GO:0007165\", \"name\": \"signal transduction\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0051716\", \"name\": \"cellular response to stimulus\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0023052\", \"name\": \"signaling\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0007165\", \"name\": \"signal transduction\"}, {\"id\": \"GO:0007154\", \"name\": \"cell communication\"}]}, {\"annotation_id\": \"GO:0005654\", \"name\": \"nucleoplasm\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0043227\", \"name\": \"membrane-bounded organelle\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0005622\", \"name\": \"intracellular anatomical structure\"}, {\"id\": \"GO:0005634\", \"name\": \"nucleus\"}, {\"id\": \"GO:0031974\", \"name\": \"membrane-enclosed lumen\"}, {\"id\": \"GO:0043231\", \"name\": \"intracellular membrane-bounded organelle\"}, {\"id\": \"GO:0070013\", \"name\": \"intracellular organelle lumen\"}, {\"id\": \"GO:0043229\", \"name\": \"intracellular organelle\"}, {\"id\": \"GO:0110165\", \"name\": \"cellular anatomical structure\"}, {\"id\": \"GO:0005654\", \"name\": \"nucleoplasm\"}, {\"id\": \"GO:0043233\", \"name\": \"organelle lumen\"}, {\"id\": \"GO:0043226\", \"name\": \"organelle\"}, {\"id\": \"GO:0031981\", \"name\": \"nuclear lumen\"}]}, {\"annotation_id\": \"GO:0003690\", \"name\": \"double-stranded DNA binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0003677\", \"name\": \"DNA binding\"}, {\"id\": \"GO:0003690\", \"name\": \"double-stranded DNA binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003676\", \"name\": \"nucleic acid binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0048511\", \"name\": \"rhythmic process\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0048511\", \"name\": \"rhythmic process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}]}, {\"annotation_id\": \"GO:0045893\", \"name\": \"positive regulation of DNA-templated transcription\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0045893\", \"name\": \"positive regulation of DNA-templated transcription\"}, {\"id\": \"GO:0048518\", \"name\": \"positive regulation of biological process\"}, {\"id\": \"GO:0016070\", \"name\": \"RNA metabolic process\"}, {\"id\": \"GO:0010557\", \"name\": \"positive regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0080090\", \"name\": \"regulation of primary metabolic process\"}, {\"id\": \"GO:0006139\", \"name\": \"nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0032774\", \"name\": \"RNA biosynthetic process\"}, {\"id\": \"GO:0141187\", \"name\": \"nucleic acid biosynthetic process\"}, {\"id\": \"GO:0009893\", \"name\": \"positive regulation of metabolic process\"}, {\"id\": \"GO:0006351\", \"name\": \"DNA-templated transcription\"}, {\"id\": \"GO:0051252\", \"name\": \"regulation of RNA metabolic process\"}, {\"id\": \"GO:0009891\", \"name\": \"positive regulation of biosynthetic process\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0010604\", \"name\": \"positive regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0019219\", \"name\": \"regulation of nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0048522\", \"name\": \"positive regulation of cellular process\"}, {\"id\": \"GO:2001141\", \"name\": \"regulation of RNA biosynthetic process\"}, {\"id\": \"GO:0009889\", \"name\": \"regulation of biosynthetic process\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0060255\", \"name\": \"regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0034654\", \"name\": \"nucleobase-containing compound biosynthetic process\"}, {\"id\": \"GO:0010467\", \"name\": \"gene expression\"}, {\"id\": \"GO:0009059\", \"name\": \"macromolecule biosynthetic process\"}, {\"id\": \"GO:0090304\", \"name\": \"nucleic acid metabolic process\"}, {\"id\": \"GO:0051254\", \"name\": \"positive regulation of RNA metabolic process\"}, {\"id\": \"GO:0010468\", \"name\": \"regulation of gene expression\"}, {\"id\": \"GO:0009058\", \"name\": \"biosynthetic process\"}, {\"id\": \"GO:1902680\", \"name\": \"positive regulation of RNA biosynthetic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0010556\", \"name\": \"regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0043170\", \"name\": \"macromolecule metabolic process\"}, {\"id\": \"GO:0006355\", \"name\": \"regulation of DNA-templated transcription\"}, {\"id\": \"GO:0019222\", \"name\": \"regulation of metabolic process\"}]}, {\"annotation_id\": \"GO:1903243\", \"name\": \"negative regulation of cardiac muscle hypertrophy in response to stress\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0032501\", \"name\": \"multicellular organismal process\"}, {\"id\": \"GO:0014745\", \"name\": \"negative regulation of muscle adaptation\"}, {\"id\": \"GO:0003008\", \"name\": \"system process\"}, {\"id\": \"GO:0014888\", \"name\": \"striated muscle adaptation\"}, {\"id\": \"GO:0014741\", \"name\": \"negative regulation of muscle hypertrophy\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0044057\", \"name\": \"regulation of system process\"}, {\"id\": \"GO:0048519\", \"name\": \"negative regulation of biological process\"}, {\"id\": \"GO:0014743\", \"name\": \"regulation of muscle hypertrophy\"}, {\"id\": \"GO:1903242\", \"name\": \"regulation of cardiac muscle hypertrophy in response to stress\"}, {\"id\": \"GO:0043500\", \"name\": \"muscle adaptation\"}, {\"id\": \"GO:0014887\", \"name\": \"cardiac muscle adaptation\"}, {\"id\": \"GO:0080134\", \"name\": \"regulation of response to stress\"}, {\"id\": \"GO:0006950\", \"name\": \"response to stress\"}, {\"id\": \"GO:0003300\", \"name\": \"cardiac muscle hypertrophy\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0051239\", \"name\": \"regulation of multicellular organismal process\"}, {\"id\": \"GO:0014898\", \"name\": \"cardiac muscle hypertrophy in response to stress\"}, {\"id\": \"GO:0014896\", \"name\": \"muscle hypertrophy\"}, {\"id\": \"GO:0043502\", \"name\": \"regulation of muscle adaptation\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0048585\", \"name\": \"negative regulation of response to stimulus\"}, {\"id\": \"GO:1903243\", \"name\": \"negative regulation of cardiac muscle hypertrophy in response to stress\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0014897\", \"name\": \"striated muscle hypertrophy\"}, {\"id\": \"GO:0090257\", \"name\": \"regulation of muscle system process\"}, {\"id\": \"GO:0003012\", \"name\": \"muscle system process\"}, {\"id\": \"GO:0010611\", \"name\": \"regulation of cardiac muscle hypertrophy\"}, {\"id\": \"GO:0010616\", \"name\": \"negative regulation of cardiac muscle adaptation\"}, {\"id\": \"GO:0048583\", \"name\": \"regulation of response to stimulus\"}, {\"id\": \"GO:0051241\", \"name\": \"negative regulation of multicellular organismal process\"}, {\"id\": \"GO:0010612\", \"name\": \"regulation of cardiac muscle adaptation\"}, {\"id\": \"GO:0010614\", \"name\": \"negative regulation of cardiac muscle hypertrophy\"}, {\"id\": \"GO:0003299\", \"name\": \"muscle hypertrophy in response to stress\"}]}, {\"annotation_id\": \"GO:0006357\", \"name\": \"regulation of transcription by RNA polymerase II\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0050794\", \"name\": \"regulation of cellular process\"}, {\"id\": \"GO:0016070\", \"name\": \"RNA metabolic process\"}, {\"id\": \"GO:0080090\", \"name\": \"regulation of primary metabolic process\"}, {\"id\": \"GO:0006139\", \"name\": \"nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:0032774\", \"name\": \"RNA biosynthetic process\"}, {\"id\": \"GO:0141187\", \"name\": \"nucleic acid biosynthetic process\"}, {\"id\": \"GO:0006351\", \"name\": \"DNA-templated transcription\"}, {\"id\": \"GO:0051252\", \"name\": \"regulation of RNA metabolic process\"}, {\"id\": \"GO:0006366\", \"name\": \"transcription by RNA polymerase II\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}, {\"id\": \"GO:0019219\", \"name\": \"regulation of nucleobase-containing compound metabolic process\"}, {\"id\": \"GO:2001141\", \"name\": \"regulation of RNA biosynthetic process\"}, {\"id\": \"GO:0006357\", \"name\": \"regulation of transcription by RNA polymerase II\"}, {\"id\": \"GO:0009889\", \"name\": \"regulation of biosynthetic process\"}, {\"id\": \"GO:0050789\", \"name\": \"regulation of biological process\"}, {\"id\": \"GO:0065007\", \"name\": \"biological regulation\"}, {\"id\": \"GO:0044238\", \"name\": \"primary metabolic process\"}, {\"id\": \"GO:0060255\", \"name\": \"regulation of macromolecule metabolic process\"}, {\"id\": \"GO:0034654\", \"name\": \"nucleobase-containing compound biosynthetic process\"}, {\"id\": \"GO:0010467\", \"name\": \"gene expression\"}, {\"id\": \"GO:0009059\", \"name\": \"macromolecule biosynthetic process\"}, {\"id\": \"GO:0090304\", \"name\": \"nucleic acid metabolic process\"}, {\"id\": \"GO:0010468\", \"name\": \"regulation of gene expression\"}, {\"id\": \"GO:0009058\", \"name\": \"biosynthetic process\"}, {\"id\": \"GO:0009987\", \"name\": \"cellular process\"}, {\"id\": \"GO:0008152\", \"name\": \"metabolic process\"}, {\"id\": \"GO:0010556\", \"name\": \"regulation of macromolecule biosynthetic process\"}, {\"id\": \"GO:0006355\", \"name\": \"regulation of DNA-templated transcription\"}, {\"id\": \"GO:0043170\", \"name\": \"macromolecule metabolic process\"}, {\"id\": \"GO:0019222\", \"name\": \"regulation of metabolic process\"}]}, {\"annotation_id\": \"GO:0007584\", \"name\": \"response to nutrient\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0031667\", \"name\": \"response to nutrient levels\"}, {\"id\": \"GO:0050896\", \"name\": \"response to stimulus\"}, {\"id\": \"GO:0042221\", \"name\": \"response to chemical\"}, {\"id\": \"GO:0007584\", \"name\": \"response to nutrient\"}, {\"id\": \"GO:0008150\", \"name\": \"biological_process\"}]}, {\"annotation_id\": \"GO:0042277\", \"name\": \"peptide binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0042277\", \"name\": \"peptide binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0008270\", \"name\": \"zinc ion binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0043169\", \"name\": \"cation binding\"}, {\"id\": \"GO:0046914\", \"name\": \"transition metal ion binding\"}, {\"id\": \"GO:0008270\", \"name\": \"zinc ion binding\"}, {\"id\": \"GO:0043167\", \"name\": \"ion binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}, {\"id\": \"GO:0046872\", \"name\": \"metal ion binding\"}, {\"id\": \"GO:0036094\", \"name\": \"small molecule binding\"}]}, {\"annotation_id\": \"IPR035500\", \"name\": \"Nuclear hormone receptor-like domain superfamily\", \"provenance_source\": \"UNIPROT\", \"type\": \"InterPro\", \"annotation_lineage\": [{\"id\": \"IPR035500\", \"name\": \"Nuclear hormone receptor-like domain superfamily\"}]}, {\"annotation_id\": \"GO:0019899\", \"name\": \"enzyme binding\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0005515\", \"name\": \"protein binding\"}, {\"id\": \"GO:0005488\", \"name\": \"binding\"}, {\"id\": \"GO:0019899\", \"name\": \"enzyme binding\"}, {\"id\": \"GO:0003674\", \"name\": \"molecular_function\"}]}, {\"annotation_id\": \"GO:0005634\", \"name\": \"nucleus\", \"provenance_source\": \"UNIPROT\", \"type\": \"GO\", \"annotation_lineage\": [{\"id\": \"GO:0043227\", \"name\": \"membrane-bounded organelle\"}, {\"id\": \"GO:0043229\", \"name\": \"intracellular organelle\"}, {\"id\": \"GO:0110165\", \"name\": \"cellular anatomical structure\"}, {\"id\": \"GO:0005575\", \"name\": \"cellular_component\"}, {\"id\": \"GO:0005622\", \"name\": \"intracellular anatomical structure\"}, {\"id\": \"GO:0043226\", \"name\": \"organelle\"}, {\"id\": \"GO:0005634\", \"name\": \"nucleus\"}, {\"id\": \"GO:0043231\", \"name\": \"intracellular membrane-bounded organelle\"}]}], \"rcsb_polymer_entity_container_identifiers\": {\"asym_ids\": [\"A\", \"B\"], \"auth_asym_ids\": [\"A\", \"B\"], \"chem_comp_monomers\": [\"ALA\", \"ARG\", \"ASN\", \"ASP\", \"CYS\", \"GLN\", \"GLU\", \"GLY\", \"HIS\", \"ILE\", \"LEU\", \"LYS\", \"MET\", \"PHE\", \"PRO\", \"SER\", \"THR\", \"TYR\", \"VAL\"], \"entity_id\": \"1\", \"entry_id\": \"2G0H\", \"rcsb_id\": \"2G0H_1\", \"uniprot_ids\": [\"P37231\"], \"reference_sequence_identifiers\": [{\"database_accession\": \"P37231\", \"database_name\": \"UniProt\", \"entity_sequence_coverage\": 1.0, \"provenance_source\": \"SIFTS\", \"reference_sequence_coverage\": 0.5366336633663367}]}, \"rcsb_polymer_entity_feature\": [{\"assignment_version\": \"34.0\", \"feature_id\": \"PF00104\", \"name\": \"Ligand-binding domain of nuclear hormone receptor (Hormone_recep)\", \"provenance_source\": \"Pfam\", \"type\": \"Pfam\", \"feature_positions\": [{\"beg_seq_id\": 65, \"end_seq_id\": 252}]}, {\"name\": \"Hydropathy values\", \"provenance_source\": \"biojava-7.2.4\", \"type\": \"hydropathy\", \"feature_positions\": [{\"beg_seq_id\": 5, \"values\": [0.08, 0.03, -0.23, -0.01, 0.23, -0.58, -0.17, -0.51, -0.43, -1.07, -0.72, -0.06, -0.66, -0.09, 0.22, -0.12, 0.22, -0.71, -0.08, -0.49, -0.6, 0.08, 0.08, 0.08, 0.47, -0.17, 0.19, -0.09, 0.02, -0.61, -1.2, -1.8, -1.41, -0.9, 0.03, -0.03, -0.34, 0.26, 0.3, 0.3, 0.9, 0.8, 0.54, 0.0, -0.24, -0.24, -0.89, 0.0, -0.34, -0.46, -1.1, -1.67, -1.12, -0.81, -0.6, 0.26, -0.63, -0.59, -1.29, -0.94, -1.02, -1.91, -1.37, -0.99, -0.91, -1.02, -0.13, 0.57, 0.27, 0.66, 1.32, 0.47, 0.58, -0.42, -0.01, -0.04, -0.74, -0.16, 0.36, -0.31, -0.31, -0.12, 0.3, 0.0, -0.61, -0.02, -0.66, -1.21, -0.32, -0.11, -0.66, -0.27, 0.59, 0.34, 0.57, 0.61, 1.12, 0.23, 0.02, -0.32, -0.17, -0.71, 0.1, 0.1, 0.06, -0.51, -0.17, 0.69, 0.72, -0.13, 0.44, 0.52, -0.04, 0.31, 0.67, 1.13, 0.87, 1.13, 1.94, 1.66, 0.77, 0.48, 0.17, -0.09, -0.04, 0.18, 0.77, 0.26, -0.34, 0.0, 0.04, 0.39, 0.74, 0.49, -0.01, -1.01, -1.31, -0.61, -0.14, -0.19, -0.23, -0.12, -0.83, -1.19, -0.87, -0.17, -0.52, -1.33, -0.59, -0.29, -1.1, -0.78, -0.78, -0.29, -0.99, -0.63, -0.04, 0.11, -0.53, 0.17, -0.04, 0.59, 0.7, 0.7, 0.81, 0.22, -0.63, -0.29, -0.99, -0.18, -0.18, -0.1, 0.6, 0.68, 1.27, 2.12, 2.71, 3.6, 3.6, 3.31, 2.77, 2.07, 1.07, 0.69, 0.18, 0.1, 0.02, -0.79, -0.23, -0.62, -0.41, 0.59, 0.38, 0.03, 0.11, -0.7, -0.7, -1.56, -0.7, -0.1, -0.99, -0.4, 0.41, -0.48, 0.33, 0.33, 1.14, 0.29, 0.29, 0.29, -0.27, -0.87, -0.87, -1.38, -1.08, -1.89, -1.03, -1.14, -0.56, -0.63, -0.03, 0.78, 0.48, 0.13, 0.73, 0.23, -0.47, -0.24, -0.31, -1.12, -1.04, -0.19, 0.17, -0.43, -0.71, 0.14, -0.67, 0.26, 1.07, 0.18, 0.18, 0.76, 0.71, 0.63, 0.09, 0.09, -0.41, -1.22, -0.62, -1.18, -1.26, -1.18, -0.92, -0.42, 0.39, 0.08, 0.08, 0.37, 0.31, -0.54, -0.58, 0.02, -0.54]}]}, {\"name\": \"Disordered regions\", \"provenance_source\": \"IUPred2(short)\", \"type\": \"disorder\", \"feature_positions\": [{\"beg_seq_id\": 1, \"values\": [0.82, 0.72, 0.61, 0.56, 0.52, 0.41, 0.29, 0.25, 0.2, 0.1, 0.09, 0.05, 0.05, 0.07, 0.05, 0.1, 0.07, 0.09, 0.12, 0.1, 0.06, 0.06, 0.08, 0.13, 0.13, 0.13, 0.18, 0.25, 0.25, 0.29, 0.3, 0.21, 0.23, 0.16, 0.16, 0.17, 0.18, 0.21, 0.15, 0.16, 0.2, 0.27, 0.29, 0.3, 0.29, 0.23, 0.23, 0.17, 0.16, 0.16, 0.09, 0.14, 0.22, 0.2, 0.28, 0.29, 0.31, 0.31, 0.3, 0.38, 0.34, 0.34, 0.26, 0.26, 0.18, 0.13, 0.18, 0.19, 0.21, 0.22, 0.15, 0.2, 0.21, 0.12, 0.2, 0.17, 0.11, 0.11, 0.11, 0.07, 0.06, 0.1, 0.07, 0.09, 0.08, 0.13, 0.11, 0.13, 0.13, 0.1, 0.06, 0.1, 0.06, 0.06, 0.05, 0.05, 0.07, 0.11, 0.07, 0.06, 0.06, 0.03, 0.03, 0.03, 0.04, 0.02, 0.02, 0.05, 0.02, 0.01, 0.01, 0.02, 0.01, 0.01, 0.01, 0.02, 0.01, 0.01, 0.01, 0.01, 0.01, 0.03, 0.03, 0.02, 0.02, 0.02, 0.03, 0.04, 0.04, 0.06, 0.06, 0.08, 0.08, 0.11, 0.19, 0.14, 0.09, 0.15, 0.18, 0.12, 0.11, 0.1, 0.12, 0.11, 0.18, 0.27, 0.17, 0.13, 0.15, 0.16, 0.15, 0.15, 0.19, 0.12, 0.09, 0.05, 0.08, 0.07, 0.08, 0.06, 0.05, 0.06, 0.03, 0.03, 0.05, 0.05, 0.05, 0.05, 0.05, 0.03, 0.01, 0.01, 0.01, 0.01, 0.01, 0.0, 0.0, 0.0, 0.01, 0.01, 0.01, 0.03, 0.02, 0.02, 0.01, 0.01, 0.01, 0.0, 0.01, 0.01, 0.02, 0.04, 0.03, 0.04, 0.08, 0.14, 0.14, 0.16, 0.16, 0.13, 0.07, 0.08, 0.04, 0.04, 0.04, 0.08, 0.05, 0.08, 0.09, 0.09, 0.17, 0.16, 0.16, 0.26, 0.16, 0.09, 0.07, 0.13, 0.13, 0.08, 0.09, 0.16, 0.13, 0.19, 0.18, 0.19, 0.19, 0.28, 0.19, 0.13, 0.1, 0.1, 0.1, 0.06, 0.06, 0.07, 0.07, 0.08, 0.05, 0.04, 0.07, 0.07, 0.07, 0.09, 0.09, 0.09, 0.12, 0.12, 0.07, 0.12, 0.2, 0.13, 0.07, 0.07, 0.12, 0.06, 0.07, 0.12, 0.13, 0.12, 0.14, 0.17, 0.21, 0.26, 0.3, 0.35, 0.38, 0.46, 0.49, 0.62, 0.66]}]}, {\"name\": \"Disordered binding sites\", \"provenance_source\": \"Anchor2\", \"type\": \"disorder_binding\", \"feature_positions\": [{\"beg_seq_id\": 1, \"values\": [0.19, 0.2, 0.21, 0.21, 0.22, 0.23, 0.24, 0.25, 0.25, 0.25, 0.26, 0.27, 0.27, 0.26, 0.26, 0.25, 0.24, 0.24, 0.24, 0.25, 0.25, 0.25, 0.25, 0.26, 0.26, 0.27, 0.27, 0.28, 0.28, 0.28, 0.28, 0.27, 0.26, 0.26, 0.26, 0.26, 0.26, 0.27, 0.28, 0.29, 0.31, 0.33, 0.35, 0.36, 0.37, 0.38, 0.38, 0.39, 0.4, 0.41, 0.4, 0.38, 0.37, 0.37, 0.36, 0.36, 0.35, 0.35, 0.34, 0.32, 0.3, 0.29, 0.28, 0.27, 0.26, 0.26, 0.25, 0.25, 0.25, 0.25, 0.26, 0.27, 0.28, 0.28, 0.28, 0.28, 0.27, 0.26, 0.25, 0.23, 0.21, 0.19, 0.18, 0.16, 0.15, 0.14, 0.13, 0.12, 0.12, 0.12, 0.12, 0.12, 0.12, 0.12, 0.12, 0.12, 0.13, 0.13, 0.13, 0.12, 0.12, 0.11, 0.1, 0.1, 0.09, 0.09, 0.08, 0.08, 0.07, 0.07, 0.07, 0.07, 0.08, 0.08, 0.08, 0.09, 0.1, 0.11, 0.12, 0.13, 0.13, 0.14, 0.14, 0.14, 0.13, 0.13, 0.12, 0.12, 0.11, 0.11, 0.1, 0.1, 0.09, 0.09, 0.1, 0.1, 0.1, 0.1, 0.09, 0.09, 0.08, 0.08, 0.07, 0.07, 0.06, 0.06, 0.05, 0.05, 0.05, 0.05, 0.06, 0.06, 0.07, 0.07, 0.08, 0.09, 0.1, 0.11, 0.11, 0.11, 0.11, 0.1, 0.1, 0.09, 0.09, 0.08, 0.08, 0.09, 0.09, 0.09, 0.09, 0.1, 0.1, 0.1, 0.1, 0.09, 0.09, 0.08, 0.07, 0.06, 0.06, 0.06, 0.06, 0.06, 0.06, 0.06, 0.07, 0.07, 0.08, 0.09, 0.1, 0.1, 0.1, 0.09, 0.09, 0.09, 0.09, 0.08, 0.08, 0.07, 0.07, 0.07, 0.07, 0.07, 0.07, 0.07, 0.07, 0.07, 0.07, 0.08, 0.09, 0.1, 0.11, 0.13, 0.14, 0.16, 0.19, 0.22, 0.26, 0.3, 0.31, 0.33, 0.34, 0.35, 0.37, 0.38, 0.38, 0.37, 0.36, 0.33, 0.3, 0.29, 0.28, 0.26, 0.24, 0.21, 0.18, 0.16, 0.15, 0.14, 0.13, 0.13, 0.12, 0.11, 0.1, 0.1, 0.1, 0.11, 0.11, 0.12, 0.14, 0.17, 0.19, 0.21, 0.25, 0.27, 0.29, 0.3, 0.32, 0.32, 0.31, 0.29, 0.27, 0.25, 0.23, 0.22, 0.21, 0.2, 0.2, 0.19, 0.19]}]}], \"rcsb_polymer_entity_feature_summary\": [{\"count\": 1, \"coverage\": 0.69373, \"type\": \"Pfam\"}], \"rcsb_polymer_entity_group_membership\": [{\"aggregation_method\": \"sequence_identity\", \"group_id\": \"165_70\", \"similarity_cutoff\": 70.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 42, \"ref_beg_seq_id\": 243}, {\"entity_beg_seq_id\": 43, \"length\": 229, \"ref_beg_seq_id\": 287}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"266_50\", \"similarity_cutoff\": 50.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 37, \"ref_beg_seq_id\": 245}, {\"entity_beg_seq_id\": 38, \"length\": 28, \"ref_beg_seq_id\": 284}, {\"entity_beg_seq_id\": 66, \"length\": 206, \"ref_beg_seq_id\": 313}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"107_95\", \"similarity_cutoff\": 95.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 271, \"ref_beg_seq_id\": 239}]}, {\"aggregation_method\": \"matching_uniprot_accession\", \"group_id\": \"P37231\", \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 271, \"ref_beg_seq_id\": 235}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"378_30\", \"similarity_cutoff\": 30.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 37, \"ref_beg_seq_id\": 245}, {\"entity_beg_seq_id\": 38, \"length\": 28, \"ref_beg_seq_id\": 284}, {\"entity_beg_seq_id\": 66, \"length\": 206, \"ref_beg_seq_id\": 313}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"113_100\", \"similarity_cutoff\": 100.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 271, \"ref_beg_seq_id\": 235}]}, {\"aggregation_method\": \"sequence_identity\", \"group_id\": \"117_90\", \"similarity_cutoff\": 90.0, \"aligned_regions\": [{\"entity_beg_seq_id\": 1, \"length\": 271, \"ref_beg_seq_id\": 239}]}], \"rcsb_polymer_entity_name_com\": [{\"name\": \"PPAR-gamma\"}], \"rcsb_related_target_references\": [{\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL1932903\", \"target_taxonomy_id\": 9615, \"aligned_target\": [{\"entity_beg_seq_id\": 1, \"length\": 270, \"target_beg_seq_id\": 235}]}, {\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL2096976\", \"target_taxonomy_id\": 9606, \"aligned_target\": [{\"entity_beg_seq_id\": 1, \"length\": 270, \"target_beg_seq_id\": 235}]}, {\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL2095161\", \"target_taxonomy_id\": 9606, \"aligned_target\": [{\"entity_beg_seq_id\": 1, \"length\": 270, \"target_beg_seq_id\": 235}]}, {\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL2095162\", \"target_taxonomy_id\": 9606, \"aligned_target\": [{\"entity_beg_seq_id\": 1, \"length\": 270, \"target_beg_seq_id\": 235}]}, {\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL2095163\", \"target_taxonomy_id\": 9606, \"aligned_target\": [{\"entity_beg_seq_id\": 1, \"length\": 270, \"target_beg_seq_id\": 235}]}, {\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL235\", \"target_taxonomy_id\": 9606, \"aligned_target\": [{\"entity_beg_seq_id\": 1, \"length\": 270, \"target_beg_seq_id\": 235}]}, {\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL2111394\", \"target_taxonomy_id\": 9606, \"aligned_target\": [{\"entity_beg_seq_id\": 1, \"length\": 270, \"target_beg_seq_id\": 235}]}, {\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL2111371\", \"target_taxonomy_id\": 9606, \"aligned_target\": [{\"entity_beg_seq_id\": 1, \"length\": 270, \"target_beg_seq_id\": 235}]}, {\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL2111325\", \"target_taxonomy_id\": 9606, \"aligned_target\": [{\"entity_beg_seq_id\": 1, \"length\": 270, \"target_beg_seq_id\": 235}]}, {\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL3559683\", \"target_taxonomy_id\": 9606, \"aligned_target\": [{\"entity_beg_seq_id\": 1, \"length\": 270, \"target_beg_seq_id\": 235}]}, {\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL2459\", \"target_taxonomy_id\": 10090, \"aligned_target\": [{\"entity_beg_seq_id\": 1, \"length\": 270, \"target_beg_seq_id\": 235}]}, {\"related_resource_name\": \"ChEMBL\", \"related_resource_version\": \"36\", \"related_target_id\": \"CHEMBL4797\", \"target_taxonomy_id\": 10116, \"aligned_target\": [{\"entity_beg_seq_id\": 1, \"length\": 270, \"target_beg_seq_id\": 235}]}, {\"related_resource_name\": \"DrugBank\", \"related_resource_version\": \"5.1\", \"related_target_id\": \"P37231\", \"target_taxonomy_id\": 9606, \"aligned_target\": [{\"entity_beg_seq_id\": 1, \"length\": 270, \"target_beg_seq_id\": 235}]}, {\"related_resource_name\": \"Pharos\", \"related_resource_version\": \"6.13.4\", \"related_target_id\": \"19023\", \"target_taxonomy_id\": 9606, \"aligned_target\": [{\"entity_beg_seq_id\": 1, \"length\": 270, \"target_beg_seq_id\": 235}]}], \"rcsb_target_cofactors\": [{\"binding_assay_value\": 3.96, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"UEIFAMIUBPSKHA-SFHVURJKSA-N\", \"cofactor_smiles\": \"Cc1nc(-c2ccc(Cl)cc2)sc1C(=O)N[C@H]1CCCN(c2cccc(C(=O)O)c2)C1\", \"cofactor_resource_id\": \"CHEMBL1934476\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL1932903\"}, {\"binding_assay_value\": 3.4, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"RBRSLSDXXMOOCE-UHFFFAOYSA-N\", \"cofactor_smiles\": \"Cc1ccnc(NC(=S)N2CCN(c3cccc(C(F)(F)F)c3)CC2)c1\", \"cofactor_resource_id\": \"CHEMBL1471788\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2096976\"}, {\"binding_assay_value\": 3.4, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"PGYNXKICBNGAOF-UHFFFAOYSA-N\", \"cofactor_smiles\": \"COc1ccc2[nH]c(C(=O)Nc3ccc(F)cc3Br)cc2c1\", \"cofactor_resource_id\": \"CHEMBL1327081\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2096976\"}, {\"binding_assay_value\": 3.4, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"GXOHYVMGAJUGMV-UHFFFAOYSA-N\", \"cofactor_smiles\": \"NS(=O)(=O)c1ccc(CNC(=O)c2cc(-c3ccccn3)nc3ccc(Cl)cc23)cc1\", \"cofactor_resource_id\": \"CHEMBL1363571\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2096976\"}, {\"binding_assay_value\": 3.4, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"PEECVRVLAKJKOM-UHFFFAOYSA-N\", \"cofactor_smiles\": \"Cc1ccc2oc(=O)cc(CN3CCCCC3)c2c1\", \"cofactor_resource_id\": \"CHEMBL1398736\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2096976\"}, {\"binding_assay_value\": 3.4, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"BKSMOTMNWVIWPR-UHFFFAOYSA-N\", \"cofactor_smiles\": \"Oc1cc(O)c2sc3nc(C(F)(F)F)c4c(c3c2n1)CCCCC4\", \"cofactor_resource_id\": \"CHEMBL1613080\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2096976\"}, {\"binding_assay_value\": 3.4, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"ANVKONNLYQQYNM-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCOc1ccc(C(=O)Nc2ccc(NC(=O)c3ccco3)c(Cl)c2)cc1Br\", \"cofactor_resource_id\": \"CHEMBL1461732\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2096976\"}, {\"binding_assay_value\": 3.4, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"RRWDFRLGOIMWST-UHFFFAOYSA-N\", \"cofactor_smiles\": \"O=C(Nc1ccc(-c2cc3ccccc3oc2=O)c(Cl)c1)c1cccnc1\", \"cofactor_resource_id\": \"CHEMBL1337717\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2096976\"}, {\"binding_assay_value\": 3.4, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"VVJDHFNDWCDHND-UHFFFAOYSA-N\", \"cofactor_smiles\": \"COc1ccc(C(=O)NNC(=O)C(Cc2ccc(O)cc2)NC(=O)c2ccccc2NC(=O)c2ccc(OC)cc2)cc1\", \"cofactor_resource_id\": \"CHEMBL1349484\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2096976\"}, {\"binding_assay_value\": 3.07, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"JNOVSMUYAXWARW-UHFFFAOYSA-N\", \"cofactor_smiles\": \"Fc1cccc(CSc2ncnc3c2oc2ccccc23)c1\", \"cofactor_resource_id\": \"CHEMBL1376488\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2095161\"}, {\"binding_assay_value\": 3.07, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"DNBGXCVAILAKLK-UHFFFAOYSA-M\", \"cofactor_smiles\": \"CN(C)c1ccc(/C=C/c2ccc3c4ccccc4ccc3[n+]2-c2ccccc2)cc1.[Cl-]\", \"cofactor_resource_id\": \"CHEMBL1366942\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2095161\"}, {\"binding_assay_value\": 3.07, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"PYIABIAKSKQJSL-UHFFFAOYSA-N\", \"cofactor_smiles\": \"O=C(CSc1nnnn1Cc1ccccc1)NCC(=O)c1ccccc1\", \"cofactor_resource_id\": \"CHEMBL1451889\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2095161\"}, {\"binding_assay_value\": 3.04, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"UWOCUWLSBMSEME-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCCOC(=O)CNc1nnc(S)nc1O\", \"cofactor_resource_id\": \"CHEMBL1510408\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2095161\"}, {\"binding_assay_value\": 3.04, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"ZWBIRAANKUOTFZ-UHFFFAOYSA-N\", \"cofactor_smiles\": \"O=C(CSc1ncnc2c1oc1ccccc12)Nc1ccccc1F\", \"cofactor_resource_id\": \"CHEMBL1588950\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2095161\"}, {\"binding_assay_value\": 2.92, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"KXOGXZAXERYOTC-UHFFFAOYSA-N\", \"cofactor_smiles\": \"COc1ccc(N)c2c1C(=O)c1ccccc1C2=O\", \"cofactor_resource_id\": \"CHEMBL600008\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2095161\"}, {\"binding_assay_value\": 2.86, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"QTYRXDNEKDYHIG-UHFFFAOYSA-N\", \"cofactor_smiles\": \"Cc1cc(C(=O)OCC(=O)c2ccc(Br)s2)no1\", \"cofactor_resource_id\": \"CHEMBL1450791\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2095162\"}, {\"binding_assay_value\": 2.8, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"BSSGDZONEDRASD-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCC(C)NC(=O)c1ccc(OCc2ccc(Cl)cc2)c(OC)c1\", \"cofactor_resource_id\": \"CHEMBL1417458\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2095162\"}, {\"binding_assay_value\": 2.79, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"LUFJCZIBTYMIQU-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCOC(=O)c1sc2nc(C)nc(S)c2c1C\", \"cofactor_resource_id\": \"CHEMBL1495560\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2095162\"}, {\"binding_assay_value\": 2.44, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"GDPWRAFBENRFGG-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CSc1oc(-c2ccccc2)nc1C(N)=O\", \"cofactor_resource_id\": \"CHEMBL602163\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2095162\"}, {\"binding_assay_value\": 2.35, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"TWKAOPADBDMWOZ-UHFFFAOYSA-N\", \"cofactor_smiles\": \"Cc1onc(-c2c(F)cccc2Cl)c1C(=O)Nc1nnc(-c2ccccc2)s1\", \"cofactor_resource_id\": \"CHEMBL1542120\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2095162\"}, {\"binding_assay_value\": 1.04, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"BXISOPKQRATYMT-UHFFFAOYSA-N\", \"cofactor_smiles\": \"N#CC1=C2SCN(Cc3ccccc3)CN2C(=O)CC1c1cccs1\", \"cofactor_resource_id\": \"CHEMBL1551015\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2095162\"}, {\"binding_assay_value\": 2.95, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"PWXGCSADNXIHHC-UHFFFAOYSA-N\", \"cofactor_smiles\": \"Cc1cc(N2C(=O)C(O)=C(C(=O)c3ccc(Cl)cc3)C2c2cccc(Br)c2)no1\", \"cofactor_resource_id\": \"CHEMBL1442411\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2095163\"}, {\"binding_assay_value\": 2.92, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"SKODCLBTTAOBCE-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCOc1ccc(CCNC(=O)CSc2cc(=O)n(CC)c3ccccc23)cc1OCC\", \"cofactor_resource_id\": \"CHEMBL1471229\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2095163\"}, {\"binding_assay_value\": 2.86, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"KMMFETCHQUVWOV-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCC(=O)Nc1nc(C)c(C(C)=O)s1\", \"cofactor_resource_id\": \"CHEMBL1459745\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2095163\"}, {\"binding_assay_value\": 2.84, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"ICKKHOVNAGLAJL-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1CCN(S(=O)(=O)c2ccc(C(=O)Nc3sccc3C(N)=O)cc2)CC1\", \"cofactor_resource_id\": \"CHEMBL1470470\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2095163\"}, {\"binding_assay_value\": 2.73, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"HAPMHAUQCLZGPL-UHFFFAOYSA-N\", \"cofactor_smiles\": \"Cn1c(=O)cc(SCC(=O)N2CCN(c3ccccc3)CC2)c2ccccc21\", \"cofactor_resource_id\": \"CHEMBL1515768\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2095163\"}, {\"binding_assay_value\": 2.63, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"RBSHUOWQMVXHMT-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCSc1nnc(-c2ccccc2SC)o1\", \"cofactor_resource_id\": \"CHEMBL1412417\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2095163\"}, {\"binding_assay_value\": -0.17, \"binding_assay_value_type\": \"pKi\", \"cofactor_in_ch_ikey\": \"MRFJHLGKGUJDAA-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CN(CCOc1ccc(CC(Nc2ccccc2S(=O)(=O)c2ccccc2)C(=O)O)cc1)c1nc2ccccc2o1\", \"cofactor_resource_id\": \"CHEMBL146123\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL235\"}, {\"binding_assay_value\": -0.17, \"binding_assay_value_type\": \"pKi\", \"cofactor_in_ch_ikey\": \"JIQZXPNJCFZXNY-MHZLTWQESA-N\", \"cofactor_smiles\": \"O=C(C1=C(N[C@@H](Cc2ccc(OCc3ccccc3)cc2)C(=O)O)CCCC1)c1ccccc1\", \"cofactor_resource_id\": \"CHEMBL1785031\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL235\"}, {\"binding_assay_value\": -0.21, \"binding_assay_value_type\": \"pKi\", \"cofactor_in_ch_ikey\": \"DDOICUKCJCTMSS-AOVJHHBVSA-N\", \"cofactor_smiles\": \"COC(=O)[C@H](Cc1ccc(OCc2ccccc2)cc1)N/C(C)=C/C(=O)c1ccccc1\", \"cofactor_resource_id\": \"CHEMBL1785030\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL235\"}, {\"binding_assay_value\": -0.22, \"binding_assay_value_type\": \"pKi\", \"cofactor_in_ch_ikey\": \"QNBBONUOVHBLSG-MHZLTWQESA-N\", \"cofactor_smiles\": \"O=C(c1ccccc1)c1ccccc1N[C@@H](Cc1ccc(OCc2ccccc2)cc1)C(=O)O\", \"cofactor_resource_id\": \"CHEMBL359377\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL235\"}, {\"binding_assay_value\": -0.23, \"binding_assay_value_type\": \"pKi\", \"cofactor_in_ch_ikey\": \"SPPJKTQILUGRMJ-LULQDDRCSA-N\", \"cofactor_smiles\": \"C/C(=C\\\\C(=O)c1ccccc1)N[C@@H](Cc1ccc(OCc2ccccc2)cc1)C(N)=O\", \"cofactor_resource_id\": \"CHEMBL1785029\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL235\"}, {\"binding_assay_value\": -0.23, \"binding_assay_value_type\": \"pKi\", \"cofactor_in_ch_ikey\": \"LJWVXKXONHTZHU-MHZLTWQESA-N\", \"cofactor_smiles\": \"O=C(c1ccccc1)c1ccc(N[C@@H](Cc2ccc(OCc3ccccc3)cc2)C(=O)O)cc1\", \"cofactor_resource_id\": \"CHEMBL147042\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL235\"}, {\"binding_assay_value\": -0.24, \"binding_assay_value_type\": \"pKi\", \"cofactor_in_ch_ikey\": \"JQWZMVNIOBTXBZ-IURSYISVSA-N\", \"cofactor_smiles\": \"CC(=O)/C=C(\\\\C)N[C@@H](Cc1ccc(OCc2ccccc2)cc1)C(=O)O\", \"cofactor_resource_id\": \"CHEMBL1785076\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL235\"}, {\"binding_assay_value\": -0.79, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"YCSNDVZQLOQWPU-UHFFFAOYSA-N\", \"cofactor_smiles\": \"COC(=O)Cc1c(C)n(C(=O)c2ccc(Cl)cc2)c2ccc(OCCc3nc(-c4ccccc4)oc3C)cc12\", \"cofactor_resource_id\": \"CHEMBL1784945\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL235\"}, {\"binding_assay_value\": -1.09, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"GVHYRTFPNQDWBE-UHFFFAOYSA-N\", \"cofactor_smiles\": \"Cc1oc(-c2ccccc2)nc1CCOc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1\", \"cofactor_resource_id\": \"CHEMBL1784944\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL235\"}, {\"binding_assay_value\": -1.78, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"SUDOVCIPXLSLMN-UHFFFAOYSA-N\", \"cofactor_smiles\": \"O=C(O)Cc1ccc(OCc2ccccc2)cc1Nc1c(Cl)cccc1Cl\", \"cofactor_resource_id\": \"CHEMBL1784954\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL235\"}, {\"binding_assay_value\": 4.0, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"VJVDLRVFJTVWEO-QFIPXVFZSA-N\", \"cofactor_smiles\": \"CC#C[C@@H](CC(=O)O)c1ccc(OCc2ccc(CN3CCCc4cccc(OC)c43)s2)cc1\", \"cofactor_resource_id\": \"CHEMBL3955132\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2111394\"}, {\"binding_assay_value\": -15.11, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"DSILKMLNLQMKEG-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCc1cc(C(=O)C2CCCCC2)ccc1OCCCOc1cccc(C2SC(=O)NC2=O)c1\", \"cofactor_resource_id\": \"CHEMBL119496\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2111325\"}, {\"binding_assay_value\": -15.14, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"BSYLKYWBLKSLBJ-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCc1cc(Oc2ccc(Cl)cc2)ccc1OCCCOc1cccc(C2SC(=O)NC2=O)c1\", \"cofactor_resource_id\": \"CHEMBL420441\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2111325\"}, {\"binding_assay_value\": -15.36, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"SXOUCNMFIUAZNE-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCc1cc(Oc2ccc(Cl)c(Cl)c2)ccc1OCCCOc1cccc(C2SC(=O)NC2=O)c1\", \"cofactor_resource_id\": \"CHEMBL318684\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2111325\"}, {\"binding_assay_value\": -15.45, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"BTMVNTBNPIYHBM-UHFFFAOYSA-N\", \"cofactor_smiles\": \"O=C1NC(=O)C(c2cccc(OCCCOc3ccc(Oc4ccccc4)cc3)c2)S1\", \"cofactor_resource_id\": \"CHEMBL96107\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2111325\"}, {\"binding_assay_value\": -15.57, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"UJHOOSFHNXHHKX-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCc1cc(CC2CCCCC2)ccc1OCCCOc1cccc(C2SC(=O)NC2=O)c1\", \"cofactor_resource_id\": \"CHEMBL122418\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2111325\"}, {\"binding_assay_value\": -15.58, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"BZLTUCWBZRKZHF-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCc1cc(OC2CCCC2)ccc1OCCCOc1cccc(C2SC(=O)NC2=O)c1\", \"cofactor_resource_id\": \"CHEMBL118169\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2111325\"}, {\"binding_assay_value\": -15.66, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"BEESZPXMMFEPAP-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCc1cc(Oc2ccc(F)cc2)ccc1OCCCOc1cccc(C2SC(=O)NC2=O)c1\", \"cofactor_resource_id\": \"CHEMBL96451\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2111325\"}, {\"binding_assay_value\": -15.77, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"OZZBRLWUSGYQBE-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCc1cc(C(=O)c2ccccc2)ccc1OCCCOc1cccc(C2SC(=O)NC2=O)c1\", \"cofactor_resource_id\": \"CHEMBL331071\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2111325\"}, {\"binding_assay_value\": -15.79, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"ZNLPWBJCSSSCCR-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCc1cc(Oc2ccccc2)ccc1OCCCOc1cccc(C2SC(=O)NC2=O)c1\", \"cofactor_resource_id\": \"CHEMBL94306\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2111325\"}, {\"binding_assay_value\": -15.95, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"JLAXJZRUAXLLMT-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCc1cc(-c2noc3ccccc23)ccc1OCCCOc1cccc(C2SC(=O)NC2=O)c1\", \"cofactor_resource_id\": \"CHEMBL418874\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2111325\"}, {\"binding_assay_value\": 3.73, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"SKUAEZOTVFSAIN-VZIDHDPNSA-N\", \"cofactor_smiles\": \"CCCCC/C=C\\\\C/C=C\\\\CCCCCCCC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@]4(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@H]4C3=C[C@H](O)[C@@]2(O)C1\", \"cofactor_resource_id\": \"CHEMBL3353023\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3559683\"}, {\"binding_assay_value\": 3.72, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"VCRNTFWOWYDPLY-LPPZWSRQSA-N\", \"cofactor_smiles\": \"CC(=O)/C=C/C=C/C(O)CC/C=C/C(=O)NCC(C)(C)O\", \"cofactor_resource_id\": \"CHEMBL2335716\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3559683\"}, {\"binding_assay_value\": 3.69, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"ACLTWGZKVIQUPD-XHAHBFBPSA-N\", \"cofactor_smiles\": \"CCCCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@]4(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@H]4C3=C[C@H](O)[C@@]2(O)C1\", \"cofactor_resource_id\": \"CHEMBL3353024\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3559683\"}, {\"binding_assay_value\": 3.65, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"PNSISTCNWNAKTQ-AIDPMJBASA-N\", \"cofactor_smiles\": \"CCCCC/C=C\\\\C/C=C\\\\CCCCCCCC(=O)O[C@H]1CC[C@]2(C)[C@@]3(O)CC[C@]4(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@H]4C3=C[C@H](O)[C@@]2(O)C1\", \"cofactor_resource_id\": \"CHEMBL3353025\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3559683\"}, {\"binding_assay_value\": 3.3, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"ATGRMAWSMIKGDM-UCGJZQJISA-N\", \"cofactor_smiles\": \"CCCCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC=C3[C@@H]4CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]4(C)CC[C@@H]32)C1\", \"cofactor_resource_id\": \"CHEMBL3353030\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3559683\"}, {\"binding_assay_value\": 3.3, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"XZUZJKFYUFSQNX-DMKUNACRSA-N\", \"cofactor_smiles\": \"CC/C=C\\\\C/C=C\\\\C/C=C\\\\CCCCCCCC(=O)O[C@@H]1C=C2[C@@H]3CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]3(C)CC[C@@H]2[C@@]2(C)CC[C@H](O)C[C@]12O\", \"cofactor_resource_id\": \"CHEMBL3353022\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3559683\"}, {\"binding_assay_value\": 3.3, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"XEMBVLIEIXDXDY-JDBVXFMYSA-N\", \"cofactor_smiles\": \"CCCCCCCC/C=C\\\\CCCCCCCC(=O)O[C@H]1C=C2[C@@H]3CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]3(C)CC[C@@H]2[C@@]2(C)CC[C@H](O)C[C@]12O\", \"cofactor_resource_id\": \"CHEMBL3353027\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3559683\"}, {\"binding_assay_value\": 3.3, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"IASUPFYZOZPFLS-VZIDHDPNSA-N\", \"cofactor_smiles\": \"CCCCC/C=C\\\\C/C=C\\\\CCCCCCCC(=O)O[C@H]1C=C2[C@@H]3CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]3(C)CC[C@@H]2[C@@]2(C)CC[C@H](O)C[C@]12O\", \"cofactor_resource_id\": \"CHEMBL3353028\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3559683\"}, {\"binding_assay_value\": 3.3, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"OJDWINNMESMCGK-NXCSPJMSSA-N\", \"cofactor_smiles\": \"CCCCCCCCCCCCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC=C3[C@@H]4CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]4(C)CC[C@@H]32)C1\", \"cofactor_resource_id\": \"CHEMBL3353029\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3559683\"}, {\"binding_assay_value\": 3.3, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"ONJYKWSANGGHSP-DMYFEHIWSA-N\", \"cofactor_smiles\": \"CCCCCCCCCCCCCCCC(=O)O[C@H]1C=C2[C@@H]3CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]3(C)CC[C@@H]2[C@@]2(C)CC[C@H](O)C[C@]12O\", \"cofactor_resource_id\": \"CHEMBL3353026\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL3559683\"}, {\"binding_assay_value\": 2.6, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"MQOBSOSZFYZQOK-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)O\", \"cofactor_chem_comp_id\": \"F5A\", \"cofactor_name\": \"FENOFIBRIC ACID\", \"cofactor_resource_id\": \"CHEMBL981\", \"mechanism_of_action\": \"Peroxisome proliferator-activated receptor alpha agonist\", \"neighbor_flag\": \"Y\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2459\"}, {\"binding_assay_value\": 2.6, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"YMTINGFKWWXKFG-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1\", \"cofactor_chem_comp_id\": \"J3O\", \"cofactor_name\": \"FENOFIBRATE\", \"cofactor_resource_id\": \"CHEMBL672\", \"mechanism_of_action\": \"Peroxisome proliferator-activated receptor alpha agonist\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2459\"}, {\"binding_assay_value\": 2.52, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"TXCGAZHTZHNUAI-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)(Oc1ccc(Cl)cc1)C(=O)O\", \"cofactor_chem_comp_id\": \"E0O\", \"cofactor_name\": \"CLOFIBRIC ACID\", \"cofactor_resource_id\": \"CHEMBL683\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2459\"}, {\"binding_assay_value\": 2.3, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"KNHUKKLJHYUCFP-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1\", \"cofactor_name\": \"CLOFIBRATE\", \"cofactor_resource_id\": \"CHEMBL565\", \"mechanism_of_action\": \"Peroxisome proliferator-activated receptor alpha agonist\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL2459\"}, {\"binding_assay_value\": 4.0, \"binding_assay_value_type\": \"pKi\", \"cofactor_in_ch_ikey\": \"BIYAHXVUPFJGKI-SGCNCOIJSA-N\", \"cofactor_smiles\": \"CC(/C=C/c1ccccc1-c1cc(C(C)(C)C)cc(C(C)(C)C)c1OCCCF)=C\\\\C(=O)O\", \"cofactor_resource_id\": \"CHEMBL129976\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL4797\"}, {\"binding_assay_value\": 4.0, \"binding_assay_value_type\": \"pKi\", \"cofactor_in_ch_ikey\": \"IJKIEQVMZRPXJB-HKHMFKSASA-N\", \"cofactor_smiles\": \"CC(/C=C/c1ccncc1-c1cc(C(C)C)cc(C(C)C)c1OCC(F)(F)F)=C\\\\C(=O)O\", \"cofactor_resource_id\": \"CHEMBL130577\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL4797\"}, {\"binding_assay_value\": 3.89, \"binding_assay_value_type\": \"pEC50\", \"cofactor_in_ch_ikey\": \"UEIFAMIUBPSKHA-SFHVURJKSA-N\", \"cofactor_smiles\": \"Cc1nc(-c2ccc(Cl)cc2)sc1C(=O)N[C@H]1CCCN(c2cccc(C(=O)O)c2)C1\", \"cofactor_resource_id\": \"CHEMBL1934476\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL4797\"}, {\"binding_assay_value\": 3.25, \"binding_assay_value_type\": \"pIC50\", \"cofactor_in_ch_ikey\": \"RQDFXWBBMXVGHA-UHFFFAOYSA-N\", \"cofactor_smiles\": \"COc1ccc(OCCOc2ccc(CC3=C(O)C(=O)c4ccccc4C3=O)cc2)cc1\", \"cofactor_resource_id\": \"CHEMBL482531\", \"neighbor_flag\": \"N\", \"resource_name\": \"ChEMBL\", \"resource_version\": \"36\", \"target_resource_id\": \"CHEMBL4797\"}, {\"cofactor_in_ch_ikey\": \"DTOSIQBPPRVQHS-PDBXOOCHSA-N\", \"cofactor_smiles\": \"CC\\\\C=C/C\\\\C=C/C\\\\C=C/CCCCCCCC(O)=O\", \"cofactor_chem_comp_id\": \"LNL\", \"cofactor_name\": \"alpha-Linolenic acid\", \"cofactor_resource_id\": \"DB00132\", \"mechanism_of_action\": \"Alpha Linolenic Acid or ALA is considered an essential fatty acid because it is required for human health, but cannot be synthesized by humans. It is in fact  a plant-derived fatty acid. Humans can synthesize other omega-3 fatty acids from ALA, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). EPA is a precursor of the series-3 prostaglandins, the series-5 leukotrienes and the series-3 thromboxanes. These eicosanoids have anti-inflammatory and anti-atherogenic properties. ALA metabolites may also inhibit the production of the pro-inflammatory eicosanoids, prostaglandin E2 (PGE2) and leukotriene B4 (LTB4), as well as the pro-inflammatory cytokines, tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta). Omega-3 fatty acids like ALA and its byproducts can modulate the expression of a number of genes, including those involved with fatty acid metabolism and inflammation. They regulate gene expression through their effects on the activity of transcription factors including NF-kappa B and members of the peroxisome proliferator-activated receptor (PPAR) family. Incorporation of ALA and its metabolites in cell membranes can affect membrane fluidity and may play a role in anti-inflammatory activity, inhibition of platelet aggregation and possibly in anti-proliferative actions of ALA. ALA is first metabolized by delta6 desaturease into steridonic acid.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [16731579], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"JAZBEHYOTPTENJ-JLNKQSITSA-N\", \"cofactor_smiles\": \"CC\\\\C=C/C\\\\C=C/C\\\\C=C/C\\\\C=C/C\\\\C=C/CCCC(O)=O\", \"cofactor_chem_comp_id\": \"EPA\", \"cofactor_name\": \"Icosapent\", \"cofactor_resource_id\": \"DB00159\", \"mechanism_of_action\": \"The anti-inflammatory, antithrombotic and immunomodulatory actions of EPA is probably due to its role in eicosanoid physiology and biochemistry. Most eicosanoids are produced by the metabolism of omega-3 fatty acids, specifically, arachidonic acid. These eicosanoids, leukotriene B4 (LTB4) and thromboxane A2 (TXA2) stimulate leukocyte chemotaxis, platelet aggregation and vasoconstriction. They are thrombogenic and artherogenic. On the other hand, EPA is metabolized to leukotriene B5 (LTB5) and thromboxane A3 (TXA3), which are eicosanoids that promote vasodilation, inhibit platelet aggregation and leukocyte chemotaxis and are anti-artherogenic and anti-thrombotic. The triglyceride-lowering effect of EPA results from inhibition of lipogenesis and stimulation of fatty acid oxidation. Fatty acid oxidation of EPA occurs mainly in the mitochondria. EPA is a substrate for Prostaglandin-endoperoxide synthase 1 and 2. It also appears to affect the function and bind to the Carbohydrate responsive element binding protein (ChREBP) and to a fatty acid receptor (G-coupled receptor) known as GP40.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [12055328, 16702329, 11552681, 17052999, 17610002, 15698426], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"GXPHKUHSUJUWKP-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O\", \"cofactor_name\": \"Troglitazone\", \"cofactor_resource_id\": \"DB00197\", \"mechanism_of_action\": \"Troglitazone is a thiazolidinedione antidiabetic agent that lowers blood glucose by improving target cell response to insulin. It has a unique mechanism of action that is dependent on the presence of insulin for activity. Troglitazone decreases hepatic glucose output and increases insulin dependent glucose disposal in skeletal muscle. Its mechanism of action is thought to involve binding to nuclear receptors (PPAR) that regulate the transcription of a number of insulin responsive genes critical for the control of glucose and lipid metabolism. Troglitazone is a ligand to both PPAR\\u03b1 and PPAR\\u03b3, with a highter affinity for PPAR\\u03b3. The drug also contains an \\u03b1-tocopheroyl moiety, potentially giving it vitamin E-like activity. Troglitazone has been shown to reduce inflammation, and is associated with a decrase in nuclear factor kappa-B (NF-\\u03baB) and a concomitant increase in its inhibitor (I\\u03baB). Unlike sulfonylureas, troglitazone is not an insulin secretagogue.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [10076568, 10097144, 10200320, 10214942, 10222233, 11752352, 12475986, 11278336, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"KBOPZPXVLCULAV-UHFFFAOYSA-N\", \"cofactor_smiles\": \"NC1=CC(C(O)=O)=C(O)C=C1\", \"cofactor_name\": \"Mesalazine\", \"cofactor_resource_id\": \"DB00244\", \"mechanism_of_action\": \"Although the mechanism of action of mesalazine is not fully understood, it is believed to possess a topical anti-inflammatory effect on colonic epithelial cells.[L36230] Mucosal production of arachidonic acid metabolites, both through the cyclooxygenase pathways, i.e., prostanoids, and through the lipoxygenase pathways, i.e., leukotrienes and hydroxyeicosatetraenoic acids, is increased in patients with chronic inflammatory bowel disease, and it is possible that mesalazine diminishes inflammation by blocking cyclooxygenase and inhibiting prostaglandin production in the colon.[L36230]\\r\\n\\r\\nFurthermore, mesalazine also has the potential to inhibit the activation of Nuclear Factor kappa B (NFkB) and consequently the production of key pro-inflammatory cytokines.[A16800,A4391,A16799] It has been proposed that reduced expression of PPAR gamma nuclear receptors (gamma form of peroxisome proliferator-activated receptors) may be implicated in ulcerative colitis, and that mesalazine produces pharmacodynamic effects through direct activation of PPAR gamma receptors in the colonic/rectal epithelium.[A16797,A16798,A16516,A16515] Other research also showed the potential involvement of inducible NO synthase (iNOS) and that mesalazine can inhibit this enzyme to amiliorate the enteropathy in inflammatory bowel diseases.[L37023] \\r\\n\\r\\nMoreover, since increased leukocyte migration, abnormal cytokine production, increased production of arachidonic acid metabolites, particularly leukotriene B4, and increased free radical formation in the inflamed intestinal tissue are all present in patients with inflammatory bowel disease it is also believed that mesalazine has in-vitro and in-vivo pharmacological effects that inhibit leukocyte chemotaxis, decrease cytokine and leukotriene production and scavenge for free radicals.[L5107]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [15824083, 18544567, 18077625, 16939423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"NIJJYAXOARWZEE-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCC(CCC)C(O)=O\", \"cofactor_chem_comp_id\": \"2PP\", \"cofactor_name\": \"Valproic acid\", \"cofactor_resource_id\": \"DB00313\", \"mechanism_of_action\": \"The exact mechanisms by which valproate exerts it's effects on epilepsy, migraine headaches, and bipolar disorder are unknown however several pathways exist which may contribute to the drug's action.\\r\\n\\r\\nValproate is known to inhibit succinic semialdehyde dehydrogenase.[A177991] This inhibition results in an increase in succinic semialdehyde which acts as an inhibitor of GABA transaminase ultimately reducing GABA metabolism and increasing GABAergic neurotransmission. As GABA is an inhibitory neurotransmitter, this increase results in increased inhibitory activity.[A457] A possible secondary contributor to cortical inhibition is a direct suppression of voltage gated sodium channel activity and indirect suppression through effects on GABA.\\r\\n\\r\\nIt has also been suggested that valproate impacts the extracellular signal-related kinase pathway (ERK).[A457] These effects appear to be dependent on mitogen-activated protein kinase (MEK) and result in the phosphorylation of ERK1/2. This activation increases expression of several downstream targets including ELK-1 with subsequent increases in c-fos, growth cone-associated protein-43 which contributes to neural plasticity, B-cell lymphoma/leukaemia-2 which is an anti-apoptotic protein, and brain-derived neurotrophic factor (BDNF) which is also involved in neural plasticity and growth. Increased neurogenesis and neurite growth due to valproate are attributed to the effects of this pathway. An additional downstream effect of increased BDNF expression appears to be an increase in GABA<sub>A</sub> receptors which contribute further to increased GABAergic activity.[A177997]\\r\\n\\r\\nValproate exerts a non-competitive indirect inhibitory effect on myo-inosital-1-phophate synthetase.[A178000] This results in reduced de novo synthesis of inositol monophosphatase and subsequent inositol depletion. It is unknown how this contributed to valproate's effects on bipolar disorder but [lithium] is known to exert a similar inositol-depleting effect.[A178003] Valproate exposure also appears to produce down-regulation of protein kinase C proteins (PKC)-\\u03b1 and -\\u03b5 which are potentially related to bipolar disorder as PKC is unregulated in the frontal cortex of bipolar patients. This is further supported by a similar reduction in PKC with lithium.[A178015] The inhibition of the PKC pathway may also be a contributor to migraine prophylaxis.[A178018] Myristoylated alanine-rich C kinase substrate, a PKC substrate, is also downregulated by valproate and may contribute to changes in synaptic remodeling through effects on the cytoskeleton.[A178021]\\r\\n\\r\\nValproate also appears to impact fatty acid metabolism.[A457] Less incorporation of fatty acid substrates in sterols and glycerolipids is thought to impact membrane fluidity and result in increased action potential threshold potentially contributing to valproate's antiepileptic action.[A178024] Valproate has been found to be a non-competitive direct inhibitor of brain microsomal long-chain fatty acyl-CoA synthetase.[A14708] Inhibition of this enzyme decreases available arichidonyl-CoA, a substrate in the production of inflammatory prostaglandins. It is thought that this may be a mechanism behind valproate's efficacy in migraine prophylaxis as migraines are routinely treated with non-steroidal anti-inflammatory drugs which also inhibit prostaglandin production.\\r\\n\\r\\nFinally, valproate acts as a direct histone deactylase (HDAC) inhibitor.[A178030] Hyperacetylation of lysine residues on histones promoted DNA relaxation and allows for increased gene transcription. The scope of valproate's genomic effects is wide with 461 genes being up or down-regulated.[A178027] The relation of these genomic effects to therapeutic value is not fully characterized however H3 and H4 hyperacetylation correlates with improvement of symptoms in bipolar patients.[A178033] Histone hyperacetylation at the BDNF gene, increasing BDNF expression, post-seizure is known to occur and is thought to be a neuroprotective mechanism which valproate may strengthen or prolong.[A178036] H3 hyperacetylation is associated with a reduction in glyceraldehyde-3-phosphate dehydrogenase, a pro-apoptotic enzyme, contributing further to valproate's neuroprotective effects.[A11814]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [24489787], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"CGIGDMFJXJATDK-UHFFFAOYSA-N\", \"cofactor_smiles\": \"COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O\", \"cofactor_chem_comp_id\": \"IMN\", \"cofactor_name\": \"Indomethacin\", \"cofactor_resource_id\": \"DB00328\", \"mechanism_of_action\": \"Indometacin is a nonspecific and reversible inhibitor of the cyclo-oxygenase (COX) enzyme or prostaglandin G/H synthase. There are two identified isoforms of COX: COX-1 is universally present in most body tissues and is involved in the synthesis of the prostaglandins and thromboxane A2, while COX-2 is expressed in response to injury or inflammation.[A177871] Constitutively expressed, the COX-1 enzyme is involved in gastric mucosal protection, platelet, and kidney function by catalyzing the conversion of arachidonic acid to prostaglandin (PG) G2 and PGG2 to PGH2.[A177871] COX-2 is constitutively expressed and highly inducible by inflammatory stimuli. It is found in the central nervous system, kidneys, uterus, and other organs. COX-2 also catalyzes the conversion of arachidonic acid to PGG2 and PGG2 to PGH2. In the COX-2-mediated pathway, PGH2 is further converted to PGE2 and PGI2 (also known as prostacyclin). PGE2 is involved in mediating inflammation, pain, and fever. Decreasing levels of PGE2 leads to reduced inflammatory reactions. Indometacin is known to inhibit both isoforms of COX, however, with greater selectivity for COX-1, which accounts for its increased adverse gastric effects relative to other NSAIDs. It binds to the enzyme's active site and prevents the interaction between the enzyme and its substrate, arachidonic acid. Indometacin, unlike other NSAIDs, also inhibits phospholipase A2, the enzyme responsible for releasing arachidonic acid from phospholipids. The analgesic, antipyretic and anti-inflammatory effects of indomethacin as well as adverse reactions associated with the drug occur as a result of decreased prostaglandin synthesis. Its antipyretic effects may be due to action on the hypothalamus, resulting in increased peripheral blood flow, vasodilation, and subsequent heat dissipation.\\r\\n\\r\\nThe exact mechanism of action of indometacin in inducing closure of a patent ductus arteriosus is not fully understood; however, it is thought to be through inhibition of prostaglandin synthesis.[L6778] At birth, the ductus arteriosus is normally closed as the tension of the oxygen increases significantly after birth.[A177880] Patent ductus arteriosus in premature infants is associated with congenital heart malformations where PGE1 mediates an opposite effect to that of oxygen. PGE1 dilates the ductus arteriosus through smooth muscle relaxation and prevents the closure of the ductus arteriosus.[A177880] By inhibiting the synthesis of prostaglandins, indometacin promotes the closure of ductus arteriosus.[L10553]\\r\\n\\r\\nIndometacin has been described as possessing anticancer and antiviral properties through activation of protein kinase R (PKR) and downstream phosphorylation of eIF2\\u03b1, inhibiting protein synthesis.[A234429, A234434]\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [12689521, 9013583], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"YASAKCUCGLMORW-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1\", \"cofactor_chem_comp_id\": \"BRL\", \"cofactor_name\": \"Rosiglitazone\", \"cofactor_resource_id\": \"DB00412\", \"mechanism_of_action\": \"Rosiglitazone acts as a highly selective and potent agonist at peroxisome proliferator activated receptors (PPAR) in target tissues for insulin action such as adipose tissue, skeletal muscle, and liver. Activation of PPAR-gamma receptors regulates the transcription of insulin-responsive genes involved in the control of glucose production, transport, and utilization. In this way, rosiglitazone enhances tissue sensitivity to insulin.\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10475242, 10548525, 10707565, 10764590, 10871190, 11752352, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"RDJGLLICXDHJDY-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1\", \"cofactor_name\": \"Fenoprofen\", \"cofactor_resource_id\": \"DB00573\", \"mechanism_of_action\": \"Fenoprofen's exact mode of action is unknown, but it is thought that prostaglandin synthetase inhibition is involved. Fenoprofen has been shown to inhibit prostaglandin synthetase isolated from bovine seminal vesicles.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [9013583], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"OELFLUMRDSZNSF-BRWVUGGUSA-N\", \"cofactor_smiles\": \"CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O\", \"cofactor_name\": \"Nateglinide\", \"cofactor_resource_id\": \"DB00731\", \"mechanism_of_action\": \"Nateglinide activity is dependent on the presence functioning \\u03b2 cells and glucose. In contrast to sulfonylurea insulin secretatogogues, nateglinide has no effect on insulin release in the absence of glucose. Rather, it potentiates the effect of extracellular glucose on ATP-sensitive potassium channel and has little effect on insulin levels between meals and overnight. As such, nateglinide is more effective at reducing postprandial blood glucose levels than fasting blood glucose levels and requires a longer duration of therapy (approximately one month) before decreases in fasting blood glucose are observed. The insulinotropic effects of nateglinide are highest at intermediate glucose levels (3 to 10 mmol/L) and it does not increase insulin release already stimulated by high glucose concentrations (greater than 15 mmol/L). Nateglinide appears to be selective for pancreatic \\u03b2 cells and does not appear to affect skeletal or cardiac muscle or thyroid tissue.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17082235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"NCEXYHBECQHGNR-QZQOTICOSA-N\", \"cofactor_smiles\": \"OC(=O)C1=CC(=CC=C1O)\\\\N=N\\\\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1\", \"cofactor_chem_comp_id\": \"SAS\", \"cofactor_name\": \"Sulfasalazine\", \"cofactor_resource_id\": \"DB00795\", \"mechanism_of_action\": \"Although the exact mechanism of action of sulfasalazine is not fully understood, it is thought to be mediated through the inhibition of various inflammatory molecules.[L44478] Research have found that sulfasalazine and its metabolites, mesalazine and sulfapyridine, can inhibit leukotrienes and prostaglandins by blocking the cyclo-oxygenase and lipoxygenase pathway.[A255143] Specific enzymes that were investigated include phospholipase A2, cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX2), and arachidonate 5-lipoxygenase.[A16801,A10316,A4391,A10319] Inhibitory activities on other non-arachidonic acid derivatives have also been observed, including PPAR gamma, NF-Kb, and IkappaB kinases alpha and beta.[A16799,A16797,A255577,A255138]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [15824083, 33468700, 18544567, 18077625, 16939423], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"WDQPAMHFFCXSNU-BGABXYSRSA-N\", \"cofactor_smiles\": \"CC(C)N=C1C=C2N(C3=CC=C(Cl)C=C3)C3=C(C=CC=C3)N=C2C=C1NC1=CC=C(Cl)C=C1\", \"cofactor_name\": \"Clofazimine\", \"cofactor_resource_id\": \"DB00845\", \"mechanism_of_action\": \"Although the precise mechanism(s) of action of clofazimine have not been elucidated, its antimicrobial activity appears to be membrane-directed. It was previously thought that, due to its lipophilicity, clofazimine participated in the generation of intracellular reactive oxygen species (ROS) via redox cycling, specifically H<sub>2</sub>O<sub>2</sub> and superoxide, which then exerted an antimicrobial effect.[A203144] A more recent and compelling theory involves clofazimine interacting with bacterial membrane phospholipids to generate antimicrobial lysophospholipids - bactericidal efficacy may, then, arise from the combined membrane-destabilizing effects of both clofazimine and lysophospholipids, which interfere with K+ uptake and, ultimately, ATP production.[A203144,L13802]\\r\\n\\r\\nThe anti-inflammatory activity of clofazimine is the result of its inhibition of T-lymphocyte activation and proliferation.[L13802] Several mechanisms have been proposed, including direct antagonism of T-cell Kv 1.3 potassium channels and indirect action by promoting the release of E-series prostaglandins and reactive oxygen species from bystander neutrophils and monocytes.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [31371410], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"FAEKWTJYAYMJKF-QHCPKHFHSA-N\", \"cofactor_smiles\": \"CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1)C(O)=O\", \"cofactor_chem_comp_id\": \"BJX\", \"cofactor_name\": \"Repaglinide\", \"cofactor_resource_id\": \"DB00912\", \"mechanism_of_action\": \"Repaglinide activity is dependent on the presence functioning &beta; cells and glucose. In contrast to sulfonylurea insulin secretatogogues, repaglinide has no effect on insulin release in the absence of glucose. Rather, it potentiates the effect of extracellular glucose on ATP-sensitive potassium channel and has little effect on insulin levels between meals and overnight. As such, repaglinide is more effective at reducing postprandial blood glucose levels than fasting blood glucose levels and requires a longer duration of therapy (approximately one month) before decreases in fasting blood glucose are observed. The insulinotropic effects of repaglinide are highest at intermediate glucose levels (3 to 10 mmol/L) and it does not increase insulin release already stimulated by high glucose concentrations (greater than 15 mmol/L). Repaglinide appears to be selective for pancreatic &beta; cells and does not appear to affect skeletal or cardiac muscle or thyroid tissue. \", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17082235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"RMMXLENWKUUMAY-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCC1=NC2=C(C=C(C=C2C)C2=NC3=CC=CC=C3N2C)N1CC1=CC=C(C=C1)C1=CC=CC=C1C(O)=O\", \"cofactor_chem_comp_id\": \"TLS\", \"cofactor_name\": \"Telmisartan\", \"cofactor_resource_id\": \"DB00966\", \"mechanism_of_action\": \"Telmisartan interferes with the binding of angiotensin II to the angiotensin II AT<sub>1</sub>-receptor by binding reversibly and selectively to the receptors in vascular smooth muscle and the adrenal gland. As angiotensin II is a vasoconstrictor, which also stimulates the synthesis and release of aldosterone, blockage of its effects results in decreases in systemic vascular resistance. Telmisartan does not inhibit the angiotensin converting enzyme, other hormone receptors, or ion channels.[L44652] Studies also suggest that telmisartan is a partial agonist of PPAR&gamma;, which is an established target for antidiabetic drugs. This suggests that telmisartan can improve carbohydrate and lipid metabolism, as well as control insulin resistance without causing the side effects that are associated with full PPAR&gamma; activators.[A1492]\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [19147680, 16938288, 18580862, 15617852, 15868121, 17691961, 16154710], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"IPOKCKJONYRRHP-FMQUCBEESA-N\", \"cofactor_smiles\": \"OC(=O)CCNC(=O)C1=CC=C(C=C1)\\\\N=N\\\\C1=CC=C(O)C(=C1)C(O)=O\", \"cofactor_name\": \"Balsalazide\", \"cofactor_resource_id\": \"DB01014\", \"mechanism_of_action\": \"The mechanism of action of 5-aminosalicylic acid is unknown, but appears exert its anti-inflammatory effects locally (in the GI tract) rather than systemically. Mucosal production of arachidonic acid metabolites, both through the cyclooxygenase pathways (catalyzes the formation of prostaglandin precursors from arachidonic acid), and through the lipoxygenase pathways (catalyzes the formation of leukotrienes and hydroxyeicosatetraenoic acids from arachidonic acid and its metabolites), is increased in patients with chronic inflammatory bowel disease. Therefore, it is possible that 5-aminosalicylic acid diminishes inflammation by blocking production of arachidonic acid metabolites in the colon through both the inhibition of cyclooxygenase and lipoxygenase.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [19708827, 20151072, 16939423, 18077625], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"HEFNNWSXXWATRW-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)CC1=CC=C(C=C1)C(C)C(O)=O\", \"cofactor_name\": \"Ibuprofen\", \"cofactor_resource_id\": \"DB01050\", \"mechanism_of_action\": \"The exact mechanism of action of ibuprofen is unknown. However, ibuprofen is considered an NSAID and thus it is a non-selective inhibitor of cyclooxygenase, which is an enzyme involved in prostaglandin (mediators of pain and fever) and thromboxane (stimulators of blood clotting) synthesis via the arachidonic acid pathway.[L4614]\\r\\n\\r\\nIbuprofen is a non-selective COX inhibitor and hence, it inhibits the activity of both COX-1 and COX-2. The inhibition of COX-2 activity decreases the synthesis of prostaglandins involved in mediating inflammation, pain, fever, and swelling while the inhibition of COX-1 is thought to cause some of the side effects of ibuprofen including GI ulceration.[A39195]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [20089905], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"ZJJXGWJIGJFDTL-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=NC=C(N=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1\", \"cofactor_name\": \"Glipizide\", \"cofactor_resource_id\": \"DB01067\", \"mechanism_of_action\": \"Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with increasing prevalence worldwide. Characterized by higher-than-normal levels of blood glucose, T2DM is a complex disorder that arises from the interaction between genetic, environmental and behavioral risk factors. Insulin is a peptide hormone that plays a critical role in regulating blood glucose levels. In response to high blood glucose levels, insulin promotes the uptake of glucose into the liver, muscle cells, and fat cells for storage. Although there are multiple events occurring that lead to the pathophysiology of T2DM, the disorder mainly involves insulin insensitivity as a result of insulin resistance, declining insulin production, and eventual failure of beta cells of pancreatic islets that normally produce insulin.[A179554] Early management with lifestyle intervention, such as controlled diet and exercise, is critical in reducing the risk of long-term secondary complications, such as cardiovascular mortality.\\r\\n\\r\\nGlipizide, like other sulfonylurea drugs, is an insulin secretagogue, which works by stimulating the insulin release from the pancreatic beta cells thereby increasing the plasma concentrations of insulin.[A177715] Thus, the main therapeutic action of the drug depends on the functional beta cells in the pancreatic islets.[L6739] Sulfonylureas bind to the sulfonylurea receptor expressed on the pancreatic beta-cell plasma membrane, leading to the closure of the ATP-sensitive potassium channel and reduced potassium conductance. This results in depolarization of the pancreatic beta cell and opening of the voltage-sensitive calcium channels, promoting calcium ion influx. Increased intracellular concentrations of calcium ions in beta cells stimulates the secretion, or exocytosis, of insulin granules from the cells.[label,T28] Apart from this main mechanism of action, the blood-glucose-lowering effect of glipizide involves increased peripheral glucose utilization via stimulating hepatic gluconeogenesis and by increasing the number and sensitivity of insulin receptors.[A177715]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17082235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"IYIKLHRQXLHMJQ-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2\", \"cofactor_chem_comp_id\": \"BBI\", \"cofactor_name\": \"Amiodarone\", \"cofactor_resource_id\": \"DB01118\", \"mechanism_of_action\": \"Amiodarone is considered a class III anti-arrhythmic drug. It blocks potassium currents that cause repolarization of the heart muscle during the third phase of the cardiac action potential. As a result amiodarone increases the duration of the action potential as well as the effective refractory period for cardiac cells (myocytes). Therefore, cardiac muscle cell excitability is reduced, preventing and treating abnormal heart rhythms.[A183137,A189747]\\r\\n\\r\\nUnique from other members of the class III anti-arrhythmic drug class, amiodarone also interferes with the functioning of beta-adrenergic receptors, sodium channels, and calcium channels channels. These actions, at times, can lead to undesirable effects, such as hypotension, bradycardia, and Torsades de pointes (TdP).[L11265] In addition to the above, amiodarone may increase activity of peroxisome proliferator-activated receptors, leading to steatogenic changes in the liver or other organs.[A20227,A20650] Finally, amiodarone has been found to bind to the thyroid receptor due to its iodine content, potentially leading to amiodarone induced hypothyroidism or thyrotoxicosis.[A182168]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [24489787, 21123845], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"HYAFETHFCAUJAY-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1\", \"cofactor_name\": \"Pioglitazone\", \"cofactor_resource_id\": \"DB01132\", \"mechanism_of_action\": \"Pioglitazone is a selective agonist at peroxisome proliferator-activated receptor-gamma (PPAR\\u03b3) in target tissues for insulin action such as adipose tissue, skeletal muscle, and liver.[L11416,A19759] Activation of PPAR\\u03b3 increases the transcription of insulin-responsive genes involved in the control of glucose and lipid production, transport, and utilization.[A19759] Through this mechanism, pioglitazone both enhances tissue sensitivity to insulin and reduces the hepatic production of glucose (i.e. gluconeogenesis) - insulin resistance associated with type 2 diabetes mellitus is therefore improved without an increase in insulin secretion by pancreatic beta cells.[L11416,A19759]\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [20018750, 15356026, 9568680, 8576907, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"WPGGHFDDFPHPOB-BBWFWOEESA-N\", \"cofactor_smiles\": \"[H][C@@](CC(=O)N1C[C@@]2([H])CCCC[C@@]2([H])C1)(CC1=CC=CC=C1)C(O)=O\", \"cofactor_chem_comp_id\": \"9I0\", \"cofactor_name\": \"Mitiglinide\", \"cofactor_resource_id\": \"DB01252\", \"mechanism_of_action\": \"Mitiglinide is thought to stimulate insulin secretion by binding to and blocking ATP-sensitive K(+) (K(ATP)) channels (Kir6.2/SUR1 complex, KATP channels) in pancreatic beta-cells. Closure of potassium channels causes depolarization which stimulates calcium influx through voltage-gated calcium channels. High intracellular calcium subsequently triggers the exocytosis of insulin granules. \", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17082235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"IIBYAHWJQTYFKB-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O\", \"cofactor_chem_comp_id\": \"PEM\", \"cofactor_name\": \"Bezafibrate\", \"cofactor_resource_id\": \"DB01393\", \"mechanism_of_action\": \"It is generally accepted that bezafibrate is likely an agonist of PPAR-alpha. However, certain other investigations have also suggested that the substance might also elicit some effects on PPAR-gamma and PPAR-delta too.\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [16168052], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"LPEPZBJOKDYZAD-UHFFFAOYSA-N\", \"cofactor_smiles\": \"OC(=O)C1=CC=CC=C1NC1=CC(=CC=C1)C(F)(F)F\", \"cofactor_chem_comp_id\": \"FLF\", \"cofactor_name\": \"Flufenamic acid\", \"cofactor_resource_id\": \"DB02266\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [9013583], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"LUKBXSAWLPMMSZ-OWOJBTEDSA-N\", \"cofactor_smiles\": \"OC1=CC=C(\\\\C=C\\\\C2=CC(O)=CC(O)=C2)C=C1\", \"cofactor_chem_comp_id\": \"STL\", \"cofactor_name\": \"Resveratrol\", \"cofactor_resource_id\": \"DB02709\", \"mechanism_of_action\": \"Resveratrol suppresses NF-kappaB (NF-kappaB) activation in HSV infected cells. Reports have indicated that HSV activates NF-kappaB during productive infection and this may be an essential aspect of its replication scheme [PMID: 9705914]. \", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [24454499], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"XNGIFLGASWRNHJ-UHFFFAOYSA-N\", \"cofactor_smiles\": \"OC(=O)C1=CC=CC=C1C(O)=O\", \"cofactor_chem_comp_id\": \"PHT\", \"cofactor_name\": \"Phthalic Acid\", \"cofactor_resource_id\": \"DB02746\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [23843199], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"GHVNFZFCNZKVNT-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCCCCCCCC(O)=O\", \"cofactor_chem_comp_id\": \"DKA\", \"cofactor_name\": \"Capric acid\", \"cofactor_resource_id\": \"DB03600\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [24998974], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"MBMBGCFOFBJSGT-KUBAVDMBSA-N\", \"cofactor_smiles\": \"CC\\\\C=C/C\\\\C=C/C\\\\C=C/C\\\\C=C/C\\\\C=C/C\\\\C=C/CCC(O)=O\", \"cofactor_chem_comp_id\": \"HXA\", \"cofactor_name\": \"Doconexent\", \"cofactor_resource_id\": \"DB03756\", \"mechanism_of_action\": \"DHA and its conversion to other lipid signalling moleccules compete with the arachidonic acid cascade from endogenous phospholipids and shift the inflammatory state to being more anti-inflammatory. DHA inhibits endotoxin-stimulated production of IL-6 and IL-8 in human endothelial cells. Derivatives of DHA are anti-inflammatory lipid mediators. Lipid mediators resolvin D1 and protectin D1 all inhibit transendothelial migration of neutrophils, so preventing neutrophilic infiltration at sites of inflammation, resolvin D1 inhibits IL-1\\u03b2 production, and protectin D1 inhibits TNF and IL-1\\u03b2 production [A19356]. Monoxydroxy derivative of DHA converted by LOX inhibit thromboxane-induced platelet aggregation. DHA supplementation has also shown to reduce the levels of serum C-reactive protein (CRP) and other circulating markers of inflammation such as neutrophils in hypertriglyceridemic men [A19438]. \\r\\nDHA acts as a ligand at peroxisome proliferator-activated receptor (PPAR) gamma and alpha that regulate lipid signalling molecule-mediated transduction pathways and modulate inflammation. \\r\\nAs a natural ligand, DHA induces a protective effect in retinal tissues by activating retinoid x receptors and subsequent ERK/MAPK signaling pathway in photoreceptors to promote their survival and differentiation, stimulating the expression of antiapoptotic proteins such as Bcl-2 and preserving mitochondrial membrane potential [A19453]. \", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [21382489, 18769551, 27079734, 15698426], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"ZQPPMHVWECSIRJ-MDZDMXLPSA-N\", \"cofactor_smiles\": \"CCCCCCCC\\\\C=C\\\\CCCCCCCC(O)=O\", \"cofactor_chem_comp_id\": \"ELA\", \"cofactor_name\": \"Oleic Acid\", \"cofactor_resource_id\": \"DB04224\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [24998974], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"WUZIMDSVRIBNNI-DEOSSOPVSA-N\", \"cofactor_smiles\": \"[H][C@@](CC1=CC=C(OCCN2C3=C(C=CC=C3)C3=C2C=CC=C3)C=C1)(OCC)C(O)=O\", \"cofactor_chem_comp_id\": \"YPA\", \"cofactor_name\": \"(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid\", \"cofactor_resource_id\": \"DB04270\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"ZXWVCCFKIRBLDP-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCC1=C(OCCCOC2=CC3=C(C=C2)N(CC(O)=O)C=C3)C=CC2=C1C=CC(=C2)C(=O)C1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"EHA\", \"cofactor_name\": \"2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID\", \"cofactor_resource_id\": \"DB04689\", \"neighbor_flag\": \"Y\", \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"QBQLYIISSRXYKL-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=C(CCOC2=CC=C(CC3C(=O)NOC3=O)C=C2)N=C(O1)C1=CC=CC=C1\", \"cofactor_name\": \"Reglitazar\", \"cofactor_resource_id\": \"DB04971\", \"mechanism_of_action\": \"Reglixane is an agonist of peroxisome proliferator-activated receptor (PPAR) gamma and alpha.\", \"neighbor_flag\": \"N\", \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"AFLFKFHDSCQHOL-IZZDOVSWSA-N\", \"cofactor_smiles\": \"CSC1=CC=C(C=C1)C(=O)\\\\C=C\\\\C1=CC(C)=C(OC(C)(C)C(O)=O)C(C)=C1\", \"cofactor_chem_comp_id\": \"MUO\", \"cofactor_name\": \"Elafibranor\", \"cofactor_resource_id\": \"DB05187\", \"mechanism_of_action\": \"Proliferator-activated receptor (PPAR) is a nuclear receptor that regulates numerical cellular processes, including lipid metabolism and inflammation.[A263828] Different subtypes of PPARs have different roles and functions, and two of these subtypes - PPAR-alpha (\\u03b1) and PPAR-delta (\\u03b4) (also known as PPAR\\u03b2) - have been identified as therapeutic targets for diabetes and lipid disorders.[A263893] PPAR\\u03b1 controls lipid flux in the liver and regulates plasma levels of triglycerides and high-density lipoprotein (HDL) cholesterol.[A263828] PPAR\\u03b4 activation leads to fatty acid transport and oxidation, increased HDL levels, and improved glucose homeostasis.[A263828] PPAR\\u03b1 and PPAR\\u03b4 also mediate anti-inflammatory actions.[A263828]\\r\\n\\r\\nWhile the exact mechanism of action has not been fully elucidated, elafibranor and its active metabolite (GFT1007) are dual \\u03b1 and \\u03b2/\\u03b4 agonists.[A263833, L50768] The signalling pathway for PPAR\\u03b4 was reported to include Fibroblast Growth Factor 21 (FGF21)-dependent downregulation of CYP7A1, the key enzyme for the synthesis of bile acids from cholesterol.[L50768]\", \"neighbor_flag\": \"N\", \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"NMRWDFUZLLQSBN-UHFFFAOYSA-N\", \"cofactor_smiles\": \"ClC1=CC=C(C(Cl)=C1)S(=O)(=O)NC1=CC(Cl)=C(OC2=CN=C3C=CC=CC3=C2)C(Cl)=C1\", \"cofactor_chem_comp_id\": \"Z12\", \"cofactor_name\": \"AMG-131\", \"cofactor_resource_id\": \"DB05490\", \"mechanism_of_action\": \"T131 is a selective modulator of PPARg (peroxisome proliferator activated receptor gamma), a receptor involved in regulating the body\\u2019s ability to respond to insulin. T131 is not structurally related to the thiazolidinedione class of PPARg agonists, which includes Actos and Avandia\", \"neighbor_flag\": \"Y\", \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_name\": \"CLX-0921\", \"cofactor_resource_id\": \"DB05854\", \"mechanism_of_action\": \"CLX-0921 has a spectrum of activity that differs from commercially available TZDs. It also increases glycogen synthesis, an activity not typically associated with rosiglitazone or pioglitazone. Thus it appears to have a distinct spectrum of activity relative to other TZDs.\", \"neighbor_flag\": \"N\", \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"IRLWJILLXJGJTD-UHFFFAOYSA-N\", \"cofactor_smiles\": \"COC1=CC=C(OC(=O)N(CC(O)=O)CC2=CC=C(OCCC3=C(C)OC(=N3)C3=CC=CC=C3)C=C2)C=C1\", \"cofactor_name\": \"Muraglitazar\", \"cofactor_resource_id\": \"DB06510\", \"mechanism_of_action\": \"Muraglitazar is one of the dual peroxisome proliferator-activated receptor (PPAR) agonists. It interacts with both PPAR alpha and gamma receptors. Working through the PPAR gamma receptor, muraglitazar has very potent insulin-sensitizing effects on liver and muscle to lower the blood sugar levels. working through the PPAR alpha receptor, muraglitazar is very potent in terms of lowering the triglycerides and raising the HDL [high-density lipoprotein] cholesterol and converting small dense LDL [low-density lipoprotein] particles to larger, more buoyant particles, so it promotes a very good lipid profile from the standpoint of prevention of atherosclerosis.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"HAAXAFNSRADSMK-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=C(CCOC2=C3C=CSC3=C(CC3SC(=O)NC3=O)C=C2)N=C(O1)C1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"8A7\", \"cofactor_name\": \"Edaglitazone\", \"cofactor_resource_id\": \"DB06519\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"FONCZICQWCUXEB-RUZDIDTESA-N\", \"cofactor_smiles\": \"CC1=C(C)C2=C(C3=CC(C)=C(O[C@H](CC4=CC=CC=C4)C(O)=O)C(C)=C3)C3=CC=CC=C3C(Br)=C2S1\", \"cofactor_name\": \"Ertiprotafib\", \"cofactor_resource_id\": \"DB06521\", \"mechanism_of_action\": \"The complete mechanism of action for ertiprotafib and related compounds in vivo may involve multiple independent mechanisms, including (but not necessarily limited to) PTP1b inhibition and dual PPARalpha/PPARgamma agonism.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [15475571], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"WMUIIGVAWPWQAW-XMMPIXPASA-N\", \"cofactor_smiles\": \"CCO[C@H](CC1=CC=C(OCCN2C3=CC=CC=C3OC3=C2C=CC=C3)C=C1)C(O)=O\", \"cofactor_name\": \"Ragaglitazar\", \"cofactor_resource_id\": \"DB06533\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [12970088, 16240504], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"CXGTZJYQWSUFET-IBGZPJMESA-N\", \"cofactor_smiles\": \"CCO[C@@H](CC1=CC=C(OCCC2=CC=C(OS(C)(=O)=O)C=C2)C=C1)C(O)=O\", \"cofactor_chem_comp_id\": \"AZ2\", \"cofactor_name\": \"Tesaglitazar\", \"cofactor_resource_id\": \"DB06536\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [16168052, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"PAWOPJKHTZCKMT-QFIPXVFZSA-N\", \"cofactor_smiles\": \"[H][C@@](CC1=CC2=C(C=C1)N(CC1=C(C)OC(=N1)C1=C(Cl)C=CC=C1)C=C2)(OCC)C(O)=O\", \"cofactor_chem_comp_id\": \"208\", \"cofactor_name\": \"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID\", \"cofactor_resource_id\": \"DB06908\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"HNICUWMFWZBIFP-IRQZEAMPSA-N\", \"cofactor_smiles\": \"[H][C@](O)(CCCCC)\\\\C=C\\\\C=C/CCCCCCCC(O)=O\", \"cofactor_chem_comp_id\": \"243\", \"cofactor_name\": \"(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid\", \"cofactor_resource_id\": \"DB06926\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"TWVYNPULGKGJOS-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCC1=C2ON=C(C2=CC=C1OCCCOC1=CC2=C(C=C1)N(CC(O)=O)C=C2)C(F)(F)F\", \"cofactor_chem_comp_id\": \"3EA\", \"cofactor_name\": \"2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID\", \"cofactor_resource_id\": \"DB07053\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"IFRKCNPQVIJFAQ-HBUOOPIGSA-N\", \"cofactor_smiles\": \"[H][C@](O)(CCC(O)=O)\\\\C=C\\\\C=C/C\\\\C=C/C\\\\C=C/C\\\\C=C/C\\\\C=C/CC\", \"cofactor_chem_comp_id\": \"4HD\", \"cofactor_name\": \"(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid\", \"cofactor_resource_id\": \"DB07111\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"FTAGQROYQYQRHF-CBVHGRPESA-N\", \"cofactor_smiles\": \"[H][C@@](O)(CCCC(O)=O)\\\\C=C\\\\C=C/C\\\\C=C/C\\\\C=C/C\\\\C=C/CC\", \"cofactor_chem_comp_id\": \"5HE\", \"cofactor_name\": \"(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid\", \"cofactor_resource_id\": \"DB07172\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"OJFOOCZBVPQYRS-PSDPTOBYSA-N\", \"cofactor_smiles\": \"[H][C@](O)(C\\\\C=C/CCCCC)\\\\C=C\\\\CC(=O)CCCCC(O)=O\", \"cofactor_chem_comp_id\": \"6OB\", \"cofactor_name\": \"(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid\", \"cofactor_resource_id\": \"DB07208\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"MLHUENSFQCPBQH-ZBKJIUGYSA-N\", \"cofactor_smiles\": \"[H][C@@](O)(CC(=O)CCCCC(O)=O)\\\\C=C/C\\\\C=C/CCCCC\", \"cofactor_chem_comp_id\": \"6OC\", \"cofactor_name\": \"(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid\", \"cofactor_resource_id\": \"DB07209\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"NPDSHTNEKLQQIJ-UINYOVNOSA-N\", \"cofactor_smiles\": \"CCCCC\\\\C=C/C=C/[C@@H](O)CCCCCCCC(O)=O\", \"cofactor_chem_comp_id\": \"9HO\", \"cofactor_name\": \"9(S)-HODE\", \"cofactor_resource_id\": \"DB07302\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"JNKJCLYKBRBEKW-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCCCCCCC1=CC=C2C=C3C=CC(CCCCC(O)=O)=[N+]3[B-](F)(F)N12\", \"cofactor_chem_comp_id\": \"C08\", \"cofactor_name\": \"difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron\", \"cofactor_resource_id\": \"DB07509\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"WMUIIGVAWPWQAW-DEOSSOPVSA-N\", \"cofactor_smiles\": \"[H][C@@](CC1=CC=C(OCCN2C3=C(OC4=C2C=CC=C4)C=CC=C3)C=C1)(OCC)C(O)=O\", \"cofactor_chem_comp_id\": \"DRF\", \"cofactor_name\": \"(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID\", \"cofactor_resource_id\": \"DB07675\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"ZLSZCJIWILJKMR-UHFFFAOYSA-N\", \"cofactor_smiles\": \"COC1=CC=C2NC=C(CCC(O)=O)C2=C1\", \"cofactor_chem_comp_id\": \"ET0\", \"cofactor_name\": \"3-(5-methoxy-1H-indol-3-yl)propanoic acid\", \"cofactor_resource_id\": \"DB07723\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"YMPALHOKRBVHOJ-UHFFFAOYSA-N\", \"cofactor_smiles\": \"COC1=CC=C(C=C1)S(=O)(=O)N1C=C(CCC(O)=O)C2=CC(OC)=CC=C12\", \"cofactor_chem_comp_id\": \"ET1\", \"cofactor_name\": \"Indeglitazar\", \"cofactor_resource_id\": \"DB07724\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"CJMVTSLLWMPEKQ-INIZCTEOSA-N\", \"cofactor_smiles\": \"[H][C@@](CC1=CC=CC=C1)(OC1=CC=C(CC)C=C1)C(O)=O\", \"cofactor_chem_comp_id\": \"GRR\", \"cofactor_name\": \"(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid\", \"cofactor_resource_id\": \"DB07842\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"DNTSIBUQMRRYIU-UHFFFAOYSA-N\", \"cofactor_smiles\": \"[O-][N+](=O)C1=CC=C(Cl)C(=C1)C(=O)NC1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"GW9\", \"cofactor_name\": \"2-chloro-5-nitro-N-phenylbenzamide\", \"cofactor_resource_id\": \"DB07863\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"TZTPJJNNACUQQR-FQEVSTJZSA-N\", \"cofactor_smiles\": \"[H][C@@](CC1=CC=CC=C1)(OC1=CC=C(C=C1)C1=CC=CC=C1)C(O)=O\", \"cofactor_chem_comp_id\": \"LRG\", \"cofactor_name\": \"(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid\", \"cofactor_resource_id\": \"DB08121\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"IRHZCQDCMUWUKV-RAXLEYEMSA-N\", \"cofactor_smiles\": \"CCC\\\\C(=C\\\\C1=CC=C(O1)C1=CC(=CC=C1)C(O)=O)[N+]([O-])=O\", \"cofactor_chem_comp_id\": \"NRO\", \"cofactor_name\": \"3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid\", \"cofactor_resource_id\": \"DB08302\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"VNDRRWBKNSHALL-UHFFFAOYSA-N\", \"cofactor_smiles\": \"OC(=O)C1=C(NC(=O)C2=C(Cl)C=C(Cl)C=C2)C=CC(OC2=NC=CC=N2)=C1\", \"cofactor_chem_comp_id\": \"PLB\", \"cofactor_name\": \"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID\", \"cofactor_resource_id\": \"DB08402\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"VHRUMKCAEVRUBK-XOVNXQNQSA-N\", \"cofactor_smiles\": \"[H][C@]1(C\\\\C=C\\\\CCCC(O)=O)C=CC(=O)\\\\C1=C/C=C/CCCCC\", \"cofactor_chem_comp_id\": \"PTG\", \"cofactor_name\": \"(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid\", \"cofactor_resource_id\": \"DB08435\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"GULUFDCOGAXLEP-UHFFFAOYSA-N\", \"cofactor_smiles\": \"FC1=CC=C(C=C1)N1N=C(C=C1NS(=O)(=O)C1=CC=CC(F)=C1)C1=CC=CS1\", \"cofactor_chem_comp_id\": \"SP0\", \"cofactor_name\": \"3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE\", \"cofactor_resource_id\": \"DB08560\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"XEFQLINVKFYRCS-UHFFFAOYSA-N\", \"cofactor_smiles\": \"OC1=CC(Cl)=CC=C1OC1=C(Cl)C=C(Cl)C=C1\", \"cofactor_chem_comp_id\": \"TCL\", \"cofactor_name\": \"Triclosan\", \"cofactor_resource_id\": \"DB08604\", \"mechanism_of_action\": \"Triclosan is a biocidal compound with multiple targets in the cytoplasm and membrane. At lower concentrations, however, triclosan appears bacteriostatic and is seen to target bacteria mainly by inhibiting fatty acid synthesis. Triclosan binds to enoyl-acyl carrier protein reductase enzyme (ENR). This complex has increased affinity for NAD+ and forms a ternary complex. This complex is unable to participate in fatty acid synthesis, weakening the cell membrane and causing cell death. Humans do not have an ENR enzyme, and thus are not affected.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [25314719], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"CPBLTMSKPQDJPW-AWEZNQCLSA-N\", \"cofactor_smiles\": \"[H][C@@](CC1=CC=CC=C1)(OC1=CC=C(Cl)C=C1)C(O)=O\", \"cofactor_chem_comp_id\": \"YRG\", \"cofactor_name\": \"(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid\", \"cofactor_resource_id\": \"DB08760\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10592235, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"DAYKLWSKQJBGCS-NRFANRHFSA-N\", \"cofactor_smiles\": \"CO[C@@H](CC1=CC=C(OCCC2=C(C)OC(=N2)C2=CC=CC=C2)C2=C1SC=C2)C(O)=O\", \"cofactor_chem_comp_id\": \"RO7\", \"cofactor_name\": \"Aleglitazar\", \"cofactor_resource_id\": \"DB08915\", \"mechanism_of_action\": \"Aleglitazar was rationally designed to be an agonist at the peroxisome proliferator-activated receptor (PPAR) for both the PPAR\\u03b1 and PPAR\\u03b3 receptor subtypes. Agonistic action at PPAR\\u03b1 controls lipid levels, which improves dyslipidemia, and agonistic action at PPAR\\u03b3 controls glucose levels, which improves insulin sensitivity in diabetes.\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [20653327, 10592235], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"BMOVQUBVGICXQN-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCC(C)(OC1=CC=C(C=C1)C1(CCCCC1)C1=CC=C(OC(C)(CC)C(O)=O)C=C1)C(O)=O\", \"cofactor_name\": \"Clinofibrate\", \"cofactor_resource_id\": \"DB09006\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [11779144], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"QHMBSVQNZZTUGM-ZWKOTPCHSA-N\", \"cofactor_smiles\": \"CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1\", \"cofactor_chem_comp_id\": \"P0T\", \"cofactor_name\": \"Cannabidiol\", \"cofactor_resource_id\": \"DB09061\", \"mechanism_of_action\": \"The exact mechanism of action of CBD and THC is not currently fully understood. However, it is known that CBD acts on cannabinoid (CB) receptors of the endocannabinoid system, which are found in numerous areas of the body, including the peripheral and central nervous systems, including the brain. The endocannabinoid system regulates many physiological responses of the body including pain, memory, appetite, and mood. More specifically, CB1 receptors can be found within the pain pathways of the brain and spinal cord where they may affect CBD-induced analgesia and anxiolysis, and CB2 receptors have an effect on immune cells, where they may affect CBD-induced anti-inflammatory processes. \\r\\n\\r\\nCBD has been shown to act as a negative allosteric modulator of the cannabinoid CB1 receptor, the most abundant G-Protein Coupled Receptor (GPCR) in the body [A32469]. Allosteric regulation of a receptor is achieved through the modulation of the activity of a receptor on a functionally distinct site from the agonist or antagonist binding site. The negative allosteric modulatory effects of CBD are therapeutically important as direct agonists are limited by their psychomimetic effects while direct antagonists are limited by their depressant effects [A32469]. \", \"neighbor_flag\": \"N\", \"pubmed_ids\": [26264914, 24288245], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"CHHXEZSCHQVSRE-UHFFFAOYSA-N\", \"cofactor_smiles\": \"COC1=CC=C(OC2=NC=NC(=C2)N(C)CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1\", \"cofactor_name\": \"Lobeglitazone\", \"cofactor_resource_id\": \"DB09198\", \"mechanism_of_action\": \"Lobeglitazone acts as an insulin sensitizer by binding and activating Peroxisome Proliferator-Activated Receptors (PPAR) gamma within fat cells. By promoting the binding of insulin at fat cells, lobeglitazone has been shown to reduce blood sugar levels, lower hemoglobain A1C (HbA1C) levels, and improve lipid and liver profiles [A19748]. Unlike [DB01132], which is a dual PPAR agonist at PPAR-alpha and PPAR-gamma, Lobeglitazone is a pure PPAR-alpha agonist. \", \"neighbor_flag\": \"N\", \"pubmed_ids\": [25648999], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"PKWDZWYVIHVNKS-UHFFFAOYSA-N\", \"cofactor_smiles\": \"FC1=C(COC2=CC=C3C=C(CC4SC(=O)NC4=O)C=CC3=C2)C=CC=C1\", \"cofactor_name\": \"Netoglitazone\", \"cofactor_resource_id\": \"DB09199\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"XMSXOLDPMGMWTH-UHFFFAOYSA-N\", \"cofactor_smiles\": \"COC1=CC=C2N=C(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)N(C)C2=C1\", \"cofactor_chem_comp_id\": \"7VA\", \"cofactor_name\": \"Rivoglitazone\", \"cofactor_resource_id\": \"DB09200\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"YZFWTZACSRHJQD-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1(COC2=CC=C(CC3SC(=O)NC3=O)C=C2)CCCCC1\", \"cofactor_name\": \"Ciglitazone\", \"cofactor_resource_id\": \"DB09201\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [12391285, 12604364, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"HEFNNWSXXWATRW-JTQLQIEISA-N\", \"cofactor_smiles\": \"CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O\", \"cofactor_chem_comp_id\": \"IBP\", \"cofactor_name\": \"Dexibuprofen\", \"cofactor_resource_id\": \"DB09213\", \"mechanism_of_action\": \"Like common NSAIDs, dexibuprofen is an active enantiomer of [ibuprofen] that suppresses the prostanoid synthesis in the inflammatory cells via inhibition of the COX-2 isoform of the arachidonic acid COX.[T28] For more information, refer to [ibuprofen].\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [20089905], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_name\": \"Omega-3 fatty acids\", \"cofactor_resource_id\": \"DB11133\", \"mechanism_of_action\": \"Omega-3 fatty acids mediate anti-inflammatory effects and increased levels of EPA or DHA has shown to decrease the levels of PGE2 and 4 series-LT. \\r\\nEicosapentaenoic acids compete with constitutive levels of arachidonic acid in cell membranes for the same desaturation enzymes and produce 3-series prostaglandins and thromboxanes, and 5-series leukotrienes which have low pro-inflammatory potential. The alteration in leukotriene biosynthesis due to higher concentration of omega-3 fatty acids compared to arachidonic acid underlies the anti-inflammatory effects. \\r\\nEPA and DHA also give rise to resolvins and related lipid signalling molecules such as protectins via cyclooxygenase and lipoxygenase pathways, which have anti-inflammatory effects. They inhibit transendothelial migration of neutrophils and inhibit TNF and IL-1\\u03b2 production. Omega-3 fatty acids also decrease adhesion molecule expression on leukocytes and on endothelial cells and decrease intercellular adhesive interactions.\\r\\nOmega-3 (or n-3) polyunsaturated fatty acids (PUFAs) and their metabolites are natural ligands for peroxisome proliferator-activated receptor (PPAR) gamma that regulates inflammatory gene expression and NF\\u03baB activation. PPAR alpha activation is also associated with induction of COX-2 expression. \\r\\nThe role of EPA and DHA in reducing triglyceride levels include inhibition of acyl-CoA:1,2-diacylglycerol acyltransferase, increased mitochondrial and peroxisomal-beta-oxidation in the liver, decreased lipogenesis in the liver, and increased plasma lipoprotein lipase activity. They also may reduce triglyceride synthesis because they are poor substrates for the enzymes responsible for TG synthesis, and EPA and DHA inhibit esterification of other fatty acids. \", \"neighbor_flag\": \"N\", \"pubmed_ids\": [21382489, 18769551], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"VFLDPWHFBUODDF-FCXRPNKRSA-N\", \"cofactor_smiles\": \"COC1=CC(\\\\C=C\\\\C(=O)CC(=O)\\\\C=C\\\\C2=CC(OC)=C(O)C=C2)=CC=C1O\", \"cofactor_chem_comp_id\": \"CC9\", \"cofactor_name\": \"Curcumin\", \"cofactor_resource_id\": \"DB11672\", \"mechanism_of_action\": \"Curcumin acts as a scavenger of oxygen species, such as hydroxyl radical, superoxide anion, and singlet oxygen and inhibit lipid peroxidation as well as peroxide-induced DNA damage [F114]. Curcumin mediates potent anti-inflammatory agent and anti-carcinogenic actions via modulating various signalling molecules. It suppresses a number of key elements in cellular signal transduction pathways pertinent to growth, differentiation, and malignant transformation; it was demonstrated _in vitro_ that curcumin inhibits protein kinases, c-Jun/AP-1 activation, prostaglandin biosynthesis, and the activity and expression of the enzyme cyclooxygenase (COX)-2 [F114].\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [15713005], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"BJBCSGQLZQGGIQ-QGZVFWFLSA-N\", \"cofactor_smiles\": \"CC(=O)NCCOC(=O)[C@H](OC1=CC=CC(=C1)C(F)(F)F)C1=CC=C(Cl)C=C1\", \"cofactor_name\": \"Arhalofenate\", \"cofactor_resource_id\": \"DB11811\", \"mechanism_of_action\": \"Partial agonist of peroxisome proliferator-activated receptor (PPAR) gamma; results in improved glucose, lipid, and weight management.\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [17519293, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"JCYNMRJCUYVDBC-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CN1C(COC2=CC=C(CC3SC(=O)NC3=O)C=C2)=NC2=CC=C(OC3=CC(C)=C(N)C(C)=C3)C=C12\", \"cofactor_name\": \"Efatutazone\", \"cofactor_resource_id\": \"DB11894\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"ZOBPZXTWZATXDG-UHFFFAOYSA-N\", \"cofactor_smiles\": \"O=C1CSC(=O)N1\", \"cofactor_chem_comp_id\": \"OD3\", \"cofactor_name\": \"2,4-thiazolidinedione\", \"cofactor_resource_id\": \"DB11898\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"GOMNOOKGLZYEJT-UHFFFAOYSA-N\", \"cofactor_smiles\": \"O=C1C(=COC2=CC=CC=C12)C1=CC=CC=C1\", \"cofactor_name\": \"Isoflavone\", \"cofactor_resource_id\": \"DB12007\", \"mechanism_of_action\": \"Isoflavones are selective estrogen receptor modulators that exert estrogenic-like effects under certain experimental conditions [A33098], as they are structurally similar to mammalian 17\\u03b2-estradiol. They may bind to both \\u03b1 and \\u03b2 isoforms of estrogen receptor (ER), but with binding affinities to ER\\u03b2 approximately 20 times higher than that to ER\\u03b1 [A33099]. The role of isoflavones on estrogen-dependent cancer has been studied, since they may mediate antiestrogenic actions by blocking the binding of endogenous estrogens and their receptor signalling [A33100]. In cell culture, [DB01645] inhibited the proliferation of MDA-MB-231 human breast cancer cells, probably by arresting the cell cycle progression at the G2\\u2013M transition [A33100]. In addition, genistein was shown to induce apoptosis, modify eicosanoid metabolism, and inhibit angiogenesis [A33100]. There is an evidence that soy isoflavones may act on androgen receptors to inhibit tyrosine kinase activity, thereby blocking the growth and proliferation of cancer cells [A33100]. \\r\\n\\r\\nIsoflavones may not significantly contribute to the hypolipidemic effects of soy protein, but may exert coronary benefits by improving endothelial function; in clinical trials of postmenopausal women, isoflavones improved flow-mediated dilation in women with impaired endothelial function [A33098]. Some observational data suggests that isoflavones improve endothelial function by increasing the number of circulating endothelial progenitor cells, which replace damaged endothelial cells [A33098]. Isoflavone may modulate the key transcription factors involved in the regulation of lipid metabolism by acting on the peroxisome proliferator-activated receptors (PPAR) alpha and gamma, which are receptors that regulate the transcription of genes involved in lipid and glucose homeostasis and lipid metabolism [A33100]. Multiple biological actions of isoflavones, such as favorable effect on the blood lipid profile and inhibition of LDL cholesterol oxidation, may lead to cardio protective effects [A33100]. \\r\\n\\r\\n[DB01645] has been shown to have antioxidant properties on hydrogen peroxide production _in vitro_ and blocks the formation of oxygen free radicals [A33100]. Studies also suggest that at micromolar concentrations, genistein increases glucose-stimulated insulin secretion in cell lines and mouse pancreatic islets via a cAMP-dependent protein kinase mechanism [A33100]. Based on the findings of experimental studies, genistein may exert a positive effect on bone formation by decreasing osteoclastic resorption factor, such as collagen C-telopeptide, and increasing osteoblastic formation markers, such as bone-alkaline phosphatase [A33100]. _In vitro_, it antagonized the catabolic effects of parathyroid hormone (PTH) in osteoblasts by reversing the PTH-induced increase in soluble receptor activator of nuclear factor-xB ligand and decrease in osteoprotegerin expression [A33100].\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [12730403], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"NHFDRBXTEDBWCZ-ZROIWOOFSA-N\", \"cofactor_smiles\": \"CC1=C(CCC(O)=O)C(C)=C(N1)\\\\C=C1/C(=O)NC2=CC=CC=C12\", \"cofactor_chem_comp_id\": \"SU6\", \"cofactor_name\": \"Orantinib\", \"cofactor_resource_id\": \"DB12072\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"ULVDFHLHKNJICZ-QCWLDUFUSA-N\", \"cofactor_smiles\": \"CC1=C(COC2=CC=C(CO\\\\N=C(/CCC(O)=O)C3=CC=CC=C3)C=C2)N=C(O1)C1=CC=CC=C1\", \"cofactor_name\": \"Imiglitazar\", \"cofactor_resource_id\": \"DB12511\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"UYGZODVVDUIDDQ-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCCCCS(=O)(=O)NC(=O)C1=CC=C2N=C(C)N(CC3=CC=C(Cl)C=C3Cl)C2=C1\", \"cofactor_name\": \"FK-614\", \"cofactor_resource_id\": \"DB12557\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"OKJHGOPITGTTIM-DEOSSOPVSA-N\", \"cofactor_smiles\": \"CO[C@@H](CC1=CC=C(OCCCOC2=CC=C(OC3=CC=CC=C3)C=C2)C=C1)C(O)=O\", \"cofactor_name\": \"Naveglitazar\", \"cofactor_resource_id\": \"DB12662\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"IETKPTYAGKZLKY-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CN1C(COC2=CC=C(CC3SC(=O)NC3=O)C=C2)=NC2=CC=CC=C2C1=O\", \"cofactor_name\": \"Balaglitazone\", \"cofactor_resource_id\": \"DB12781\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"MQOBSOSZFYZQOK-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O\", \"cofactor_chem_comp_id\": \"F5A\", \"cofactor_name\": \"Fenofibric acid\", \"cofactor_resource_id\": \"DB13873\", \"mechanism_of_action\": \"Having performed clinical studies with in vivo transgenic mice and in vitro human hepatocyte cultures, it is believed that the principal mechanism of action of fenofibric acid is demonstrated through its capability to activate peroxisome proliferator receptor alpha (PPAR-alpha) [FDA Label].\\r\\n\\r\\nBy activating PPAR-alpha, fenofibric acid increases lipolysis and the elimination of triglyceride-rich particles from plasma by actuating lipoprotein lipase and reducing production of apoprotein C-III, which acts as an inhibitor of lipoprotein lipase activity [FDA Label]. The resultant decrease in triglycerides causes an alteration in the size and composition of low-density-lipoprotein from small, dense particles to large, buoyant ones [FDA Label]. The size of these larger low-density-lipoprotein particles have a greater affinity for cholesterol receptors and are therefore catabolized more rapidly [FDA Label]. Additionally, fenofibric acid's activation of PPAR-alpha also induces an increase in the synthesis of apoproteins apo A-I, apo A-II, and high-density-lipoprotein [FDA Label].\\r\\n\\r\\nMoreover, the use of fenofibric acid can also act to reduce serum uric acid levels in ordinary or hyperuricemic individuals by increasing the urinary excretion of uric acid [FDA Label].\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [11779144], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_name\": \"Fish oil\", \"cofactor_resource_id\": \"DB13961\", \"mechanism_of_action\": \"The specific mechanism of action by which the fish oil EPA and DHA acids are capable of reducing serum triglyceride levels is not yet fully understood [FDA Label, A32933]. Nevertheless, it is proposed that such omega-3-fatty acids may not be the preferred substrates of the enzyme diacylglycerol O-acyltransferase that participates in the generation of triglycerides; that  they might interact with nuclear transcription factors that manage lipogenesis; or that their presence and increase in levels can cause cellular metabolism to subsequently shift toward a decrease in triglyceride synthesis and an increase in fatty acid oxidation [A32933]. Moreover, the EPA and DHA acids are also believed to be able to promote apolipoprotein B degradation in the liver through the stimulation of an autophagic process [A32933]. It may also be possible that these fish oil acids can accelerate the clearance of very-low-density lipoprotein (VLDL) particles and chylomicron [A32933]. The combination of all these actions results in fewer VLDL particles being assembled and secreted, which is of considerable importance as VLDL particles are the major endogenous source of triglycerides [A32933].\\r\\n\\r\\nMoreover, new paradigms of how inflammation is contained and dissipated involve various newly discovered chemical mediators, resolvins, and protectins [A32933]. Such agents are believed to be directly involved in blocking neutrophil migration, infiltration, recruitment, as well as blocking T-cell migration and promoting T-cell apoptosis [A32933]. Additionally, such protectins can also reduce tumor necrosis factor and interferon secretion [A32933]. Of particular importance, however, is the fact that protectins and resolvins are exclusively derived from omega-3-fatty acids and that EPA is the substrate of the resolvins family and DHA can be converted to both resolvins and protectins [A32933]. It is believed that these effects of such fish oil acids underlie the actions that fish oil have demonstrated on eliciting stability for vulnerable inflammatory plaques [A32933].\\r\\n\\r\\nFinally, fish oil acids have demonstrated certain direct electrophysiological effects on the myocardium [A32933]. In animal studies, it was shown that the ventricular fibrillation threshold could be increased in both animals fed or infused with omega-3-fatty acids [A32933]. Further studies subsequently revealed that such fatty acids could reduce both sodium currents and L-type calcium currents on a cellular and ion channel level [A32933]. It is consequently hypothesized that during ischemia, a reduction in the sodium ion current protects hyperexcitable tissue, and a reduction in the calcium ion current could reduce arrhythmogenic depolarizing currents - and that perhaps the use of EPA and DHA fish oil acids could facilitate such activity [A32933]. For the time being, however, omega-3-fatty acids in pharmaceutical supplement form have not been shown to elicit such protection against heart conditions [L2662].\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [28760435], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_name\": \"Medical Cannabis\", \"cofactor_resource_id\": \"DB14009\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [26264914], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"SSNHGLKFJISNTR-DYSNNVSPSA-N\", \"cofactor_smiles\": \"[H][C@]1(CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1O)C(C)=C.[H][C@@]12CCC(C)=C[C@@]1([H])C1=C(O)C=C(CCCCC)C=C1OC2(C)C\", \"cofactor_name\": \"Nabiximols\", \"cofactor_resource_id\": \"DB14011\", \"mechanism_of_action\": \"The primary psychoactive component of Cannabis, delta 9-tetrahydrocannabinol (\\u03949-THC), demonstrates its effects through weak partial agonist activity at Cannabinoid-1 (CB1R) and Cannabinoid-2 (CB2R) receptors. This activity results in the well-known effects of smoking cannabis such as increased appetite, reduced pain, and changes in emotional and cognitive processes. In contrast to THC's weak agonist activity, CBD has been shown to act as a negative allosteric modulator of the cannabinoid CB1 receptor, the most abundant G-Protein Coupled Receptor (GPCR) in the body [A32469]. Allosteric regulation is achieved through the modulation of receptor activity on a functionally distinct site from the agonist or antagonist binding site. The negative allosteric modulatory effects of CBD are therapeutically important as direct agonists are limited by their psychomimetic effects while direct antagonists are limited by their depressant effects [A32469]. \\r\\n\\r\\nThere is further evidence that CBD also activates 5-HT1A serotonergic and TRPV1\\u20132 vanilloid receptors, antagonizes alpha-1 adrenergic and \\u00b5-opioid receptors, inhibits synaptosomal uptake of noradrenaline, dopamine, serotonin and gaminobutyric acid and cellular uptake of anandamide, acts on mitochondria Ca2 stores, blocks low-voltage-activated (T-type) Ca2 channels, stimulates activity of the inhibitory glycine-receptor, and inhibits activity of fatty amide hydrolase (FAAH) [A31555, A31574].\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [26264914], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"QQKNSPHAFATFNQ-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=C(CCC(=O)C2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C(O1)C1=CC=CC=C1\", \"cofactor_name\": \"Darglitazone\", \"cofactor_resource_id\": \"DB14034\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [1588563, 37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"MVDXXGIBARMXSA-PYUWXLGESA-N\", \"cofactor_smiles\": \"O=C1NC(=O)C(CC2=CC=C3O[C@@H](CC4=CC=CC=C4)CCC3=C2)S1\", \"cofactor_name\": \"Englitazone\", \"cofactor_resource_id\": \"DB14035\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"NEJVQQBBTRFOHB-FCXRPNKRSA-N\", \"cofactor_smiles\": \"COC1=CC(\\\\C=C\\\\C(=O)CC(=O)\\\\C=C\\\\C2=CC=C(OS(O)(=O)=O)C(OC)=C2)=CC=C1O\", \"cofactor_name\": \"Curcumin sulfate\", \"cofactor_resource_id\": \"DB14635\", \"mechanism_of_action\": \"Curcumin acts as a scavenger of oxygen species, such as hydroxyl radical, superoxide anion, and singlet oxygen and inhibit lipid peroxidation as well as peroxide-induced DNA damage [L34044]. Curcumin mediates potent anti-inflammatory agent and anti-carcinogenic actions via modulating various signalling molecules. It suppresses a number of key elements in cellular signal transduction pathways pertinent to growth, differentiation, and malignant transformation; it was demonstrated _in vitro_ that curcumin inhibits protein kinases, c-Jun/AP-1 activation, prostaglandin biosynthesis, and the activity and expression of the enzyme cyclooxygenase (COX)-2 [L34044].\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [15713005], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"OQDQIFQRNZIEEJ-UHFFFAOYSA-N\", \"cofactor_smiles\": \"OC(=O)CCCC1=CC2=C(C=CC(Cl)=C2)N1S(=O)(=O)C1=CC2=C(C=C1)N=CS2\", \"cofactor_chem_comp_id\": \"BJB\", \"cofactor_name\": \"Lanifibranor\", \"cofactor_resource_id\": \"DB14801\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"OXVFDZYQLGRLCD-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC(O)C1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1\", \"cofactor_name\": \"Leriglitazone\", \"cofactor_resource_id\": \"DB15021\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"QLJYLJGYIDIJPT-VIFPVBQESA-N\", \"cofactor_smiles\": \"CO[C@@H](CC1=CC=C(N)C=C1)C(O)=O\", \"cofactor_name\": \"GED-0507-34-Levo\", \"cofactor_resource_id\": \"DB16109\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"ZUGQWAYOWCBWGM-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CC1=C(CSC2=CC=C(OC(C)(C)C(O)=O)C(C)=C2)SC(=N1)C1=CC=C(C=C1F)C(F)(F)F\", \"cofactor_name\": \"Sodelglitazar\", \"cofactor_resource_id\": \"DB16332\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"QNLWMPLUWMWDMQ-YTTGMZPUSA-N\", \"cofactor_smiles\": \"OC(=O)[C@H](CC1=CC=C(OCCN2C3=C(C=CC=C3)C3=C2C=CC=C3)C=C1)NC1=CC=CC=C1C(=O)C1=CC=C(F)C=C1\", \"cofactor_name\": \"Chiglitazar\", \"cofactor_resource_id\": \"DB19023\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"ZZCHHVUQYRMYLW-HKBQPEDESA-N\", \"cofactor_smiles\": \"CC1=C(CCOC2=CC=C(C[C@H](NC3=CC=CC=C3C(=O)C3=CC=CC=C3)C(O)=O)C=C2)N=C(O1)C1=CC=CC=C1\", \"cofactor_chem_comp_id\": \"570\", \"cofactor_name\": \"Farglitazar\", \"cofactor_resource_id\": \"DB19311\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"cofactor_in_ch_ikey\": \"SRFCAWATPLCLMG-UHFFFAOYSA-N\", \"cofactor_smiles\": \"CCOC1=NN(CC2=CC=C(OCC3=CSC(=N3)C3=CC=CC=C3)C=C2)C=C1CCC(O)=O\", \"cofactor_name\": \"Sipoglitazar\", \"cofactor_resource_id\": \"DB19312\", \"neighbor_flag\": \"N\", \"pubmed_ids\": [37713619], \"resource_name\": \"DrugBank\", \"resource_version\": \"5.1\", \"target_resource_id\": \"P37231\"}, {\"binding_assay_value\": 10.3, \"binding_assay_value_type\": \"pKi\", \"cofactor_smiles\": \"CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1\", \"cofactor_chem_comp_id\": \"EDK\", \"cofactor_resource_id\": \"CHEMBL434063\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [28799755], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 9.7, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"C/C(=C/C(=O)c1ccccc1)N[C@@H](Cc1ccc(OCCc2nc(-c3ccccc3)oc2C)cc1)C(=O)O\", \"cofactor_chem_comp_id\": \"544\", \"cofactor_resource_id\": \"CHEMBL410478\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [15293980], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 9.7, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"Cc1c(C)n(Cc2ccc(Cl)c(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12\", \"cofactor_chem_comp_id\": \"A8R\", \"cofactor_resource_id\": \"CHEMBL3678128\", \"neighbor_flag\": \"Y\", \"patent_nos\": [\"US9051265\"], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 9.47, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"Cc1oc(-c2ccccc2)nc1CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1\", \"cofactor_chem_comp_id\": \"570\", \"cofactor_resource_id\": \"CHEMBL107367\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [10691680], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 9.42, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"CC[C@@H](OC(=O)N(Cc1ccccc1)C(=O)Nc1cc(OC)cc(OC)c1)c1cc(-c2ccc(OC(C)(C)C(=O)O)cc2)no1\", \"cofactor_chem_comp_id\": \"Q35\", \"cofactor_resource_id\": \"CHEMBL3585575\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [25734377], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 9.11, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"O=S(=O)(Nc1cc(-c2cccs2)nn1-c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1\", \"cofactor_chem_comp_id\": \"SP3\", \"cofactor_resource_id\": \"CHEMBL208472\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [16640330], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 9.03, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"CCc1cc(F)c2ccccc2c1CNC(=O)c1c(OC)cc(O)c2c1OC1=CC(O)=C(C(C)=O)C(=O)[C@]12C\", \"cofactor_chem_comp_id\": \"FCM\", \"cofactor_resource_id\": \"CHEMBL2042814\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [22727448], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 9.0, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"COc1ccc(C(=O)n2c(C)c(Cc3cccc(O[C@@H](C)C(=O)O)c3)c3cc(OC(F)(F)F)ccc32)cc1\", \"cofactor_chem_comp_id\": \"241\", \"cofactor_resource_id\": \"CHEMBL179330\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [15603954], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 8.7, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"COc1ccc(C(=O)n2c(C)c(Cc3ccccc3O[C@@H](C)C(=O)O)c3cc(OC(F)(F)F)ccc32)cc1\", \"cofactor_chem_comp_id\": \"240\", \"cofactor_resource_id\": \"CHEMBL181937\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [15603954], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 8.7, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H](C)c3ccc([N+](=O)[O-])cc3)cc12\", \"cofactor_chem_comp_id\": \"3K2\", \"cofactor_resource_id\": \"CHEMBL3695811\", \"neighbor_flag\": \"Y\", \"patent_nos\": [\"US8957093\"], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 8.7, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"O=C(Nc1ccccc1)c1cc([N+](=O)[O-])ccc1Cl\", \"cofactor_chem_comp_id\": \"GW9\", \"cofactor_resource_id\": \"CHEMBL375270\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [31294974], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 8.62, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"CCCc1nc2c(C)cccc2n1Cc1ccc2c(c1)COc1ccccc1/C2=C(\\\\\\\\C)c1noc(=O)[nH]1\", \"cofactor_chem_comp_id\": \"KK4\", \"cofactor_resource_id\": \"CHEMBL4278109\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [30351933], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 8.54, \"binding_assay_value_type\": \"pKd\", \"cofactor_smiles\": \"CCCOc1ccc(C[C@@H](Cc2ccccc2)C(=O)O)cc1CNC(=O)c1ccc(N2CCCCC2)cc1\", \"cofactor_chem_comp_id\": \"EK8\", \"cofactor_resource_id\": \"CHEMBL3317858\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [25017035], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 8.52, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"COc1ccc(-c2c(C(=O)NS(=O)(=O)c3ccccc3)n(Cc3cccc(C(F)(F)F)c3)c3ccccc23)cc1\", \"cofactor_chem_comp_id\": \"NSI\", \"cofactor_resource_id\": \"CHEMBL376627\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [16919947], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 8.52, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"Cc1oc(-c2ccccc2)nc1CCCc1ccc(C[C@@H](C(=O)O)n2nccn2)cc1\", \"cofactor_chem_comp_id\": \"UNT\", \"cofactor_resource_id\": \"CHEMBL594034\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [19783444], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 8.52, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"CC[C@H](NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1\", \"cofactor_chem_comp_id\": \"538\", \"cofactor_resource_id\": \"CHEMBL1230353\", \"neighbor_flag\": \"Y\", \"patent_nos\": [\"US8957093\"], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 8.43, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"CCc1ccc2ccccc2c1CNC(=O)c1c(OC)cc(O)c2c1OC1=CC(O)=C(C(C)=O)C(=O)[C@]12C\", \"cofactor_chem_comp_id\": \"KRC\", \"cofactor_resource_id\": \"CHEMBL2042803\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [22727448], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 8.4, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"Cc1oc(-c2ccccc2)nc1CCOc1cccc(Cc2nn(-c3ccccc3)nc2CC(=O)O)c1\", \"cofactor_chem_comp_id\": \"ZAA\", \"cofactor_resource_id\": \"CHEMBL491751\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [19201606], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 8.4, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"O=S(=O)(Nc1cc(Cl)c(Oc2cnc3ccccc3c2)c(Cl)c1)c1ccc(Cl)cc1Cl\", \"cofactor_chem_comp_id\": \"Z12\", \"cofactor_resource_id\": \"CHEMBL1236924\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [28485590], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 8.0, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"COc1ccc2c(-n3c(=O)n(Cc4cccc([C@@]5(C)OC(=O)NC5=O)c4)c4ccccc43)noc2c1\", \"cofactor_chem_comp_id\": \"082\", \"cofactor_resource_id\": \"CHEMBL1947144\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [22070604], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 7.89, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"CCO[C@@H](Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)O\", \"cofactor_chem_comp_id\": \"AZ2\", \"cofactor_resource_id\": \"CHEMBL282686\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [18805005], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 7.72, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"CO[C@@H](Cc1ccc(OCCc2nc(-c3ccccc3)oc2C)c2ccsc12)C(=O)O\", \"cofactor_chem_comp_id\": \"RO7\", \"cofactor_resource_id\": \"CHEMBL519504\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [19349176], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 7.72, \"binding_assay_value_type\": \"pKd\", \"cofactor_smiles\": \"COc1cc(CCc2ccccc2)c(C(=O)O)c(O)c1C/C=C(\\\\\\\\C)CCC=C(C)C\", \"cofactor_chem_comp_id\": \"YFB\", \"cofactor_resource_id\": \"CHEMBL2337127\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [23286787], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 7.58, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"O=C(O)c1c(Sc2ccccc2)c2cc(Cl)ccc2n1Cc1ccc(Cl)cc1\", \"cofactor_chem_comp_id\": \"NZA\", \"cofactor_resource_id\": \"CHEMBL370152\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [16153845], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 7.52, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"CN(CCOc1ccc(C[C@@H]2SC(=O)NC2=O)cc1)c1ccccn1\", \"cofactor_chem_comp_id\": \"BRL\", \"cofactor_resource_id\": \"CHEMBL121106\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [9934490], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 7.46, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"CCCOc1ccc(C[C@@H](Cc2ccccc2)C(=O)O)cc1CNC(=O)c1ccc(-c2ncccn2)cc1\", \"cofactor_chem_comp_id\": \"EK1\", \"cofactor_resource_id\": \"CHEMBL2377530\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [23490155], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 7.4, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"CC[C@@H](NC(=O)c1ccc2c(c1)nc(C)n2Cc1ccc(Cl)c(Cl)c1)c1ccccc1\", \"cofactor_chem_comp_id\": \"M0T\", \"cofactor_resource_id\": \"CHEMBL1825106\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [21798739], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 7.39, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"Cc1cnc(Oc2ccc3nc(COc4cccc(C(=O)O)c4)n(C)c3c2)c(C)c1\", \"cofactor_chem_comp_id\": \"RTF\", \"cofactor_resource_id\": \"CHEMBL4164423\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [30220602], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 7.35, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"CCCCC/C=C(\\\\\\\\C/C=C\\\\\\\\CCCCCCCC(=O)O)[N+](=O)[O-]\", \"cofactor_chem_comp_id\": \"LNB\", \"cofactor_resource_id\": \"CHEMBL554608\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [19719236], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 7.32, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"CCCCCCCN(CCc1ccc(O[C@](C)(CC)C(=O)O)cc1)c1nc2ccccc2o1\", \"cofactor_chem_comp_id\": \"DRJ\", \"cofactor_resource_id\": \"CHEMBL479207\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [17403688], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 7.3, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"CCCc1c(OCCCOc2ccc3c(ccn3CC(=O)O)c2)ccc2cc(C(=O)c3ccccc3)ccc12\", \"cofactor_chem_comp_id\": \"EHA\", \"cofactor_resource_id\": \"CHEMBL201880\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [16451087], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 7.3, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"CCCc1cc(C(=O)c2ccc(-c3ccccc3)cc2)ccc1OCCCN1CCCc2c(OC(C)(C)C(=O)O)cccc21\", \"cofactor_chem_comp_id\": \"2PQ\", \"cofactor_resource_id\": \"CHEMBL508163\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [19301897], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 7.17, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"COc1cc(O)c2c(c1C(=O)NCc1cc(CCCC(=O)O)cc3ccccc13)OC1=CC(O)=C(C(C)=O)C(=O)[C@]12C\", \"cofactor_chem_comp_id\": \"24L\", \"cofactor_resource_id\": \"CHEMBL1945221\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [22225641], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 7.17, \"binding_assay_value_type\": \"pEC50\", \"cofactor_smiles\": \"Cn1c(COc2cccc(C(=O)O)c2)nc2ccc(Oc3ccc(Cl)c(F)c3)cc21\", \"cofactor_chem_comp_id\": \"RTE\", \"cofactor_resource_id\": \"CHEMBL4164753\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [30220602], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 7.1, \"binding_assay_value_type\": \"pIC50\", \"cofactor_smiles\": \"Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc([N+](=O)[O-])cc3)cc12\", \"cofactor_chem_comp_id\": \"3JX\", \"cofactor_resource_id\": \"CHEMBL3348830\", \"neighbor_flag\": \"Y\", \"patent_nos\": [\"US8957093\"], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}, {\"binding_assay_value\": 7.05, \"binding_assay_value_type\": \"pKi\", \"cofactor_smiles\": \"CCO[C@@H](Cc1ccc(OCCN2c3ccccc3Oc3ccccc32)cc1)C(=O)O\", \"cofactor_chem_comp_id\": \"DRF\", \"cofactor_resource_id\": \"CHEMBL24038\", \"neighbor_flag\": \"Y\", \"pubmed_ids\": [15293980], \"resource_name\": \"Pharos\", \"resource_version\": \"6.13.4\", \"target_resource_id\": \"19023\"}], \"rcsb_id\": \"2G0H_1\"}}, \"interface_chains\": {\"chain1\": \"nan\", \"chain2\": \"nan\", \"assembly_chain1\": \"A\", \"assembly_chain2\": \"B\"}, \"enrichment_timestamp\": \"2026-01-03T13:49:56.915600\"}",
        "valueReference": {
          "@type": "PropertyValue",
          "name": "ParsedPDBMetadata",
          "value": {
            "resolution": 2.3,
            "experimentalMethod": null,
            "depositionDate": "2006-02-13T00:00:00+0000",
            "releaseDate": "2006-05-16T00:00:00+0000",
            "sourceOrganism": [
              "Homo sapiens"
            ],
            "spaceGroup": null,
            "rFactor": null,
            "entityCount": 3,
            "chainCount": 2,
            "uniqueSequences": 1,
            "isHomomer": true,
            "homomerType": "monomer",
            "taxonomyIds": [
              9606
            ],
            "primaryTaxonomyId": 9606
          }
        }
      },
      {
        "@type": "PropertyValue",
        "name": "PDBMetadataStatus",
        "value": "Complete metadata available",
        "description": "This PDB entry is current and all metadata has been fetched successfully"
      },
      {
        "@type": "PropertyValue",
        "name": "Resolution",
        "value": 2.3,
        "unitCode": "",
        "description": "X-ray crystallography resolution"
      },
      {
        "@type": "PropertyValue",
        "name": "SourceOrganism",
        "value": "Homo sapiens",
        "description": "Homo sapiens (taxonomy ID: 9606)",
        "taxonomyId": 9606,
        "taxonomyUrl": "https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=9606"
      },
      {
        "@type": "PropertyValue",
        "name": "HomomericStructure",
        "value": true,
        "description": "This is a homomeric monomer"
      },
      {
        "@type": "PropertyValue",
        "name": "HomomerType",
        "value": "monomer",
        "description": "Type of homomeric assembly"
      },
      {
        "@type": "PropertyValue",
        "name": "ChainCount",
        "value": 2,
        "description": "Number of chains in the structure (from RCSB API)"
      },
      {
        "@type": "PropertyValue",
        "name": "UniqueSequenceCount",
        "value": 1,
        "description": "Number of unique amino acid sequences (from RCSB API)"
      },
      {
        "@type": "PropertyValue",
        "name": "Chain_A_Sequence",
        "value": "ESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY",
        "description": "Amino acid sequence for chain A (length: 271) from RCSB API",
        "chainId": "A",
        "entityId": "1",
        "sequenceLength": 271,
        "sequenceSource": "RCSB API",
        "sourceUrl": "https://www.rcsb.org/structure/2G0H"
      },
      {
        "@type": "PropertyValue",
        "name": "Chain_B_Sequence",
        "value": "ESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY",
        "description": "Amino acid sequence for chain B (length: 271) from RCSB API",
        "chainId": "B",
        "entityId": "1",
        "sequenceLength": 271,
        "sequenceSource": "RCSB API",
        "sourceUrl": "https://www.rcsb.org/structure/2G0H"
      },
      {
        "@type": "PropertyValue",
        "name": "PrimaryCitation",
        "value": "Structure-Based Drug Design of a Novel Family of PPARgamma Partial Agonists: Virtual Screening, X-ray Crystallography, and in Vitro/in Vivo Biological Activities",
        "description": "Primary publication for this structure"
      },
      {
        "@type": "PropertyValue",
        "name": "PublicationDOI",
        "value": "10.1021/jm051129s",
        "description": "DOI of the primary publication"
      },
      {
        "@type": "PropertyValue",
        "name": "Entity_1",
        "value": "Chains: A, B, Length: 271",
        "description": "Entity 1 information",
        "organism": "Homo sapiens",
        "taxonomyId": 9606,
        "taxonomyUrl": "https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=9606"
      },
      {
        "@type": "PropertyValue",
        "name": "NCBI_Taxonomy_ID",
        "value": "9606",
        "description": "NCBI Taxonomy ID for Homo sapiens",
        "url": "https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=9606"
      },
      {
        "@type": "PropertyValue",
        "name": "ClusterID",
        "value": "2G0H_1",
        "description": "Sequence cluster ID from BLASTClust analysis"
      },
      {
        "@type": "PropertyValue",
        "name": "ClusterSize",
        "value": 8,
        "description": "Number of interfaces in this cluster"
      },
      {
        "@type": "PropertyValue",
        "name": "ClusterMembers",
        "value": [
          "4OAR_3",
          "4RE8_3",
          "4FN9_1",
          "3P0U_1",
          "3CJW_1",
          "1S9P_1",
          "1S9P_5"
        ],
        "description": "List of other interfaces in the same cluster (excluding current interface)"
      },
      {
        "@type": "PropertyValue",
        "name": "ClusterMethod",
        "value": "BLASTClust sequence clustering",
        "description": "Method used for sequence-based clustering"
      },
      {
        "@type": "PropertyValue",
        "name": "ClusterMethodOptions",
        "value": "-S 25 -L 0.5 -b F",
        "description": "BLASTClust parameters used for sequence clustering"
      }
    ],
    "hasMolecularFunction": {
      "@type": "DefinedTerm",
      "name": "protein binding",
      "inDefinedTermSet": "http://purl.obolibrary.org/obo/GO_0005515"
    },
    "bioChemInteraction": {
      "@type": "Protein",
      "name": "Homodimer partner for interface 2G0H_1",
      "description": "Homodimer interaction partner in chain nan"
    }
  },
  "additionalProperty": [
    {
      "@type": "PropertyValue",
      "name": "InterfaceSource",
      "value": "QSalign",
      "description": "Source of interface ID: QSalign"
    },
    {
      "@type": "PropertyValue",
      "name": "physio",
      "value": false,
      "description": "Physiological (TRUE) or non-physiological (FALSE)"
    },
    {
      "@type": "PropertyValue",
      "name": "label",
      "value": 0,
      "description": "Numeric label (1=physio, 0=non-physio)"
    },
    {
      "@type": "PropertyValue",
      "name": "PDB_ID",
      "value": "2G0H",
      "description": "Protein Data Bank identifier"
    },
    {
      "@type": "PropertyValue",
      "name": "AuthChain1",
      "value": "nan",
      "description": "First chain in interface"
    },
    {
      "@type": "PropertyValue",
      "name": "AuthChain2",
      "value": "nan",
      "description": "Second chain in interface"
    },
    {
      "@type": "PropertyValue",
      "name": "AuthChain1",
      "value": "nan",
      "description": "First chain in the interface (may be updated from assembly)"
    },
    {
      "@type": "PropertyValue",
      "name": "AuthChain2",
      "value": "nan",
      "description": "Second chain in the interface (may be updated from assembly)"
    },
    {
      "@type": "PropertyValue",
      "name": "SymmetryOp1",
      "value": "nan",
      "description": "Symmetry operation for chain 1"
    },
    {
      "@type": "PropertyValue",
      "name": "SymmetryOp2",
      "value": "nan",
      "description": "Symmetry operation for chain 2"
    },
    {
      "@type": "PropertyValue",
      "name": "LabelChain1",
      "value": "A",
      "description": "First chain in the assembly interface"
    },
    {
      "@type": "PropertyValue",
      "name": "LabelChain2",
      "value": "B",
      "description": "Second chain in the assembly interface"
    },
    {
      "@type": "PropertyValue",
      "name": "Buried Surface Area (BSA)",
      "value": 1462.43,
      "unitCode": "",
      "description": "Total buried surface area at the interface"
    },
    {
      "@type": "PropertyValue",
      "name": "Atomic Contacts",
      "value": 45,
      "description": "Number of atomic contacts at the interface"
    },
    {
      "@type": "PropertyValue",
      "name": "Gene",
      "value": "PPARG",
      "description": "Gene name associated with the protein"
    },
    {
      "@type": "PropertyValue",
      "name": "Superfamily",
      "value": "1.10.565.10",
      "description": "Protein superfamily classification"
    },
    {
      "@type": "PropertyValue",
      "name": "Pfam",
      "value": "PF00104",
      "description": "Pfam domain classification"
    },
    {
      "@type": "PropertyValue",
      "name": "BSA Polar",
      "value": 571.250000000002,
      "unitCode": "",
      "description": "Polar component of buried surface area"
    },
    {
      "@type": "PropertyValue",
      "name": "BSA Apolar",
      "value": 891.17,
      "unitCode": "",
      "description": "Apolar component of buried surface area"
    },
    {
      "@type": "PropertyValue",
      "name": "Fraction Polar",
      "value": 0.39061698679595,
      "description": "Fraction of polar contacts at the interface"
    },
    {
      "@type": "PropertyValue",
      "name": "Fraction Apolar",
      "value": 0.609376175269927,
      "description": "Fraction of apolar contacts at the interface"
    },
    {
      "@type": "PropertyValue",
      "name": "ClusterID",
      "value": "2G0H_1",
      "description": "Sequence cluster ID from BLASTClust analysis"
    },
    {
      "@type": "PropertyValue",
      "name": "ClusterSize",
      "value": 8,
      "description": "Number of interfaces in this cluster"
    },
    {
      "@type": "PropertyValue",
      "name": "ClusterMembers",
      "value": [
        "4OAR_3",
        "4RE8_3",
        "4FN9_1",
        "3P0U_1",
        "3CJW_1",
        "1S9P_1",
        "1S9P_5"
      ],
      "description": "List of other interfaces in the same cluster (excluding current interface)"
    },
    {
      "@type": "PropertyValue",
      "name": "ClusterMethod",
      "value": "BLASTClust sequence clustering",
      "description": "Method used for sequence-based clustering"
    },
    {
      "@type": "PropertyValue",
      "name": "ClusterMethodOptions",
      "value": "-S 25 -L 0.5 -b F",
      "description": "BLASTClust parameters used for sequence clustering"
    }
  ]
}